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Pulmonary hypertension is a cause of significant morbidity and mortality in newborn
infants. Right ventricular function, or dysfunction, is an important consequence of
pulmonary hypertension and may be an important determinant of disease severity.
This work aimed to improve the assessment and management of infants with
pulmonary hypertension by:
1. identifying non-invasive measures of right ventricular function in infants
2. determining the mechanisms of right ventricular dysfunction
3. demonstrating the variability of the relationship between RV function and
PAP
Five echocardiographic measures were selected to assess RV function; tricuspid
valve Doppler inflow, right ventricular output (RVO), RV myocardial performance
index (RVMpi), pulse wave tissue Doppler imaging (PWTDI) and colour tissue
Doppler imaging (CTDI). Using a case-control design each measure was performed
in a control group of infants with normal cardiovascular function, and a PHT group
of infants with elevated pulmonary artery pressure. This design allowed assessment
of each measure, and provided normative data for those measures (RVmpi, PWTDI
and CWTDI) which had not previously been performed in infants.
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All measures were found to be technically feasible, and to provide some
quantification of haemodynamic performance. However, the load-dependence ofTV
Doppler and the global nature of RVmpi and RVO meant that these measures could
not be considered pure measures of RV myocardial function alone. By contrast,
Tissue Doppler imaging measures allowed separate assessment of systolic and
diastolic function. This study was an important first demonstration of the feasibility
and application of TD1 in an infant disease state. Future studies are indicated to
assess the load-dependence of TDI measures in infants, the repeatability of the
technique and use of TDI in other infant diseases with myocardial dysfunction.
The mechanisms of RV dysfunction in infants with PHT were investigated by
comparison of RV function data between control and PHT groups. Accepting the
limitations of the measures used, the results indicated the presence of impaired
systolic and early diastolic function in infants with PHT. This finding highlighted
the importance of diastolic dysfunction in the failing infant heart, and the usefulness
ofmeasures such as TDI which allow assessment of both systolic and diastolic
dysfunction. There are also potential therapeutic implications, and the theoretical
benefit of drugs with both inotropic and lusitropic actions in this setting was an
important area identified for future research.
Finally, no linear relationship was identified between RV function measures and
PAP in the PHT group. It was concluded that pulmonary artery pressure should not
be used as a proxy measure of RV function in infants and thus emphasised the
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1.1 Pulmonary hypertension in the newborn infant
Pulmonary hypertension is defined in this work as elevated pressure in the
pulmonary arterial system. Pulmonary hypertension is a common neonatal problem
occurring in approximately 1 in 1000 live births [1,2] and is a cause of significant
morbidity and mortality in the neonatal unit [3]. Pulmonary hypertension is
commoner in term than preterm infants [4],
Pulmonary vascular resistance, and hence pulmonary artery pressure, is elevated in
the fetus and falls rapidly after birth.Pulmonary hypertension present from birth is
therefore often referred to as "persistent pulmonary hypertension of the newborn"
(PPHN). However, the term PPHN is avoided in the remainder of this thesis as it
does not distinguish specific disease processes or pathophysiological mechanisms.
1.1.1 Aetiology of pulmonary hypertension
Pulmonary hypertension in newborn infants may be associated with underlying
pulmonary or cardiac disease, or may occur in isolation in which case it is termed
idiopathic pulmonary hypertension.
The underlying pathological mechanisms of elevated pulmonary artery pressure may
involve one or a combination of the following: failure of normal pulmonary
vasodilatation at birth, structural abnormalities of the pulmonary vascular bed,
obstructed or reduced pulmonary blood flow and excessive pulmonary blood flow.
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These mechanisms of pulmonary hypertension and the disease processes associated
with them are listed in Table 1.1, and discussed further below.
Table 1.1: Mechanisms of pulmonary hypertension in the newborn infant and
associated disease processes (modified from Ostrea et al (2|)
Persistent Pulmonary Vasoconstriction Perinatal asphyxia
Meconium aspiration syndrome
Neonatal respiratory distress syndrome
Sepsis/pneumonia including group B
streptococcal infection
Bronchopulmonary dysplasia









Obstructed left ventricular outflow (e.g.
aortic coarctation, aortic valve stenosis)
Excessive pulmonary blood flow Systemic-to-pulmonary shunts (e.g.
ventriculo-septal defect, patent ductus
arteriosus)
Systemic arterio-venous malformations
(e.g. vein of Galen malformation)
Obstructed / reduced pulmonary blood
flow
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1.1.1.1 Persistent pulmonary vasoconstriction
Before birth the pulmonary vasculature is constricted, PVR is high and only 8% of
total cardiac output passes through the pulmonary circulation. Under normal
circumstances PVR falls rapidly at birth as a consequence of lung inflation and
increasing oxygen levels. Failure of these transitional mechanisms at birth, leading
to persistent pulmonary vasoconstriction, may be due to a combination of three inter¬
related factors; hypoxia, impaired lung inflation and inflammation [5],
Hypoxia reduces production of the vasodilators nitric oxide and prostacyclin, reduces
smooth muscle sensitivity to nitric oxide and increases production of the
vasoconstrictor endothelin-1 [6]. Hypoxia may occur due to a global perinatal
hypoxic insult (perinatal asphyxia), or impaired gas exchange (as in meconium
aspiration, pneumonia, or respiratory distress syndrome) or more rarely cyanotic
heart disease.
Impaired lung inflation prevents the normal stretching and unkinking of pulmonary
blood vessels and shear-stress-triggered release of vasodilating cytokines NO and
prostacyclin [7, 8], Impaired lung inflation may contribute to PHT in meconium
aspiration and respiratory distress syndrome [7-9].
Inflammation associated with persistent pulmonary vasoconstriction at birth is seen
in conditions such as sepsis, pneumonia (especially group B streptococcal infection)
and meconium aspiration [7], Inflammatory cytokines produced in the lungs in these
conditions may act directly as pulmonary vasoconstrictors [6].
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1.1.1.2 Abnormal pulmonary vascular bed
Infants may be born with abnormal pulmonary vascular architecture leading to a
fixed elevation of PVR at birth. The abnormality may be limited to the pulmonary
blood vessels alone, as in the rare condition alveolar capillary dysplasia [10], or
associated with pulmonary hypoplasia as in oligohydramnios, thoracic dystrophy and
congenital diaphragmatic hernia (CDH) [4, 11]. In the case of CDH pulmonary
arteries have reduced cross-sectional areas, increased medial wall thickness and
abnormal muscularisation, all of which contribute to elevated PVR [12, 13].
1.1.1.3 Obstructed pulmonary blood flow
Obstructed pulmonary blood flow represents a relatively rare mechanism of
pulmonary hypertension in which the pulmonary arterial vessels may be of normal
structure and function, but as a consequence of distal obstruction to flow, high
pressure is generated proximally. This occurs in pulmonary venous obstruction (e.g.
total anomalous pulmonary venous drainage) and structural and functional
obstruction of the left heart (e.g. hypoplastic left heart, critical aortic stenosis, aortic
coarctation) [14, 15].
1.1.1.4 Excessive pulmonary blood How
Abnormally high flow through normal pulmonary vasculature may also be a cause of
pulmonary hypertension. High flow states may result from systemic-to-pulmonary
shunts as in PDA and ventricular-septal defect, or rarer arterio-venous fistulae such
as vein of Galen aneurysmal malformation (VGAM) [16],
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It is important to note that in an individual disease state the pathophysiology of
pulmonary hypertension may be multi-factorial. In congenital diaphragmatic hernia,
for example, elevated PVR results both from abnormal vessel architecture and from
hypoxia-induced pulmonary vasoconstriction [11, 17]. Furthermore, the underlying
mechanisms of pulmonary hypertension in a newborn infant are dynamic. Initial
pulmonary vasoconstriction, due to failure of smooth muscle relaxation, may be
followed by abnormal remodelling of the vessel architecture. Specifically, prolonged
hypoxia causes smooth muscle cells to change phenotype, altering the relative levels
of contractile proteins and switching myocytes from contractile elements to
proliferative cells. Microscopically, vessels demonstrate thickening of the vascular
media, hyperplasia and hypertrophy of smooth muscle and excess extracellular
matrix deposition. The result is increased vessel stiffness, reduced distensibility and
an irreversible increase in PVR [18, 19],
1.2 Cardiopulmonary consequences of pulmonary
hypertension
Increased pulmonary artery pressure has two major consequences for circulatory
function in the newborn: hypoxaemic right-to-left shunting and myocardial
dysfunction.
1.2.1 Right to left shunting
In infants with severe pulmonary hypertension, elevations in pulmonary arterial
pressure above systemic arterial pressure create a pressure gradient for blood flow
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across the patent ductus, from the main pulmonary artery to the proximal descending
aorta. The degree of ductal shunt will be directly related to pulmonary arterial and
systemic arterial pressure differences.
Low pulmonary flow, due to high pulmonary artery pressure, also leads to reduced
pulmonary venous return and low left atrial pressures. Meanwhile, right atrial
pressure is elevated due to increased afterload on the right heart. This pressure
gradient between atria causes right to left shunting through the patent foramen ovale
and mixing of venous and arterial blood in the left atria.
Right-to-left ductal and inter-atrial shunting in PHT mimics the fetal circulation and
led Gersony to use the term "persistent fetal circulation" in his first descriptions of
infants with pulmonary hypertension [20], The clinical consequence of these right-
to-left intra and extra-cardiac shunts is systemic hypoxaemia and the classical
presentation of a cyanosed infant without significant respiratory distress, as first
described by Chu et al [21],
1.2.2 Myocardial dysfunction
The second major feature of the circulation in pulmonary hypertension is myocardial
dysfunction. This was first reported by Rowe and Hoffman in 1972, in three infants
who presented with the classical features of pulmonary hypertension at birth;
cyanosis, tachypnoea and heart failure within the first 24 hours of life. These infants
had clinical evidence of congestive heart failure and poor ventricular function
demonstrated by ventricular angiography, together with ischaemic changes on
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electrocardiograms [22]. Reimenschneider et al in 1979 confirmed the finding of
myocardial dysfunction in newborn infants with pulmonary hypertension, reporting a
series of infants in whom cyanosis was accompanied by clinical evidence of
congestive heart failure and hypotension [23]. The concept ofmyocardial
dysfunction in infants with pulmonary hypertension is central to the studies in this
thesis, and is therefore expanded below.
1.3 Mechanisms ofmyocardial dysfunction in pulmonary
hypertension
To understand the mechanisms ofmyocardial dysfunction in pulmonary hypertension
it is useful to first consider the normal physiology and anatomy of the right ventricle.
1.3.1 Normal physiology and anatomy
RV function, at its most basic, may be divided into systolic and diastolic function.
Systolic function refers to ventricular contraction and ejection, whilst diastolic
function refers to ventricular relaxation and filling [24],
1.3.1.1 Systolic function
Systole consists of an initial isovolumic contraction phase, during which myocardial
contraction increases RV pressure without volume change, and is followed by a more
prolonged ejection phase during which ventricular volume reduces and blood is
ejected across the pulmonary valve. Systolic function is determined by the inherent
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contractile function of the myocardium, termed "contractility" or "inotropy", as well
as the loading conditions of the heart i.e. preload and afterload. The Frank-Starling
mechanism describes how as loading increases (leading to increased end-diastolic
pressure and volume) so the force of contraction (contractility), and resultant stroke
volume, will increase too. This gives rise to the relationship demonstrated in Figure
1.1.
Changes in inherent contractility will alter this relationship independently by shifting
the relationship up or down. At a cellular level both length-dependent and inotropy-
dependent mechanisms both alter contractile function by changing calcium handling
within the myocyte [25]. Techniques used in research and clinical practice often
cannot distinguish the relative contributions of loading and inotropy to systolic
function, and therefore in this thesis the term "contractility" is used to refer to
combined effects of these on contractile function. It is important to make the
distinction, however, that loading conditions may also directly affect the measures of
systolic function (independent of an effect on contractility) and that this must be
taken into account when interpreting such measures, as is discussed later.
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Figure 1.1: The Frank-Starling relationship; effects of loading and inotropic










Diastole is dependent on both myocardial relaxation and chamber stiffness, or
compliance, as well as atrial contraction, tricuspid valve function and heart rate.
Myocardial relaxation is an active process which involves myocardial inactivation
i.e. a reduction in contractile force due to uptake of calcium into the sarcoplasmic
reticulum of the myocytes [26], Chamber stiffness is determined by the passive
properties of the ventricular wall dependent on the cellular cytoskeleton, extracellular
matrix, wall thickness and chamber geometry [27],
Diastole consists of three distinct phases. 1) Isovolumic relaxation occurs first and is
characterised by a fall in ventricular pressure without a volume change, after closure
of the pulmonary valve and before tricuspid valve opening. The term isovolumic
relaxation is rather misleading as this phase involves changes in ventricular
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geometry which require synchronous contraction and relaxation of different
ventricular regions[26]. 2) Next is the early (E) filling phase, immediately after
tricuspid valve opening, which is dependent on the active myocardial relaxation and
passive properties of the ventricle as discussed above. 3) Finally in late diastole
atrial contraction occurs producing a final (A) phase of filling before systole.
1.3.2 Pathophysiology of myocardial failure in pulmonary
hypertension
Having briefly considered normal myocardial function, the mechanisms of
myocardial dysfunction in pulmonary hypertension are now discussed. For the
purpose of this work the term "myocardial dysfunction" refers to systolic and/or
diastolic dysfunction.
Changes in myocardial function in response to acute and chronic pulmonary
hypertension have been studied in a variety of models; principally adults and
animals. In acute pulmonary hypertension the first response of the RV to increased
afterload (pulmonary artery pressure) is an increase in systolic contractility. This has
been demonstrated using invasive catheter techniques to measure elastance, a "gold-
standard" measure of contractility, in newborn lambs with respiratory distress
syndrome and associated pulmonary hypertension, and in adult animal models of
acute pulmonary hypertension. [26-28],
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However, acute increases in afterload which cause excessive dilatation of the RV
will increase its volume beyond the maximal point on the Frank-Starling relationship
and lead to reductions in stroke work. Left ventricular function is also affected under
these circumstances by the process of inter-ventricular dependence. As the RV
dilates the interventricular septum is displaced, and the LV is compressed, impairing
LV filling and contraction. The result may be acute and fatal biventricular failure as
has been demonstrated in a canine model of pulmonary embolus where acute, severe
increase in afterload leads to cardiogenic shock. [28],
Chronic exposure to increased afterload leads to right ventricular hypertrophy, which
has been demonstrated to occur within 96 hours in animal models [29], The
hypertrophied RV becomes more concentric, thick-walled and less compliant. These
changes are partially adaptive and compensatory, and may initially improve function.
However, progressive hypertrophy may be a maladaptive process and detrimental to
cardiac function [30], In rat models of pulmonary hypertension Buermans et al have
demonstrated that increasing pulmonary artery pressure tips the balance of RV
function from compensated hypertrophy to progressive cardiac failure [31]. This
"pivotal divergence" from a compensated ventricle with preserved function to a
failing ventricle appears to involve the activation of pro-apoptotic gene pathways,
together with changes in myocardial energy metabolism and calcium signaling
contributing to impaired ventricular function [32], Animal models have identified
that it is RV diastolic function which is particularly affected in the failing ventricle,
demonstrated by increased RV stiffness and prolonged isovolumic relaxation times
[33, 34]. Hypertrophy and remodelling of the RV also impairs LV function as it
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continues to displace the interventricular septum. In addition, the enlarged RV has
increased metabolic demands which may not be met in a situation of ongoing
hypoxia, with resultant risk ofmyocardial ischaemia and worsening failure [33].
In summary, the term "myocardial failure" when applied to the setting of pulmonary
hypertension in animal models at least, refers to a combination of systolic and
diastolic dysfunction, secondary left ventricular dysfunction and myocardial
ischaemia.
Do the same mechanisms of cardiac failure occur in newborn infants with pulmonary
hypertension? Despite 35 years passing since the original reports of myocardial
dysfunction in infants with pulmonary hypertension, little is known about the
mechanisms of RV failure in infants other than can be extrapolated from animal and
adult data. No studies have yet investigated whether RV failure in newborn infants,
or an age-appropriate animal model, involves both systolic and/or diastolic
dysfunction. These are potentially important areas to investigate as they may help
clinicians choose better, more targeted therapies.
1.3.3 The spectrum of myocardial dysfunction and contributing
factors
Not every ventricle demonstrates the same response to elevated pulmonary artery
pressure. The variable ability of the right ventricle to function, or fail, in the face of
high afterload was first recognised in the earliest report of myocardial failure in
PPHN by Riemenschneider et al. Thirteen infants were reported who had severe
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central cyanosis, but only ten of these had congestive heart failure and hypotension.
It was reasoned that there existed a "spectrum" of myocardial dysfunction in the face
of increased afterload [23]. This also highlights the fact that disease severity in
pulmonary hypertension is determined by the degree ofmyocardial function or
dysfunction, and not the absolute pulmonary pressure. Infants with the same
absolute level of pulmonary hypertension may be profoundly unwell or entirely
asymptomatic [34, 35]. This peculiarity is well recognised by clinicians experienced
in treating infants with pulmonary hypertension, yet has been little reported in the
literature.
Variability in RV function has two major implications for the assessment and
management of infants with pulmonary hypertension:
1. Measurement of pulmonary artery pressure alone does not allow prediction of
the degree of RV function or dysfunction in pulmonary artery pressure
2. Direct measurement or RV function in pulmonary hypertension provides an
assessment of severity of illness
The variable response of the RV to increased afterload is a central concept in this
thesis and underlies the importance of direct assessment of RV function in
pulmonary hypertension.
What are the reasons for the variability of RV function in the face of increased PVR?
Chapter 1 . 32
RV function in a sick infant may be determined by many variable factors. Increased
afterload, i.e. raised pulmonary artery pressure, will undoubtedly be an important
determinant of function, other factors however are also important in determining RV
function, as shown in Figure 1.2 and discussed below. Specifically, these include
mechanical factors which may influence afterload and preload, metabolic factors and
morphology and molecular characteristics of the heart itself.
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1.3.3.1 Preload and ventricular function
Preload, or venous return to the heart, is one of the most important determinants of
ventricular function, via the Frank-Starling Mechanism. Alterations in preload may
produce variable RV function despite a constant afterload. Preload is itself
dependent on intravascular volume and on venous and arterial vascular tone. Shock,
hypovolaemia, sepsis and use of vasoactive drugs may all alter preload and hence
ventricular function.
1.3.3.2 Positive pressure ventilation and ventricular function
Sick infants with severe pulmonary hypertension frequently require respiratory
support in the form of conventional or high frequency ventilation. Use of positive
pressure ventilation may produce variable effects on ventricular function by altering
preload, afterload and ventricular function directly. Adult and animal work suggests
that increasing mean airway pressure will tend to reduce preload, increase afterload
and directly impair ventricular function [36, 37]. Studies in infants are limited but
those performed have shown increased pulmonary vascular resistance, reduced
myocardial contractility (systolic function) and an overall reduction in cardiac output
as airway pressures are increased within the clinical range [36, 37]. There are
however no studies specifically investigating the effects of ventilation in infants with
pulmonary hypertension in whom abnormal pulmonary vasculature may be
differently susceptible to changes in airway pressure.
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1.3.3.3 Afterload modification: right-to-left shunts
Another important factor which may determine RV performance in infants with
pulmonary hypertension is the presence or absence of a right-to-left shunt which may
reduce the total RV afterload. This may take the form of a patent ductus arteriosus, or
a ventricular or atrial septal defect. These allow blood to shunt from the RV to the
systemic circulation when pulmonary pressures rise above systemic pressures,
decompressing the RV to prevent further dilatation and therefore maintaining
function on the ascending limb of the Frank-Starling curve. Indeed, in infants with
pulmonary hypertension secondary to congenital diaphragmatic hernia, use of
prostaglandin El has been advocated to maintain ductal patency as a means of
maintaining good RV function. This measure might contribute to improved survival
in these infants [17, 38],
1.3.3.4 Inherent factors: ventricular morphology and genetics
Inherent characteristics of the right ventricle itselfmay influence function. It has
already been discussed that ventricular morphology changes in response to persistent
increases in afterload, and that this may alter function. Animal models have
demonstrated that the RV becomes hypertrophied and more concentric in shape in
response to increased PVR. This is thought to be an adaptive response to create a
chamber, more like the LV, which is less compliant and better able to generate
higher end-systolic pressures and preserve RV function to bring about improved
survival [39]. However, as previously discussed, cardiac hypertrophy in pulmonary
hypertension can progress from an adaptive compensatory process to a situation of
worsening cardiac failure [31]. In this way progressive remodelling may partially
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explain observed variation in right ventricular function, with initial improvement
followed by worsening failure.
Genetic and molecular factors may also contribute to variable RV function in
response to increased afterload. Abraham et al have suggested a role for
polymorphisms of the angiotenisn converting enzyme (ACE) gene in producing
variable RV response in adult hypertension [40], Thirty-two patients with primary
pulmonary hypertension were studied and those with ACE DD genotype ([Djeletion
versus [IJnsertion of a polymorphism of part of the gene) demonstrated preservation
of cardiac output compared to non-DD patients. Differential ACE genotype
expression may therefore play a role in variable RV function in pulmonary
hypertension. However, as yet, neither ACE genotype, nor other candidate genes
have been studied in infant pulmonary hypertension.
1.3.3.5 Metabolic factors
In sick infants with severe pulmonary hypertension co-existent metabolic
derangements may be responsible for changes in myocardial function.
Hypocalcaemia, hypomagnesaemia, hypoxia and acidosis may all directly influence
myocardial function and contribute to variation in function, independent of changes
in afterload [41, 42],
In summary, variable RV function in pulmonary hypertension may be a consequence
ofmany varied factors which may influence ventricular function, not simply
afterload alone. This emphasises the point made at the beginning of this section; that
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RV function in pulmonary hypertension cannot be predicted solely by measurement
of pulmonary artery pressure. Instead, assessment of the clinical severity of the
pulmonary hypertension requires direct, repeated assessment of right ventricular
function.
1.4 Assessment of RV function in the newborn infant
RV function assessment in infants with pulmonary hypertension is important for the
following reasons:
• RV dysfunction is a key consequence of pulmonary hypertension and a
determinant of disease severity
• RV function is variable and dependent on many factors of which PVR is
just one. Measurement of pulmonary artery pressures alone may
therefore be an inadequate predictor of RV dysfunction or disease
severity
• To identify when therapies are required and assess the response to
therapy
Accepting the importance of assessing RV function in infants with pulmonary
hypertension the remainder of this chapter will discuss potential means of assessing
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myocardial function in infants, and their prior use in the setting of pulmonary
hypertension.
An ideal measure ofRV function in infants would be:
• Quantifiable
• Accurate and repeatable
• Non-invasive and safe
• Rapidly performed at the cotside
• Able to quantify the different components ofmyocardialfunction, i.e.:
o In systole allow measurement ofcontractility independent ofloading
conditions
o In diastole allow separate measurement ofmyocardial relaxation
(active) and compliance (passive), independent ofloading conditions
Unfortunately no ideal measure ofRV function exists. With the above criteria in
mind this section discusses the following means of RV assessment:
• Indirect clinical assessment of cardiac function
• Invasive conductance catheters
• Cardiac magnetic resonance imaging
• Echocardiographic assessment
The deficiencies of methods in current clinical practice will be highlighted and
alternative techniques will be considered, including new echocardiographic
techniques whose use in the clinical setting forms the basis of this thesis.
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1.4.1 Indirect clinical assessment of cardiac function
Infants with severe pulmonary hypertension are usually managed in neonatal or
paediatric intensive care units. Routine monitoring in these settings includes heart
rate, blood pressure, oxygen saturation, respiratory rate and clinical assessment of
perfusion including capillary refill time. Together with laboratory adjuncts (paCf,
pH, serum lactate) these measures provide a broad indication of general condition but
are poor measures of cardiac function [43].
Measurement of pre- and post-ductal oxygen saturations can give some indication of
pulmonary artery pressure relative to systemic pressure. A widening pre-post ductal
saturation difference with lower post-ductal saturations indicates supra-systemic
pulmonary artery pressures and increasing right to left shunt. However, this provides
no absolute quantification of PA pressure and can give no indication of resultant RV
myocardial function.
These measures, though arguably the easiest and most widely used indicators of
circulatory function in infants with PHT are too non-specific to be used as the sole
indicators ofRV function.
1.4.2 Invasive conductance catheter measures of RV function
Invasive conductance catheters inserted via central veins into the ventricle are the
gold standard measure of ventricular function.
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Using catheters with high fidelity micro-anemometer tips, the relationships of
pressure and time, and pressure and volume can be obtained during each cardiac
cycle as shown, for example from the left ventricle, in Figure 1.3.
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Figure 1.3: Pressure-volume and pressure-time relationships obtained using
invasive conductance catheters inserted into the ventricle
1.3 A: Example of the ventricular pressure-volume relationship. From Burkhoff et al[44]
Volume (ml)
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Systolic function (i.e. myocardial contractility) is assessed using two principal
indices; the maximum rate of change of pressure with time in the isovolumic phase
of systole (dP/dTmax) and maximum elastance (Emax) [44],
dP/dT max is obtained from the pressure-time relationship (as seen in Figure 1.3), and
is a highly sensitive marker of changes in contractile state[46]. However, dP/dT max
also demonstrates a degree of load dependence which limits its interpretation as a
pure measure of contractile function [47],
E max is obtained from analysis of the end systolic pressure-volume relationship
(ESPVR) at the top left hand corner of the P-V loop. A series of P-V loops at
different loading conditions can be created by reducing preload, for example by
balloon occlusion of the inferior vena cava. Emax is the slope of the steepest tangent
to the loop at this point (see Figure 1.4), and in the RV represents the best load-
independent measure of contractile function [48], However, Emax appears to be less
sensitive to inotropic manipulations in contractile state than dp/dt max [49], Despite
their limitations dP/dT max and E max represent the most sensitive and load
independent measures of contractile function available for in-vitro.
The components of diastolic function are myocardial relaxation and passive
properties (chamber stiffness) both ofwhich may also be assessed by catheter
measures. There are two principal measures ofmyocardial relaxation; 1) dP/dt min is
an instantaneous value reflecting the maximum rate of pressure fall, and 2) x is the
Chapter 1 ,42
time constant of isovolumic relaxation. Additionally, the isovolumic relaxation time
(IVRT) is the time interval between pulmonary valve closure and tricuspid valve
opening may be measured and is a partially load-dependent measure of diastolic
function [24],[27]. Chamber stiffness is assessed by analysis of the end-diastolic
pressure-volume relationship (EDPVR), i.e. the bottom right corner of the pressure-
volume loop, as shown in Figure 1.4. The slope of a tangent drawn to the curve at
EDPVR is the chamber stiffness constant (Kc). Of note chamber stiffness is also
dependent on the volume of the ventricle and as such Kc is dependent on inherent
properties of the ventricle and ventricular volume [7],
Figure 1.4: Evaluation of systolic and dh
loops
At end systolic pressure-volume relationship
(ESPVR) the slope of the steepest tangent to
the pressure-volume curve represents maximal
elastance (E max)
At the end diastolic pressure-volume
relationship (EDPVR) the slope of the tangent
(AP/AV) is the stiffness constant (Kc) a
measure of chamber stiffness.
Diagram from Leite-Moreira [24].
ic function from pressure-volume
V
Although these gold standard measures provide the most accurate means of in vitro
assessment ofmyocardial function they are unsuitable for use in the clinical setting
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especially in the sick infant. Insertion of intra-cardiac catheters in small infants is
technically challenging and is associated with significant and potentially fatal risks.
Specifically, invasive catheters are associated with myocardial or vessel perforation,
infection, thrombosis, pericardial effusion, arrhythmia, and pulmonary hypertensive
crisis [50-52], For these reasons use of catheters to assess RV function in infants
with pulmonary hypertension cannot be considered for research purposes in this
thesis or recommended as a routine clinical tool.
1.4.3 Cardiac Magnetic Resonance Imaging
In the past decade there has been great interest in the use of magnetic resonance
imaging (MRI) to assess cardiac structure and function. The development of modem
scanners with high temporal and spatial resolution has enabled studies of newborn
infants [53], This may be particularly useful for defining cardiac anatomy in
congenital heart disease. Cardiac MRI also allows accurate assessment of ventricular
volume and blood flows throughout the cardiac cycle using ECG-triggered phase
velocity mapping [45]. However, MRI has significant practical drawbacks which
prevent its clinical use as a repeatable assessment of RV function in infants with
pulmonary hypertension: 1) few suitable scanners and experienced personnel exist,
2) many infants with severe pulmonary hypertension are too unstable to consider
moving them to an MRI scanner for a lengthy scan [12], 3) it is impracticable to
transfer infants repeatedly for multiple assessments as may be required during the
course of the illness.
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1.4.4 Echocardiographic assessment of ventricular function
Echocardiography (cardiac ultrasound) meets many of the criteria for a useful
measure ofRV function as discussed at the beginning of this chapter. Specifically the
technology is safe, well tolerated, non-invasive and readily available in many
neonatal units [54],
A number of different echocardiographic measures can be made. This thesis is based
on assessment of RV function using some of these measures. In this section each
potential measure is discussed with regard to its current use, suitability as a measure
ofmyocardial function and practicality. The measures discussed below are:
• Qualitative assessment of ventricular function using 2-d echocardiography
• Volumetric assessment: Ejection fraction and fractional shortening
• Doppler calculation of right ventricular output
• Doppler assessment of pulmonary artery pressure
• Doppler assessment of tricuspid valve flow
• Doppler derived myocardial performance index
• Tissue Doppler imaging of myocardial function
1.4.4.1 Qualitative assessment of ventricular function from 2-dimensional
echocardiography
This is the most commonly used technique employed in the clinical setting to assess
infant RV function. Subjective, qualitative assessment of ventricular function is
made from 2-dimensional images of the heart obtained from apical and parasternal
(long and short axis) views. Function, in different regions of the ventricular free
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walls and septum, is classified as normal or mildly, moderately or severely impaired,
or else hyperdynamic. The technique is rapid and easily performed with even the
most basic echocardiography equipment. However the technique is subjective with
high inter-user variability [55], and makes no distinction between systolic or diastolic
function and no accurate quantification of function. Though in widespread use, this
technique is a poorly reproducible measure of function and certainly cannot be
considered a "gold-standard" measure.
1.4.4.2 Volumetric assessment: Ejection fraction and Fractional shortening
These are measures of systolic function based on changes in ventricular dimensions
during the cardiac cycle and are widely used in clinical practice to assess LV
function. Attempts have been made to measure RV ejection fraction (RVEF) in
newborn infants using an area-length method involving measurements from apical
views of the ventricle [56], However, these simplified attempts to estimate RV
volume are inaccurate due to the complex, asymmetric geometry of the RV. They
are also time consuming and observer dependent [57], In addition these measures do
not distinguish systolic and diastolic function and therefore provide little insight into
the mechanisms of ventricular dysfunction. Indeed, it is well recognised that in 30-
50% of adults with heart failure, left ventricular failure ejection fraction remains
normal despite the presence of significant diastolic dysfunction [58],
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1.4.4.3 Doppler assessment of right ventricular output
Pulse wave Doppler can be used to assess the timing and velocity of blood flow
within the heart. These measurements can be used to calculate ventricular outputs
and provide some indication ofmyocardial function. Flow across the pulmonary
valve (right ventricular output, RVO) or aortic valve (left ventricular output, LVO)
are calculated by multiplication ofDoppler velocity time intervals with heart rate and
the cross sectional area of the valve (measured using two dimensional
echocardiography). Calculation of ventricular outputs, using echocardiography in
normal infants, demonstrates reasonable agreement with simultaneous invasive
measures [59, 60],
Two existing studies have measured RVO in infants with pulmonary hypertension:
Walther et al have demonstrated that right ventricular output was reduced in preterm
infants with pulmonary hypertension in the setting of respiratory distress syndrome
[8]. Evans and Kluckow replicated this finding in preterm respiratory distress
syndrome but found no specific association between RVO and pulmonary artery
pressure when multivariate analysis was performed [61]. There are no prior studies
of echocardiographically-assessed RVO in term infants with other-cause pulmonary
hypertension.
The presence of atrial or ductal shunts complicates interpretation of RVO as a
measure of cardiac performance and systemic blood flow. This has led Kluckow et
al to propose the use of SVC flow, also measured echocardiographically, as a shunt-
independent measure of systemic blood flow [62], SVC flow represents a relatively
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fixed proportion of total systemic blood flow, irrespective of the presence of atrial or
ductal shunting. SVC flow has been demonstrated to be low in a proportion of
preterm infants and to be associated with 1VH in this group [63, 64], However, no
studies have assessed SVC flow specifically in infants with PHT. One reason for this
may be the technical difficulty of imaging the SVC and obtaining Doppler measures
of SVC flow beyond the first 24 hours of age.
A major drawback of any measure of cardiac output, be it RVO or SVC flow, is that
these are global measures of cardiovascular function which are dependent on
preload, afterload, and myocardial function (both systolic and diastolic) and therefore
provide limited information about myocardial function alone. In addition,
measurement of RVO is cumbersome involving many steps at which error may be
introduced and multiplied (i.e. measurement of valve diameter and calculation of
velocity-time integrals). This makes the technique prone to high user variability [65],
1.4.4.4 Doppler assessment of Tricuspid inflow
Measurement of inflow velocities across the atrio-ventricular valves allows some
assessment of diastolic function. Doppler flows across the atrio-ventricular valves
consist of an E wave in early diastole and a later A wave. The E wave represents
ventricular filling immediately after opening of the AV valve and its velocity is
dependent on atrial pressure (preload), active myocardial relaxation and the
compliance of the ventricle. The later A wave is due to active atrial contraction prior
to closure of the tricuspid valve.
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Tricuspid inflows have been used to assess RV function in adults with pulmonary
hypertension, in whom a pattern of reduced E wave velocity and reduced E:A ratio,
has been interpreted as demonstrating increased myocardial stiffness (reduced
compliance) and impaired relaxation [66].
Although atrio-ventricular valve Doppler is established in clinical use to assess
diastolic function in adult and paediatric disease [67], there are to date, no studies
specifically reporting the use of tricuspid valve Doppler to assess RV function in
infants with pulmonary hypertension.
In addition there are limitations to use of this technique in newborn infants. First
tricuspid inflow velocities are highly preload dependent and cannot therefore be
interpreted as demonstrating myocardial function or compliance alone [26],
Furthermore, in infants there is a physiological change in velocities after birth which
complicates interpretation. In later infancy, childhood and adulthood E waves
dominate (E:A ratio >1) indicating that the majority of ventricular filling occurs
early in diastole, however in the newborn E wave velocities are lower than A wave
velocities [68] (so-called E-A reversal), reflecting lower RV compliance, and
dependence on atrial contraction to ensure ventricular filling. A final important
factor limiting use of tricuspid valve Dopplers in infants is fusion of the E and A
wave at higher heart rates which can make measurement of individual velocities
difficult.
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1.4.4.5 Doppler-derived myocardial performance index
The myocardial performance index (MP1), or eponymously named Tei index, is
calculated from Doppler flows across the inlet and outlet valves (tricuspid and
pulmonary in the case of the RV) and has been proposed as a "global" measure of
both systolic and diastolic function [69-71], The MPI is calculated from the
equation:
ISOVOLUMIC RELAXATION TIME + ISOVOLUMIC CONTRACTION TIME
RV EJECTION TIME
In practice the index is calculated using the RV ejection time and the time interval
from the cessation to onset of diastolic filling, as shown in Figure 1.5 below.
Figure 1.5: Calculation of the Myocardial Performance Index (Tei Index)
a, period from cessation to
beginning of tricuspid inflow; b,
period of RV ejection. ET, RV
ejection time; ICT, isovolumic
contraction time; IRT, isovolumic
relaxation time.
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MPI was proposed as a rapid means of quantifying ventricular function which can be
easily obtained from quick measurements and limited echocardiographic views. One
of the major advantages of the index is that it is time interval based and therefore not
dependent on angle of insonation of the Doppler beam. In addition the index
demonstrates good inter-observer variability and heart rate independence including in
normal infants and in the fetus [72],
MPI has been used in RV assessment in adults and children with pulmonary
hypertension and in a newborn piglet model of hypoxia-induced pulmonary
hypertension [73-75], In all of these PHT states RVmpi is consistently elevated and
has therefore been suggested to provide a practical quantitative measure of global
ventricular function. No studies have yet assessed MPI as a measure of ventricular
function in newborn infants with pulmonary hypertension.
There are, however, limitations to MPI as a measure of ventricular function.
Although proposed as a "global" measure, this in itself is a drawback: an elevated
MPI does not indicate whether systolic, diastolic function, or indeed both are
impaired. Furthermore the MPI appears to be significantly load dependent i.e.
changes in MPI may indicate simply a change in preload or afterload and not
ventricular function [76], Despite its ease ofmeasurement and the attractiveness of a
quantifiable measure of ventricular function, the MPI must therefore be interpreted
cautiously.
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1.4.4.6 Tissue Doppler imaging of myocardial function
Tissue Doppler imaging (TDI) is a new form of imaging which potentially provides
the most useful direct echocardiographic measure of ventricular function to date.
Use of this technique in infants is a major focus of the work presented in this thesis.
TDI is therefore discussed in detail below.
Traditionally, Doppler technology has been used to assess blood flows within the
heart and blood vessels and is based on reflection of ultrasound from moving
erythrocytes. TDI technology, however, assesses not the velocity of blood flows but
the velocity of the myocardium. TDI myocardial velocities are considered to provide
quantitative measures of ventricular function. The ability to perform TDI has
resulted from the development of echocardiographic machines capable of filtering
out low amplitude, high frequency Doppler signals reflected from erythrocytes, and
selecting out the low frequency signals form the myocardium [77].
Two forms of tissue Doppler imaging exist: pulse wave TDI (PWTDI) and colour
TDI (CTDI). Pulse wave tissue Doppler is simpler and involves use of pulsed wave
Doppler to measure the velocity of a segment ofmyocardium in real-time. A
Doppler profile of velocities throughout each cardiac cycle is obtained from which
peak velocities and accelerations can be measured. The disadvantage of this
technique is that it only allows assessment of velocities in one part of the
myocardium at any one time, and that each section of myocardium must therefore be
studied separately, prolonging the examination.
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CTDI is more complex. Colour Doppler is overplayed on a grey scale 2d image of
the heart and used to colour each pixel of the heart image according to its velocity
and direction of motion. Those parts of the heart moving toward the transducer
appear red, those moving away appear blue, with brighter hues corresponding to
faster velocities. The velocities measured by CTDI are mean velocities, unlike the
peak velocities measured by PWTDI. CDTI allows offline, simultaneous
measurement ofmultiple regions of the myocardium from a single echo loop of just a
few cardiac cycles. CTDI has the advantage that data can be collected very quickly at
the bedside and later in-depth analysis performed offline. From a single echo loop
myocardial velocities can be measured post-acquisition in multiple regions of the
heart. However, the ability to collect CTDI data remains limited to more modern and
expensive echocardiography machines which can perform the high frame rates
required to achieve adequate temporal resolution. This is a particular issue in subjects
with higher heart rates and therefore a major theoretical limitation for the use of
CTDI in infants.
Although the velocities measured in PWTDI are peak velocities and those in CTDI
are mean (and therefore lower), the appearance of the velocity waveforms is similar
and highly characteristic. Figure 1.6 below is a schematic representation of the TDI
trace produced over one cardiac cycle. In systole there is an initial brief positive
deflection which represents isovolumic contraction (IVC) and accompanies the QRS
complex of the ECG. This is followed by a prolonged positive deflection (S wave)
which corresponds to systolic ejection. After the S wave is a short period of
isovolumic relaxation (isovolumic relaxation time, IVRT) followed by two negative
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velocities. The first of these is the E' wave, which represents early diastolic filling,
and is a measure ofmyocardial relaxation and chamber stiffness. The second
negative velocity is the A' wave which represents late diastolic filling due to atrial
contraction, and therefore corresponds to the p wave on the ECG.
Figure 1.6: Schematic diagram of Tissue Doppler waveform
QRS
ECG4 T P_/\ /Y
Tissue Doppler waveform over one cardiac cycle (top) with corresponding ECG below.
IW - isovolumic contraction velocity; S -peak systolic myocardial velocity; IVRT - isovolumic
relaxation time; E' - peak early diastolic myocardial velocity; A' - peak late diastolic
myocardial velocity;
Practicalities ofcollecting Tissue Doppler Imaging data
Tissue Doppler velocities are typically obtained from an apical view of the heart in
the longitudinal plane. Longitudinal motion is less affected by the rotational twisting
of the heart during contraction and therefore allows more practicable measurement of
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velocities in a single plane. When interpreting TDI velocities in a single plane,
however, it must be borne in mind that in some disease processes longitudinal and
circumferential fibre function may be differentially affected [78].
From apical views, longitudinal velocities can be measured from any region of the
interventricular septum or right and left ventricular free walls. Myocardial velocities
decrease from the base of the ventricle towards the apex which is a relatively fixed
point at which velocities are low, restricting assessment [78]. The convention in TDI
analysis has therefore been to measure velocities at the base of the ventricle where
longitudinal movement and velocities are highest. TDI analysis at the mitral valve
annulus is used to assess left ventricular function, analysis at tricuspid valve annulus
to assess RV function, and analysis of the basal interventricular septum, at the crux
of the heart, to assess septal function, as shown in Figure 1.7. Of note, velocities
tend to be higher in the RV than the LV [79],
Figure 1.7: Positions for obtaining TDI myocardial velocities
Apical four-chamber view.
A, right ventricular velocities measured at lateral
tricuspid valve annulus;
B, septal velocities measured at basal region of
interventricular septum;
C, left ventricular velocities measured at lateral
mitral valve annulus
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As with any Doppler technique the velocities measured are dependent on the angle of
insonation of the Doppler beam, according to the equation:
Frequency shift x velocity of sound in medium
Velocity =
2 x frequency of transmitted sound x cos 0
Provided that the angle of insonation (0) is between 0 and 15 degrees cosG can be
assumed to be 1. However, at larger angles of insonation cos0 becomes smaller and
velocities will be underestimated. This is a limitation of all the Doppler methods
described, including TD1.
TDI measurements and their relation to myocardial function
Systolic cardiac function
Three measures of systolic function have been proposed which are measurable from
TDI traces; 1) the IVV (isovolumic contraction velocity), 2) systolic ejection velocity
(S) and 3) IVA the isovolumic acceleration (i.e. acceleration to reach peak IVV).
The S wave is a prolonged systolic TDI velocity making it easy to identify and
measure. Early studies in adults and animals demonstrated a good correlation
between S wave velocity in the LV and invasive catheter derived measures of LV
function (dP/dTmax and maximum elastance; Emax) [80, 81]. However Lindqvist et al,
studying S velocities in the right ventricle in a pig model found no such relationship
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[82], Furthermore in another pig model RV S wave velocity demonstrated
significant load dependence when either preload or afterload was manipulated [49],
In Lindqvisf s experiments RV IVV was also measured, and unlike S wave velocity
was found to correlate well with dp/dt max, whilst showing no correlation with
pulmonary artery pressure. This was interpreted as indicating afterload-
independence [82]. However, in their similar pig model Vogel et al demonstrated
that RV IVV was significantly affected by changes in load produced by balloon
inflation in the pulmonary artery (afterload) and occlusion of the IVC (preload) [49],
However, before discounting IVV as a measure ofmyocardial function because of its
potential load dependence it should be considered that these experiments used
extreme loading conditions which may greatly exceed the variations in loading in a
disease state. Under more moderate loading conditions, as in Lindqvist et afs study,
IVV may still be relatively load-independent and consequently a useful measure of
myocardial systolic function.
RV IVA, measured using CTDI, has also been investigated as a measure of
contractile performance. In Vogel et al's pig study IVA was the only TDI measure
which appeared to demonstrate load independence whilst also correlating well with
catheter indices of contractile function during pharmacological manipulations in
contractility using dobutamine and esmolol [49], Pauliks et al have recently
reproduced this finding in adults, demonstrating that LV IVA increases in a dose
dependent manner with ascending dobutamine dose [83], However, whilst IVA
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appears the most robustly load-independent TD1 measure of contractile function
there are practical limitations to its use.
Measurement of 1VA is best performed using CTDI on the most modern
echocardiography equipment, and indeed studies using PWTDI on older echo
technology have been unable to measure 1VA [82], Furthermore at higher heart rates
the measurement of fast accelerations over very short time intervals becomes
increasingly inaccurate and also current technology may not allow fast enough frame
rates to measure accurately the rapid changes in velocity.
Diastolic myocardial function assessed by TDI
The diastolic velocities in the TDI waveform are the early diastolic E' velocity and
later diastolic A' velocity. TDI E' velocity is determined by myocardial relaxation
and passive ventricular compliance whilst A" represents later filling due to atrial
contraction [27]. From the TDI waveform, diastolic function can be assessed by
measurement of the E' and A' velocities and also by measurement of the isovolumic
relaxation time (IVRT) prior to onset of the E' wave.
Experimental studies in adults have shown that the LV E' velocity relates well to an
invasive catheter-derived index ofmyocardial relaxation (Tau; the constant of
isovolumic pressure decay) [84], Flowever, in the LV of the healthy heart E' has also
been shown to be significantly preload dependent (i.e. dependent on atrial filling,
pressure and atrio-ventricular pressure gradient) [85]. Conveniently, E' appears to be
load independent in the failing heart [86].
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As discussed earlier, E wave velocities obtained from conventional (non TDI)
tricuspid valve Doppler are a composite determined by preload (filling pressures),
myocardial relaxation and passive compliance of the ventricle. It has therefore been
proposed that calculation of a ratio of E:E' can be used to assess filling pressures
(preload). This is supported by adult studies demonstrating good correlation between
E:E' and invasive tilling pressures in both the right and left sides of the heart [87,
88], However, other workers have used E:E' ratio in the LV as a measure of the
"compliance" properties of the ventricle [89], Though much is claimed for the utility
of the E:E' ratio, it should not be over-interpreted. E:E' is ultimately dependent (like
E velocity) on both preload and compliance but does not indicate the relative
contributions of these.
Isovolumic relaxation time (IVRT) provides a different measure of diastolic function
which can be measured from TDI velocity waveforms. IVRT is the time from the
end of the S velocity to the beginning of the E' velocity and represents
predominantly a period ofmyocardial relaxation but also involves a change in the
shape (but not the volume) of the ventricle, adjusting its configuration in preparation
for diastolic filling [24, 27], In addition IVRT is not a pure measure ofmyocardial
relaxation but is also dependent on loading conditions and tricuspid valve
competency [90].
In summary TDI E' velocities provide a measure of myocardial relaxation, though
with variable preload dependence. E:E' ratio may be used to give a more specific
Chapter 1 , 59
indication of preload and ventricular compliance but cannot identify the relative
contributions of these. IVRT provides additional measures of myocardial relaxation
but the former may be load dependent and the latter in particular is open to error in
measurement which may be increased at higher heart rates. It is important to note
that most of the work to validate these measures has been conducted in animal and
adult models and in the LV, rather than the RV. Whether these measures perform in
the same way in the RV is relatively unproven.
Use ofTDI to assess RV function in pulmonary hypertension and in infants
The use ofTDI to assess RV function in pulmonary hypertension has been limited to
adult studies. Lindqvist et al have demonstrated a correlation between IVRT and
pulmonary artery pressure, using PWTDI in the RV in male adults [91], These data
highlight the load-dependence of IVRT since it is unclear whether the prolonged
IVRT was a direct effect of increased afterload and/or a consequence of impaired
myocardial relaxation secondary to the increased afterload. Two other groups have
compared TDI velocities in adult patients with primary pulmonary hypertension with
those of matched normal controls. These studies demonstrated a significant reduction
in IVA and S wave velocities in systole and significant reductions in E' wave
velocity and E':A' ratio, but not A' wave velocity in diastole [92, 93], These
observations support the findings of both systolic (contractile) and diastolic
dysfunction in pulmonary hypertension. A study by Kjaegaard et al in 17 healthy
adults in whom hypoxic increases in PVR were induced, also demonstrated
significant reductions in S and E wave velocities and TDI IVRT [74]. This group
observed no significant differences in IVA, nevertheless the increase in pulmonary
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artery pressure in response to hypoxia was relatively small (mean increase in PAP of
<10mm Hg). There are no studies using TDI to assess RV function in infants with
PHT.
Existing use of TDI in newborn infants has been limited to description of normative
TDI velocities. Mori et al demonstrated the feasibility of measuring PWTDI
velocities in 130 normal infants within the first 24 hours of life and again in the next
seven days. Only systolic S wave velocity and diastolic E'and A' wave velocities
were measured however. Velocities were higher in the RV than the LV which in
turn was higher than the IVS [94], TDI has not been employed in disease states in
newborn infants, but has been employed antenatally to assess RV function in both
fetuses with heart failure and control fetuses. In this study E', A' and S velocities
were all seen to increase during fetal life, and E' velocity was significantly reduced
in those with heart failure. This finding was interpreted as indicative of diastolic
relaxation dysfunction [95] . However, this was a small study with just seven fetuses
in the heart failure group and with varied causes of heart failure.
There are no studies reporting use of CTDI in newborn infants either in health or
disease. This may be because the level of technology required is not currently
available in clinical or research neonatal intensive care settings. Therefore, there is
no information on the feasibility of this technique in infants.
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Summary ofTPI measures
Table 1.2 summarises the discussion of TDI indices and their functional correlates:
Table 1.2: Tissue Doppler Imaging indices and their relation to myocardial
function and loading conditions
TDI indices Myocardial function
correlate
Load dependence Existing infantdata
Systolic IVA Myocardial contractility Load independent No infant data
IW Myocardial contractility May demonstrate load
dependence
No infant data



















IVRT Myocardial relaxation and
loading conditions
Load dependent No infant data
E:E' Ventricular stiffness and
preload (atrial filling
pressure)
Highly load dependent No infant data
In summary TDI is a new form of echocardiographic analysis which makes non¬
invasive assessment of the components of systolic and diastolic function possible for
the first time. This technology remains predominantly a research tool, and has had
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very limited reported use in newborn infants. However TDI may be a very useful tool
for assessment of infant RV function especially in the setting of pulmonary
hypertension. In this thesis the feasibility of both PWTDI and CTDI in normal
infants and those with PHT will be investigated, and these techniques used to
investigate the mechanisms of RV dysfunction in PHT.
1.4.4.7 Echocardiographic assessment of pulmonary artery pressure
The discussion above has focused on echocardiographic methods of assessing right
ventricular function and specifically in the setting of pulmonary hypertension. It is
timely at this point to consider also the means of directly assessing PAP, using
echocardiography in infants. It is emphasised, however, that pulmonary artery
pressure per se is a not a measure of RV function, an important issue which is
fundamental to this thesis.
Three echocardiographic techniques of assessing PAP are available:
• Tricuspid regurgitation jet velocity
• Ductal shunt assessment
• RV systolic time intervals
Measurement of the velocity of tricuspid valve regurgitant flow (TR) in systole
allows calculation of the pressure gradient between RA and RV using a modified
Bernoulli formula ( Pressure gradient = 4 x (velocity)2 ). If the pulmonary valve is
not stenotic then peak RV pressure equals PAP. This technique demonstrates good
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agreement with invasive measurement of pulmonary artery pressure in infants and
acceptable repeatability [96] and is now widely employed in current clinical practice.
However, it must be noted that frequently TR is not present or an incomplete
Doppler trace is obtained which may underestimate PAP: Skinner et al reported that
only 19% of term and 31% of preterm infants had pansystolic TR from which peak
velocity could be confidently measured [97],
The presence of a patent ductus arteriosus also allows estimation of PAP [98].
Shunting through a patent ductus arterious is dependent on the pressure gradient
between the pulmonary artery and descending aorta at any point in the cardiac cycle.
Quantification of PA pressures by calculation of the pressure gradient across a patent
ductus (using the modified Bernoulli equation) should be cautioned against because
peak PA pressure is achieved before peak aortic pressure and therefore the peak
systolic pressures do not coincide. Instead, ductal shunting should be interpreted in a
still informative, but more qualitative light. Exclusive left to right shunting indicates
PA pressures below systemic. Bidirectional shunting of low velocity indicates PA
pressures just below or approaching systemic pressures, and exclusive right to left
shunting indicates supra-systemic PA pressures.
Other measures of PA pressure are proxy measures based on Doppler-derived RV
systolic time intervals. The ratio of time to peak velocity (TPV): RV ejection time
(RVET) falls with increasing pulmonary artery pressure and has been shown to
correlate with PAP derived from tricuspid regurgitation. However, this technique
shows poor repeatability, and furthermore TPV may be variably affected by the
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presence of ductal shunting, RV dysfunction and gestational age/body size [99], In
view of these limitations this technique was not used in the work presented in this
thesis.
It is important to stress that although these convenient echocardiographic measures
provide rapid assessment of pulmonary artery pressure in infants, the pulmonary
artery pressure cannot be considered a measure ofRV function or vice versa,
function and hence illness severity, is highly variable in the face of increased PVR
and determined by many factors other than afterload alone.
1.5 Conclusion
Right ventricular dysfunction is an important consequence of pulmonary
hypertension in the newborn infant and a principal determinant of disease severity.
However, RV function may not be directly related to pulmonary artery pressure
alone. Direct assessment of RV function is therefore highly desirable in infants with
PHT, but at present no quantifiable measures are routinely available in clinical
practice. Furthermore, the mechanisms of RV dysfunction in infants have not been
elucidated i.e. the relative contributions of systolic and diastolic dysfunction.
Understanding of these may assist in guiding future therapies.
Echocardiographic techniques, including the new developments of tissue Doppler
imaging, may allow non-invasive quantification of RV function in infants, and
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EXPERIMENTAL DESIGN AND METHODS
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2.1 Introduction
The purpose of this chapter is to explain which methods were used in the research
and why they were chosen. Initially, the aims of the research and the corresponding
testable hypotheses are stated. Next, the process by which these hypotheses were
developed into an protocol is discussed. Finally, the experimental design and
experimental methods are described in detail.
2.2 Aims and hypotheses
2.2.1 Aims
The previous chapter discussed the importance of assessing RV function in infants
with pulmonary hypertension, and potential means of doing so. The overall aim of
this research was to identify new methods of assessment and treatment of RV
dysfunction in infants with pulmonary hypertension.
At the outset, the fundamental research questions were:
1. Which measures can be used to assess RV function in the infant with
pulmonary hypertension?
2. What are the mechanisms ofRV dysfunction in pulmonary hypertension?
3. What is the relationship between RV function and pulmonary artery pressure
in pulmonary hypertension?
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The first question relates to identifying practicable techniques for assessing RV
function in infants. This was considered important as current assessment of RV
function in clinical practice is limited and without accepted standards. Furthermore,
new techniques, not previously investigated in infants, may provide improved
assessment of RV function.
The second question seeks to improve understanding of the relative contributions of
systolic and diastolic dysfunction to RV dysfunction in infants with PHT. Studies in
adults and animals have previously demonstrated both systolic and diastolic RV
dysfunction in PHT, but no such studies have been performed in infants [93, 100],
Understanding the mechanisms of RV dysfunction in infants may improve therapy.
The third question seeks to investigate the relationship between RV function and
PAP. If RV function is variable in PHT then this emphasises the importance of
measuring RV function directly and not solely using the absolute PAP as a measure
of illness severity or to predict RV function. Conversely, if the two are linearly
related, as studies in animals and older children have suggested [75, 101], then
measures of RV function might be used as proxy measures of PAP, for example in
those circumstances when a TR jet is absent and PAP cannot be directly measured.
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2.2.2 Hypotheses
These experimental aims and research questions were stated as testable hypotheses,
(corresponding numerically to the research questions) as follows:
In infants with pulmonary hypertension:
I. RVfunction can be quantified, in the clinical setting, by non-invasive
echocardiographic measures
II. RV dysfunction in PHT is characterised by systolic and diastolic dysfunction
III. RVfunction is not linearly related to pulmonary artery pressure
2.3 Development of the hypotheses into an experimental
design
The fundamental design of this research was the assessment of RV function in
infants with pulmonary hypertension and in normal control infants, using a selected
number of echocardiographic measures, i.e. a clinical, case-control design. This was
intended to allow assessment of these different measures and to elucidate the
mechanisms of RV dysfunction in PHT, ultimately to allow more informed clinical
therapy.
2.3.1 Overview of experimental design
The overall experimental design is summarised in Figure 2.1. Initially, each of the
selected measures of RV function was performed in every subject in the control
group and each subject in the PHT group. This design allowed assessment of each
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pre-selected echocardiographic measure in both normal and PHT infants, thus testing
the hypothesis that RV function could be non-invasively assessed by these measures.
The second research question and hypothesis were investigated by comparison of RV
function (assessed using the echocardiographic measures) between control and PHT
groups to determine the mechanisms ofRV dysfunction in the PHT group.
The final hypothesis, that RV function is not linearly related to PHT, was
investigated separately by repeated paired measurement of pulmonary artery pressure
and RV function (using all of the selected echocardiographic measures of RV
function) in infants in the PHT group.
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Figure 2.1: Experimental design
The use of a control group provides normative data and a feasibility assessment of the
echocardiographic measures of RV function in normal infants. The PHT group allows
assessment of the same measures in the disease setting and comparison of RV function in
PHT and normal controls, as well as investigation of the mechanisms of dysfunction.
In the PHT group, serial paired measurement of PA pressure and RV function, using all of
the selected measures, allowed investigation of the relationship between these two
variables.
2.3.2 Use of a human population
Human infants in a clinical neonatal unit setting were selected as the study
population. Mechanisms of RV dysfunction in PHT have previously been studied in
adults and older children [75, 92, 93]. However, direct extrapolation from these
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studies to the infant may not be valid; RV dysfunction may be different in the infant
due to the different aetiologies of PHT and the different morphology of the infant RV
compared to that of the older child or adult. Animal models, including newborn
piglet models, have also been employed to investigate mechanisms of RV
dysfunction in PHT, allowing assessment in a controlled laboratory environment
[73]. However, inter-species variation may limit extrapolation of these data to the
newborn human infant. For these reasons, it was felt preferable to directly study
mechanisms of RV dysfunction in human infants with PHT and not in a proxy
model, be it an older human or an animal.
As well as investigating the mechanisms or RV dysfunction, this thesis also aimed to
investigate new techniques to assess RV function in infants in a clinical setting.
Clearly, investigating the feasibility of these techniques for use in infants is best done
in a real infant population and not in a controlled animal or adult model.
2.3.3 Importance of a pulmonary hypertension population and
control population
A control population of normal infants and a population of infants with PHT were
studied in this work. A control population was considered necessary for two reasons:
1) to investigate the feasibility of the new measures ofRV function assessment in
normal infants, and 2) to provide normative data for each measure of RV function for
comparison with data from the PHT group.
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2.3.4 Choice of echocardiographic techniques to assess RV function
The techniques selected for assessment of RV function in this study had to be both
ethically acceptable for use in sick human infants and, if they are to be recommended
for future clinical use, available using currently available technology.
Echocardiography was selected because this technology is non-invasive, can be
performed at the cot-side and is already widely used and tolerated in neonatal
practice [54]. Invasive conductance catheters represent the "gold standard" for
assessment of ventricular function and would ideally have been included in this study
both as a means of assessing systolic and diastolic function in PHT and as a means of
validating echocardiographic data. However, use of conductance catheters in infants
is both technically challenging and associated with serious risks and side effects [50-
52], Cardiac catheterisation was therefore not an ethically acceptable option in this
study. The validity of the echocardiographic measures of RV function was instead
assumed on the basis of extensive existing data validating these techniques against
conductance catheter data in adult and animal studies [49, 82],
The echocardiographic measures selected for study were chosen on their likely
ability to meet the criteria for an "ideal measure", i.e. one that can be rapidly
obtained from limited echocardiographic views and provides accurate, load-
independent, quantification of systolic and diastolic function.
The measures selected were:
• tricuspid valve Doppler inflow velocities
• right ventricular output (RVO)
• myocardial performance index (MPI)
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• Tissue Doppler imaging (PWTDI and CTDI)
The relative merits, disadvantages, and current use of each of these techniques are
now discussed in relation to their inclusion in this study.
Tricuspid valve Doppler inflow velocities were included in this study because they
are well described measures of diastolic function in infants (though not thus far
reported in pulmonary hypertension) which can be rapidly obtained from limited
echocardiographic views [27].
RVO was included because there has been considerable interest in ventricular output
as a practicable clinical measure of cardiac performance in the newborn infant [61,
102], If the most basic function of the heart is to maintain an adequate cardiac output
and systemic perfusion, then it is logical to measure cardiac output (or RVO) as a
measure of global cardiac function. However, RVO calculation may be prone to
high error [103]. Furthermore, precisely because this is a "global" measure of
function, it provides no insight into degrees of systolic or diastolic dysfunction.
Myocardial performance index (MPI) was selected for use in this study as it has the
potential to provide rapid quantitative assessment ofRV function. MPI has the
advantages of being obtained from minimal echocardiographic views, independent of
angle of insonation and independent of heart rate [72, 102]. Additionally, adult and
animal studies have already shown the utility of this "global" measure of RV
function in pulmonary hypertension, though no studies, prior to this one, had been
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performed in infants with PHT [73, 104], Although primarily a research tool, use of
MPI in newborn infant disease states has already crept into clinical practice,
particularly in Japan (Personal communication, Dr K Suzuki). This represents
another reason why proper assessment ofMPI in the infant disease setting is now
necessary.
Tissue Doppler imaging (both PWTDI and colour TD1) is a relatively new
echocardiographic technique, with limited reported use in infants [94, 105]. The
inclusion ofTDI as a measure of RV function in this study therefore represented an
important assessment of this technique in normal infants and infants with pulmonary
hypertension. TDI was also selected as a measure ofRV function in this study
because of its powerful potential to assess directly both systolic and diastolic
myocardial function, and therefore determine the contributions of these to
myocardial dysfunction in infants with PHT. Importantly, TDI measures of
myocardial function, unlike tricuspid valve Doppler and MPI, appear to be relatively
load-independent [49, 82],
Both PWTDI and CTDI were used in this study. Though both techniques use
Doppler ultrasound to detect low velocity myocardial velocities, they are subtly
different [77]. PWTDI is simpler and is widely available on most current cardiac-
level ultrasound machines. PWTDI provides real-time, online analysis of myocardial
velocities in a single region of myocardium. The main limitations of PWTDI are that
separate regions ofmyocardium cannot be assessed simultaneously, and that the
PWTDI has high temporal resolution but poor spatial resolution.
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CTDI is more complex and involves colour coding each pixel of myocardium in a 2-
dimensional cine-loop. This cine-loop is recorded and then offline TDI analysis
performed within any selected region (or regions) of the heart. CTDI therefore
allows post-acquisition of any region of the myocardium within the recorded loop
and simultaneous TDI analysis in multiple regions of myocardium. CTDI also
allows improved spatial resolution compared to PWTDI. It was not clear which, if
either, of these techniques was better suited to assessment of RV function in the
newborn infant. Both were therefore included.
A number of echocardiography measures ofRV function were not included in this
study. Qualitative assessment of RV function, although the most widely used clinical
method, is highly observer dependent and provides no objective quantification of
ventricular function. The intention of this study was instead to identify a quantitative
measure, or measures, of function which could be used to objectively monitor RV
function. Geometric measures of ventricular function (ejection fraction and
fractional shortening) were not used in this study. Though previously reported in
infants [56], these techniques are time consuming and inherently inaccurate due to
the complex asymmetrical geometry of the RV. Furthermore, they are load
dependent and do not distinguish systolic and diastolic function. Velocity of
circumferential fibre shortening (VCFc) and stress-velocity index (the relation of
VCFcto wall stress) are two further measures of systolic function which have been
used to assess left ventricular function in infants [102, 106], These techniques have
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not been attempted, let alone validated, in the infant RV and are arguably too
cumbersome for consideration as a practical clinical tool [107],
2.3.5 Assessment of feasibility of RV function measures
An aim of this work, as stated at the beginning of this chapter, was to identify new
means of assessing RV function. Accordingly, the hypothesis was generated that
new echocardiography measures could be used to quantify RV function in infants
i.e. that the echocardiographic techniques were feasible. This assessment of
feasibility was important because some of the echocardiographic techniques used in
this study (RVMpi, TDI) have rarely been attempted in infants before, and fewer still
used in the setting of infant pulmonary hypertension.
Assessment of feasibility was based on the following criteria:
o Echocardiographic images, for collection of the raw echocardiographic data,
could be practically obtained
o Raw echocardiographic data could be analysed and meaningful measures of
RV function calculated
o The technique was weII-tolerated by the infant; i.e. there was no clinically
significant deterioration in their condition during, or immediately after,
collection of echocardiographic data
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For each technique feasibility reporting included;
• the proportion of infants in whom echocardiographic data could not be
obtained
• the proportion of infants in whom data could not be analysed to generate
meaningful measures of RV function
• Consideration of the variability of the measure in the sample population (as
summarised by standard deviation)
• the proportion of infants who became distressed or had a clinically significant
deterioration during each measure
A clinically significant deterioration was defined as a significant colour change,
desaturation or bradycardia. This was based on continuous clinical assessment by
the researcher, attending nursing staff and clinicians. At the first indication of
clinically significant deterioration, the echocardiogram in progress was interrupted,
nursing and attending clinicians alerted, and appropriate measures taken to treat the
deterioration e.g. increased inspired oxygen, stimulation.
Of note, feasibility assessment did not include validation of the echocardiographic
measures against a "gold standard1', nor assessment of the reproducibility or
repeatability of the measures. Validation and acceptable reproducibility are important
requirements for a clinical measure. As previously discussed, however, validation of
echocardiographic measures against the "gold standard" conductance catheter
method, is not ethically acceptable in infants. Also, it was not practicable to make
assessments of reproducibility, because of limited time and subject numbers.
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2.3.6 Measurement of pulmonary artery pressure
Assessment of pulmonary artery pressure was a pre-requisite in infants to be
included in the PHT group in this study. This is most accurately done invasively
using pulmonary artery catheters but insertion of catheters for this purpose, with the
attendant risks, would have been unethical in the study population. Instead, PAP was
estimated non-invasively using the Doppler echocardiographic techniques of
tricuspid valve regurgitation velocity and patterns of shunting through a patent
ductus arteriosus (when present) [96, 98],
2.4 Recruitment of Control and PHT groups
2.4.1 Site of study
All subjects were recruited from the inpatient population of the Neonatal Unit (NNU)
of the Royal Children's Hospital (RCH), Melbourne, Australia. Patients managed in
this unit are ex utero transfers, referred within the neonatal period from throughout
Victoria and interstate Australia for management of surgical neonatal problems,
respiratory, cardiac, renal, metabolic, infective and neurological diseases, in both
term and preterm infants. The Neonatal Unit at RCH has particular specialist
experience in the management of congenital diaphragmatic hernia, severe respiratory
disease requiring high frequency oscillatory ventilation, and intra-cranial arterio¬
venous malformations (vein of Galen malformations).
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Recruitment of patients for echocardiographic assessment of ventricular function was
approved by the Research and Ethics Committee of the Royal Children's Hospital.
Infants were recruited between March 2006 and May 2007.
2.4.2 Control group - Eligibility Criteria
Infants were eligible for inclusion in the control group if they:
1. Were inpatients in the Neonatal Unit
2. Were haemodynamically stable and not receiving any cardiovascular
medications
3. Were in sinus rhythm
Infants were excluded from the control group if:
1. They had evidence of structural or functional cardiac disease (on clinical or
echocardiographic assessment)
2. They had evidence of pulmonary hypertension on clinical or
echocardiographic assessment
3. The were too unstable to tolerate echocardiographic examination without
clinically significant deterioration, as judged by the attending clinician,
nursing staff or study researcher
4. An echocardiogram could not be practicablely performed; e.g. presence of
surgical wound preventing access to chest.
5. They had previously been included in the study
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2.4.3 PHT Group - Eligibility Criteria
Infants were eligible for inclusion in the PHT group if:
1. They were inpatients in the NNU of the Royal Children's Hospital,
Melbourne
2. They had echocardiographic evidence of pulmonary hypertension
3. They were in sinus rhythm
Infants were excluded from the PHT group if:
1. They had structural heart disease (not including a patent ductus arteriosus or
patent foramen ovale)
2. The were too unstable to tolerate echocardiographic examination without
clinically significant deterioration, as judged by the attending clinician,
nursing staff or study researcher
3. An echocardiogram could not be practicablely performed; e.g. presence of
surgical wound preventing access to chest.
For the purposes of inclusion criteria, pulmonary hypertension was defined as peak
pulmonary artery pressure of at least two thirds peak systolic systemic pressure when
estimated from tricuspid regurgitation jet, or the presence of significant right-to-left
shunting through the patent ductus arteriosus (i.e. bidirectional ductal shunting or
exclusive right-to-left ductal flow). Measurement of pulmonary artery pressure using
these techniques is discussed below. If an infant was suspected of having pulmonary
hypertension but pulmonary artery pressures could not be assessed by
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echocardiography (i.e. no ductal shunt or tricuspid regurgitation jet), then they were
not recruited to the study.
Infants with patent arterial ducts and/or patent foramen ovale were not excluded from
the PHT group. Patent arterial ducts and patent foramen ovale are relatively
common findings in the first days of life. In infants with pulmonary hypertension and
right-to-left shunting, ductal patency may be prolonged. In addition, in some infants
with severe PHT, prostaglandin El may be utilised to maintain ductal patency and
allow right-to-left ductal shunting as a means of reducing afterload on the pressure
and volume loaded RV. This study did not seek to distinguish the effects of ductal
and foramen ovale patency on RV function and therefore did not exclude infants on
the presence or absence of these shunts, although their presence and associated
shunting were noted.
Infants with all causes of PHT were recruited. The limited and unpredictable
numbers of infants admitted to the NNU with PHT meant that it was not
practicalable to limit the PHT group to infants with a single diagnosis.
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2.4.4 Experimental conditions
All experiments were conducted within the Neonatal Unit. Echocardiography was
performed at the subject's cot-side. Subjects were studied when they were settled or
sleeping. Those infants who were feeding enterally were studied approximately 30
minutes after a feed. To pacify those infants who were awake during the
experiments, up to 0.5 mL of a 33% sucrose solution was given orally. This was in
accordance with protocols for clinical management of infants in the NNU. A
number of enrolled infants were already sedated and muscle relaxed for clinical
reasons, which assisted echocardiographic study. Infants were positioned in a flat,
supine position for all echocardiographic studies. ECG electrodes, transcutaneous
CO2 probes and temperature probes were moved to allow access to the chest and
upper abdomen for echocardiography.
Most experiments were conducted in the evenings and at weekends, as this was the
only time when access to the echocardiography machine was available.
Conveniently, this was also the time when the NNU was quietest and infants were
less likely to be disturbed by environmental noise and activity, or for clinical
purposes. No attempt was made by the researcher to alter the clinical management
of any study subject prior to or during the study.
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2.5 Demographic and therapeutic data








Data were also obtained on the clinical treatments that each subject was receiving,
specifically:
• Ventilation or respiratory support i.e. use of nasal prong oxygen, continuous
positive airway pressure (CPAP), conventional ventilation, high frequency
jet ventilation (HFJV) and high frequency oscillatory ventilation (HFOV)
• Inspired oxygen concentration
• Cardiovascular drugs i.e. dopamine, dobutamine, milrinone, adrenaline,
noradrenaline
• Inhaled nitric oxide
• Prostaglandin El infusion (employed to maintain ductal patency)
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2.6 Physiological data
A three lead electrocardiogram (ECG) was recorded simultaneously with all
echocardiographic data (Philips IE33, Philips, Bothwell, WA). ECG gain was
adjusted (typically 60-75%) to ensure that distinct P waves and QRS complexes were
identifiable. An adequate ECG recording was essential for determination of cardiac
cycle phases on echocardiograms. This was particularly important when identifying
myocardial velocities in tissue Doppler imaging. Heart rate was calculated
automatically from the ECG and monitored continuously.
Systemic blood pressure (BP) was recorded in all infants in the PHT group at the
beginning of each study. BP data were required for comparison with pulmonary
artery pressure. BP was obtained from the bedside clinical monitor (Philips
Intellivue 80/90, Philips, Bothwell, WA) using a cuff sphygmomanometer or
invasive arterial catheter if one was already in use for clinical monitoring (radial,
posterior tibial or umbilical artery catheter).
Transcutaneous oxygen saturation (SaCC) was monitored for the study duration if it
was already in use for clinical monitoring of the patient. SaCE data provided
additional information on the safety and tolerability of different echocardiographic
measures.
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2.7 Echocardiographic data acquisition
All echocardiographic measures were made using a Philips IE33 (Philips Medical,
Bothell, WA), with an 8 MHz probe. All echocardiograms were performed by the
study researcher (NP), who trained formally in echocardiography as a Specialist
Trainee in paediatric cardiology, and is an extensive user of echocardiography in the
clinical neonatal setting. NP had been previously trained in the use ofTDI by a
supervising Paediatric Cardiologist (Dr Michael Cheung) who has extensive clinical
and research experience with this technique.
An initial "screening" echocardiogram was performed in each infant to identify
structural heart disease which would exclude the infant from the study. This
echocardiogram typically took approximately 20 minutes. If an abnormality was
detected on the screening echocardiogram then the attending neonatal Consultant
was informed and referral made to the Paediatric Cardiology department for further
assessment. Confirmation of structural heart disease excluded the infant from the
study. If an infant had a previously documented structural echocardiogram
performed for clinical purposes by the study researcher (NP) or another experienced
echocardiographer (Paediatric Cardiology Fellow or Consultant) then no screening
echocardiogram was performed.
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After the initial screening examination the following echocardiographic data were
obtained:
• Tricuspid valve Doppler (pulse wave and continuous wave Doppler)
• Pulmonary valve pulse wave Doppler
• 2-dimensional image of right ventricular outflow tract including pulmonary
valve
• 2-dimensional image of patent ductus arteriosus (when present) and ductal
flow pulse wave Doppler
• CTDI data acquisition
• PWTDI data acquisition
These raw data were used to obtain the measures of RV function: tricuspid valve
inflow velocities, MP1 and RVO, CTDI and PWTDI myocardial velocities, and
estimation of pulmonary artery pressure.
In collecting echocardiographic data, consideration was given to any displacement of
the heart from the normal position. This was a particular issue in infants with
congenital diaphragmatic hernia in whom the heart is usually displaced towards the
contralateral side, away from the diaphragmatic defect and herniating abdominal
contents.
All echocardiographic data were obtained over five cardiac cycles and a mean
obtained. All Doppler data was recorded from a minimal angle of insonation (<15°).
No angle correction was made.
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2.7.1 Tricuspid valve pulse wave Doppler and continuous wave
Doppler
The tricuspid valve was imaged from a 4-chamber view obtained from an apical
position (i.e. below the left nipple in normal infants, or more medially in infants with
left congenital diaphragmatic hernia). Colour Doppler was used to visualise blood
flow and then the Doppler sample volume was placed in the centre of the colour
flow, between the valve tips, as demonstrated in Figure 2.2. A pulse wave Doppler
waveform was obtained at this position, for offline measurement of inflow velocities.
These data were required for measurement of tricuspid valve inflow velocities (E and
A wave velocities) and calculation ofMPI.
Figure 2.2: Apical 4 chamber view for tricuspid valve Doppler recording
Doppler beam
Doppler sample volume positioned between valve tips of tricuspid valve. Care taken to
minimise angle of insonation to <15°
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Colour Doppler was then used to identify any tricuspid regurgitation (TR) jet. If TR
was present then continuous wave Doppler was used to record the velocity along a
plane through the middle of the TR jet. This data was required for assessment of
pulmonary artery pressures using TR jet velocity.
Pulse wave Doppler was used for assessment of inflow velocities because the
technology allows assessment of low velocities within a small sample volume,
excluding extraneous blood flow velocities along the axis of the Doppler beam.
However, pulse wave Doppler is unable to measure the higher velocities seen in TR
jets in pulmonary hypertension. Instead, continuous wave Doppler was used to
assess these higher velocities, but had the disadvantage that the recorded Doppler
waveform was a composite of all velocities along the entire plane of Doppler beam.
2.7.2 Pulmonary valve pulse wave Doppler
Pulmonary valve pulse wave Doppler data was required to calculate RVO and MPI.
The pulmonary valve was visualised using 2-d echocardiography from a left
parasternal long axis view as shown in Figure 2.3. This position was displaced
medially in infants with left-sided congenital diaphragmatic hernia. In each infant
the image was optimised, by depth and angle adjustment, to ensure that the
pulmonary valve was positioned centrally in the echo window (as seen in Figure 2.3).
Colour Doppler was then used to visualise blood flow across the pulmonary valve.
The pulse wave Doppler sample was then positioned within the midstream at the
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level of the pulmonary valve leaflet tips and the Doppler velocity waveform
obtained.
Figure 2.3: Parasternal long axis view of pulmonary valve for pulse wave
Doppler recording and pulmonary valve diameter measurement
LV, left ventricle; RV, right ventricle, RVOT, right ventricular outflow tract; PV, pulmonary valve; MPA,
main pulmonary artery. Pulse wave Doppler sample placed between pulmonary valve leaflets.
Measurement "a" is the valve diameter measured between hinge points on the 2-dimensional image.
2.7.3 Pulmonary valve diameter
Pulmonary valve diameter was required for calculation of RVO, and was measured
from a 2-dimensional view of the valve obtained from a parasternal long-axis view.
Valve diameter was measured at the hinge points of the valve, at end systole using
frame-by-frame analysis (see Figure 9). This measurement was repeated over five
consecutive cardiac cycles, to reduce measurement error. The decision to measure
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valve diameter at the hinge point was based on a previous study which demonstrated
the highest inter-user repeatability for measurements at this position, compared to
measurements of pulmonary trunk and right ventricular outflow tract diameters [65],
2.7.4 Imaging and Doppler flow of patent ductus arteriosus
Two-dimensional echocardiography, with the addition of colour Doppler, was used
to identify the presence or absence of flow in a patent ductus from a high left
parasternal (ductal) imaging window. This technique of assessing ductal flow has
been previously well described and is accepted clinical practice [55, 108-110] .
Maximum ductal diameter was measured, from the colour Doppler flow image, at the
confluence of the patent ductus and the main pulmonary artery, using frame-by-
frame analysis. Pulse wave Doppler of ductal flow was obtained by positioning the
Doppler sample in the ductus at the same confluence of ductus and pulmonary artery
(Figure 2.4). If ductal flow velocity exceeded the limits of the pulse wave scale
(>1,5m/sec) then continuous wave Doppler was used instead. Ductal Doppler flow
recordings were required for determination of pulmonary artery pressures.
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Figure 2.4: Ductal view and position for Doppler recording of ductal flow
RVOT, right ventricular outflow tract; MPA, main pulmonary artery; RPA, right (branch) pulmonary
artery; LPA, left (branch) pulmonary artery.
2.7.5 Pulse wave TDI
In the 2-dimensional apical four chamber view, pulse wave Doppler was selected and
the Doppler sample was positioned in the myocardial region of interest. The smallest
TDI sample volume size was used (2 mm). TDI was then selected, producing a
waveform ofmyocardial velocities against time, from the region ofmyocardium
within the Doppler sample. The velocity scale was adjusted to produce an optimum
Doppler waveform (typically scale <10 cm/sec) and the sweep speed set to maximum
(150 mm/sec). TDI gain and reject settings were adjusted to produce the highest
resolution image avoiding blurring of the waveform and "speckling". Blurred




PWTDI was acquired in real time at the following positions; the basal right ventricle
at the lateral tricuspid valve annulus, the basal interventricular septum (1VS) at the
insertion of the mitral and tricuspid valves, and the basal left ventricle at the lateral
mitral valve annulus (Figure 2.5). Raw PWTDI data was used for measurement of
myocardial velocities and diastolic time intervals.
Figure 2.5: Positions for acquisition of PWTDI data from apical 4 chamber
view
RA, right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle.
A - basal right ventricle position, position for collection of RV TDI data
B - basal interventricular septum, position for collection of IVS TDI data
C - basal left ventricle, position for collection of LV TDI data
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2.7.6 Colour TD1 loop acquisition
An optimal apical four chamber view of the heart was obtained using 2-dimensional
echocardiography and then colour TDI mode selected. The velocity scale was
adjusted to select out myocardial velocities (<10 cm/sec) and colour gain was
adjusted to achieve good colour-coding of the myocardium, without extraneous
colorization of blood flows within the heart (Figure 2.6). A colour coded TDI cine-
loop of six consecutive cardiac cycles was then stored digitally for offline analysis of
CDTI myocardial velocities.





Left image: 2-dimensional apical four chamber view, with colour TDI mode selected
Right image: Corresponding schematic diagram of apical four chamber view. TDI sample volume in
basal RV position for collection of RV TDI data
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2.8 Post-acquisition analysis of echocardiographic
measures of RV function
From the raw echocardiographic data, the following measures ofRV function were
obtained by post-acquisition analysis:
• Tricuspid valve inflow velocities
• Right ventricular output
• Myocardial performance index
• PWTDI myocardial velocities and diastolic time intervals
• CTDI myocardial velocities
All measurements of Doppler velocities and time intervals were repeated over five
consecutive cardiac cycles, to take into account physiological variation including the
influence of respiratory variation.
2.8.1 Tricuspid valve inflow velocities
Peak E and A wave velocities were measured manually from the pulse wave Doppler
waveform of tricuspid inflow, using inbuilt analysis software on the Philips IE33. If
no E wave could be clearly distinguished then a velocity of "0" was recorded.
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2.8.2 Right ventricular output (RVO)
RVO was calculated using the flow calculation:
velocity-time integer (VTI) x heart rate x cross sectional area ofpulmonary valve
RVO =
weight
The units ofVTI were cm, of heart rate were beats-per-minute, and of CSA were
cm2. RVO was expressed in mL/kg/min.
Velocity time integer (VTI) was obtained from the pulmonary valve pulse wave
Doppler flow waveform. Using the trace function of the analysis software on the
IE33, each Doppler flow (one cardiac beat) was manually traced out and the area
under the traced curve automatically calculated. The area under the curve is the VTI,
which represents the distance travelled by a column of blood, across the valve, in
each heartbeat. The heart rate was automatically calculated from the accompanying
ECG.
The cross sectional area (CSApv) of the pulmonary valve was obtained using the
following formula:
CSApV = tt (valve diameter)2 / 4
The valve diameter was obtained by measurement from the two-dimensional, long
axis image.
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Calculation of RVO in this way is liable to significant error [103], Error present in
any of the three variables (VTI, valve diameter and heart rate) is multiplied when
inserted into the formula to calculate RVO. Furthermore any error in measurement
of valve diameter is increased by squaring this measurement to obtain CSA.
2.8.3 Myocardial performance index
RVmpi is the sum of RV isovolumic contraction (IVCT) and isovolumic relaxation
time (1VRT), divided by the RV ejection time (RVET). RVMpi was calculated from
tricuspid valve inflow and pulmonary valve outflow pulse wave Dopplers, (Figure
2.7) as has previously been described by Ishii et al [111]. The time period from
cessation to beginning of tricuspid inflow (a) and the right ventricular ejection time
(b) were measured. RVmpi is equal to (a-b)/b. One limitation of RVmpi calculated
in this way is that heart rate (and therefore IVRT and ICT) may vary between the
tricuspid and pulmonary valve Dopplers. Care was therefore taken to select paired
pulmonary and tricuspid Doppler flows between which R-R intervals varied by less
than 5 beats per minute.
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a - time interval cessation to beginning of consecutive tricuspid valve inflow
b - right ventricular ejection time
ICT, Isovolumic contraction time; IVRT, Isovolumic relaxation time
2.8.4 PWTDI data analysis
Post acquisition analysis was performed on each PWTDI waveform to obtain the
following velocities and time intervals:
Systolic velocities:
• Isovolumic velocity (IVV)
• Systolic ejection velocity (S)
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Diastolic velocities:
• Early diastolic velocity (E')
• Late diastolic velocity (A')
Time intervals:
• (Diastolic) Isovolumic relaxation time (IVRT)
• Diastolic filling time (DMDT)
• R-R interval
These velocities and time intervals are shown in Figure 2.8 below. All velocities and
time intervals were measured from five consecutive cardiac cycles and means
obtained.
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IVV, systolic isovolumic contraction velocity; S, systolic ejection velocity; E\ early diastolic velocity;
A', late diastolic velocity (occurs after P wave on ECG); IVRT, isovolumic relaxation time. DMDT (not
indicated) is the time from beginning of E' to cessation of A' velocities.
Velocities and time intervals were measured manually using the measurement
software on the Philips IE33. Maximal velocities in the PWTDI waveform were
measured. Specific velocities were identified by their characteristic appearance and
their timing in relationship to the ECG. IVV is a brief positive deflection
corresponding to the ECG Q wave. S occurs after IVV and is a prolonged systolic
velocity beginning at the ECG R wave. The E' wave is a negative deflection after
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the S wave and before the P wave of the ECG. The A' wave is a negative deflection
immediately following the P wave of the ECG. Distinguishing these components of
the PWTDI waveform was important in the setting of abnormal myocardial function
where the velocities may be significantly altered from the normal pattern and care
was taken to identify velocities correctly.
IVRT was measured from the cessation of the S wave to the beginning of the E'
wave. However, based on the researcher's experience, it was predicted that in some
infants IVRT may be difficult to measure accurately. Specifically it was felt that the
combination of high infant heart rates, short IVRT and spectral broadening of the
PWTDI waveform may introduce error into this measurement.
Given these concerns of inaccurate IVRT measurement, it was also decided to
measure another time interval: diastolic filling time (DMDT). DMDT has not been
reported before and was a new measurement. DMDT was defined as the period from
onset of the E' wave to cessation of A' wave. These time points are easily
identifiable allowing more reliable measurement of DMDT than IVRT. DMDT
represents the period during which there is diastolic displacement of the myocardium
associated with ventricular filling. DMDT was employed as a reciprocal measure of
IVRT: this makes the assumption that changes in IVRT produce reciprocal inverse
changes in DMDT i.e. lengthening of IVRT will produce a shortening of DMDT.
This assumption is not supported by any prior evidence, a limitation which is
discussed in interpretation of the diastolic time interval data later in this work.
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R-R interval was measured from the beginning of one 1VV to the beginning of the
next IVV. R-R interval was measured so that IVRT and DMDT could be "corrected"
for heart-rate by calculation of IVRT:R-R ratio and DMDT:R-R ratio. This
correction was intended to allow comparison of these time intervals between infants
with different heart rates. The validity of this correction was tested by investigation
of the relationship between IVRT and R-R interval, and the relationship between
DMDT and R-R interval.
2.8.5 Colour Tissue Doppler Imaging Analysis
Post acquisition analysis of TD1 data was performed using Philips Qlab software
operating on the Philips 1E33. Digitally recorded colour-coded TDI cine-loops,
obtained in the four-chamber view over five consecutive heart beats were uploaded
for analysis.
The myocardial region of interest for analysis was selected from the four-chamber
view by manually drawing a sample volume ("M-line"). The sample volume was
drawn along the longitudinal plane of the myocardium and adjusted to a standard
length of 5 mm and width of 2.5 mm. The cine CTDI loop was then played at low
speed and the sample volume's position manually adjusted throughout each cardiac
cycle to maintain position within the myocardial region of interest. Care was taken
to position the sample volume within the myocardium and not in the epicardium,
pericardium or within the cardiac chambers.
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The sample volume was positioned in the basal RV at the lateral tricuspid annulus to
assess RV velocities, and at the basal interventricular septum at the medial insertions
of the tricuspid and mitral valves to assess interventricular septum velocities. These
were the same positions in which PWTDI velocities were obtained.
CTDI analysis ofmyocardial velocities was performed at frame rates of 189-212 Hz,
i.e. within the sample volume the myocardial velocity was measured 189-212 times
per minute. The CTDI waveform produced is a graph of the average velocity within
the sample volume, against time, over the duration of the recorded echo loop (i.e five
cardiac cycles in this study). Figure 2.9 is a representative CTDI waveform
produced in this way.
Curve processing was not used in analysis of the CTDI data. This functionality of
the processing software allows "smoothing" of the CTDI waveform but may lead to
loss of short-lived velocities within the waveform, such as IVV.
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Figure 2.9: Analysis of CTDI data to produce myocardial velocity waveform
Four chamber apical view in CTDI mode (left) and corresponding schematic diagram (right). CTDI
sample volume positioned in right basal myocardial region. Analysis of myocardial velocities in this
region using Qlab software generates velocity waveform as seen below.
Sample CTDI myocardial velocity waveform (left) and corresponding schematic diagram (right). IVA,
isovolumic acceleration; IVV, isovolumic contraction velocity; S, systolic ejection velocity; E', early diastolic
velocity; A', late diastolic velocity.
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IVV, S, E and A waves were identified from their appearance and timing in relation
to ECG data, as was similarly described for PWTDI velocities. CTDI velocities were
manually measured using Qlab software. Isovolumic acceleration (IVA) was also
measured. IVA has previously been reported as a load-independent measure of
systolic ventricular function [49], IVA was calculated by positioning the measuring
caliper at the peak A' wave velocity and adjacent peak IVV velocity. The slope of
the line between these two points represents IVA.
Time intervals (IVRT, DMDT) were not measured from the CTDI waveform.
Following initial trial attempts to measure these intervals on CTDI, it was realised
that the Qlab software restricted measurement of time intervals to those between
fixed frames, or sample points, which in turn were dependent on the frame rate.
Sample points could not be manually positioned at the preferred positions at which
time intervals would ideally have been measured. It was therefore decided not to
measure time intervals from CTDI data.
2.9 Estimation of pulmonary artery pressure
Pulmonary artery pressure was estimated using two techniques, 1) velocity of
tricuspid regurgitation (TR) and 2) pattern of ductal shunting.
If TR was present then a maximal velocity was measured from the continuous wave
Doppler waveform of the tricuspid valve regurgitant jet flow. A modified Bernoulli
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equation was then used to calculate the pressure gradient between the right atrium
and right ventricle [96]:
Pressure gradient = 4 x (maximal TR velocity)2
Pulmonary artery pressure was quantified by adding 5 mmHg (an estimation of right
atrial pressure) to this gradient. PAP calculated in this way was divided by systemic
systolic BP and was classified as greater than two-thirds systemic (but less than
systemic), systemic or supra-systemic. PAP was only estimated in this way if TR
Doppler waveform had been obtained from which peak TR velocity could be clearly
obtained. An incomplete waveform with an indistinct maximal velocity was not
considered suitable for calculation of PAP pressure.
PAP pressure was also estimated by assessment of ductal shunting [55, 97], The
pulse wave Doppler waveform of ductal flow was assessed visually. If shunting was
exclusively, or predominantly left-to-right, but of low velocity (<2 m/sec), then this
was considered to demonstrate sub-systemic PHT. If shunting was bidirectional and
of low velocity (<2m/sec), then this was considered to demonstrate systemic PAP. If
ductal shunting was exclusively or predominantly right to left, this was considered to
demonstrate supra-systemic PAP.
No attempt was made to quantify peak PAP from ductal shunt velocities. Although a
ductal pressure gradient may theortetically be calculated from ductal shunt velocities
using a modified Bernoulli equation, this cannot be used to accurately determine
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PAP without corresponding knowledge of the timing of peak systolic pulmonary
artery and systemic pressures [55],
Repeated measures of all RV function data and PAP were made in the PHT group to
investigate the relationship of PAP and RV function. In these studies, it was
important to quantify PAP and therefore only the TR jet velocity method was used.
If no TR jet was present, or the maximal TR velocity could not be clearly identified
on the Doppler waveform, then the study was not included in later analysis.
2.9 Data storage
All raw echocardiography data was saved in digital format to recordable digital
versatile disc (Sony DVD-R, 8x, 4.7GB; Sony Corporation; Tokyo, Japan). Control
studies were randomly assigned a unique three digit code to anonymise data. Studies
were uploaded from DVD to the IE33 for subsequent analysis.
2.10 Statistical analysis
All demographic data and treatment data obtained from the clinical notes, were
recorded in a pre-formatted spreadsheet (Microsoft Excel; Microsoft Corporation,
Seattle, WA, USA). All echocardiographic data, recorded from five consecutive
cardiac cycles, were entered manually into a separate spreadsheet for each subject.
Subject means were combined to generate separate control and PHT group datasets.
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The proportion of infants in whom echocardiographic data could not be acquired or
analysed, was calculated for each measure ofRV function.
Group data were tested for normality (Gaussian distribution) using a Kolmogorov-
Smirnov test. Continuous, normally distributed data were summarised as a mean and
standard deviation (SD) for each Group. Nominal categorical data were summarised
as a frequency and as a percentage of the total group size.
All subsequent statistical analysis was performed using GraphPad Prism version 4.00
for Windows (GraphPad Software, San Diego California USA). In all statistical
analyses, a P value of <0.05 was considered significant. Baseline demographic and
treatment data were compared between control and PHT groups. Continuous data
were compared using Mann-Whitney tests. Categorical data were compared using
Fisher's exact test.
In statistical analysis of the echocardiographic data the fundamental questions were:
1. For each echocardiographic measure of RV function is there a significant
difference between control and PHT Groups?
2. In the PHT Group, is PAP linearly related to RV function (assessed by each
echocardiographic measure)?
To answer the first question, RV function data (for each echocardiographic measure)
were compared between control and PHT Groups. These data were displayed
graphically as a mean and standard deviation of each of the two Groups, for each
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echocardiographic measure of RV function. Mann-Whitney tests were used to
investigate the statistical significance of differences between the two groups. Mann-
Whitney tests were chosen because this test allows comparison of unpaired data sets
in which the difference between medians may not be normally distributed.
To answer the second question, linear regression analysis was performed to
investigate the relationship between PAP and each measure ofRV function. These
relationships were presented graphically by plotting each paired measure of RV
function (y axis) and PAP (x axis), and generating a "best-fit" line. Linear regression
analysis was summarised by reporting the slope and r2 for each echocardiographic
measure of RV function.
2.12 Summary
This chapter has sought to explain how the research study was developed and
designed to meet the clinical aim: to improve assessment and treatment of RV
dysfunction in infants with PHT. Three fundamental research questions and
corresponding hypotheses have been presented and their relevance argued. The
development of a case control study design in a neonatal population to test the
hypotheses, was discussed. The inclusion, and exclusion, of echocardiographic
measures to assess RV function in the study population, the practicalities of
obtaining data using these, and analysis of these data have then been explained.
The subsequent chapters present the results of the studies performed according to
these methods. The study population characteristics are presented first. Thereafter
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each chapter presents RV function data obtained using each specific
echocardiographic measure, in both PHT and control groups. A final results chapter
presents the paired PAP and RV function data for investigation of the relationship
between PAP and RV function.
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CHAPTER 3
DESCRIPTION OF STUDY POPULATION
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3.1 Introduction
The purpose of this chapter is to describe the study population, and compare baseline
characteristics between control and PHT groups. Enrolment to each group is
discussed in relation to the entire inpatient population of the NNU at RCH, for the
duration of the study period. The characteristics of the subjects in each group are
then reported; demographic details, diagnoses, and current treatments. Differences in
baseline characteristics between the control and PHT groups, and their significance
to inter-group analyses, are discussed.
3.2 Study population enrolment
The study population was enrolled between 12th May 2006 and 30th April 2007.
During this period a total of 611 infants were admitted to the NNU at RCH, of whom
38 had a diagnosis of pulmonary hypertension. Nine of these infants had congenital
heart disease and were not eligible for enrolment in the PHT group. A further 13
infants were not enrolled for one or more of the following reasons:
• Pulmonary artery pressure of less than two-thirds systemic arterial pressure
• No tricuspid regurgitation jet or no patent arterial duct by which pulmonary
artery pressure could be assessed echocardiographically
• The infant was too unstable to tolerate echocardiography
• Access was not available to the patient due to ongoing clinical care
• Access was not available to echocardiography machine
• The study researcher was not available to perform the study
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A total of 16 infants were therefore recruited to the PHT group. Twenty-eight infants
were recruited to the control group. A further two eligible infants were not enroled
to the control group because their parents declined to provide consent for study.
Control group size was limited by the duration of the study, access to
echocardiography equipment and availability of the study researcher.
3.3 Demographic characteristics
The demographic data are summarised in Table 3.1 for each group, and discussed
below.


















Weight (kg) 3.2 ± 0.7 3.3 ± 0.7 0.57
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3.3.1 Gestation and age
Mean gestation for control and PHT infants was approximately 38 weeks, and not
significantly different between the two groups. Eight infants in the control group
were premature with gestational ages at birth from 28 to 36 weeks. Three infants in
the PHT group were preterm with gestational ages of 35 to 36 weeks. This is
consistent with previous reports that PHT is predominantly, though not exclusively, a
disease of the term infant [4],
Corrected gestational age was not significantly different between PHT and control
Groups (approximately 40 weeks). Age, in days, ranged from seven to 58 in the
control group, and from one to 91 days in the PHT group. The higher mean age in
the control group, compared to the PHT group, approached statistical significance
(P=0.05). The older age of the control infants reflects the fact that most were
recruited and studied when they were stable, after an initial diagnosis had been made
and treatment instituted. Very often control infants were studied just prior to their
discharge from the NNU. In contrast PHT group infants were generally recruited
and studied early in their admission, immediately after a diagnosis of PHT had been
made. Eight infants in the PHT group were recruited and studied on day one of life
which is consistent with previous reports that most causes of PHT in the newborn
present in the first 72 hours of life [112]. Four exceptions were infants who were
over two weeks old when they were recruited to the PHT group. Two of these
infants were already inpatient in the NNU when the study commenced. The other
two infants were referred to the NNU at RCH, from other hospitals, at the ages of six
and 12 weeks and subsequently enrolled in the study.
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The differences in age of the infants in the two groups is of relevance because RV
function is known to change in early post-natal life [67, 113], With the transition
from fetal to ex-utero circulation the RV becomes less thick-walled and more
compliant. Accordingly, early diastolic filling is reduced in the fetus and early in
post-natal life but increases thereafter. The difference in ages between the control
and PHT groups, and its potential influence on RV function, is of relevance when
comparing the two groups in subsequent chapters.
3.3.2 Diagnoses
Table 3.2 lists the primary diagnoses of the infants in the PHT group and the degree
of pulmonary hypertension demonstrated on initial echocardiogram. In all of these
infants PHT was either the primary diagnosis (i.e. idiopathic PHT) or associated with
the primary diagnosis (CDH, meconium aspiration syndrome, alveolar capillary
dysplasia, vein of Galen malformation).
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Table 3.2: Primary diagnoses in the PHT group












12 Idiopathic PHT systemic
13 Idiopathic PHT systemic
14 Vein of Galen Malformation supra-systemic
15 Meconium aspiration supra-systemic
16 Alveolar-capillary dysplasia systemic
*PAP assessed from ductal shunt alone
Eleven infants in the pulmonary hypertension group had CDH. Pulmonary
hypertension, due to structurally and functionally abnormal pulmonary vasculature,
is recognised as a significant cause ofmorbidity and mortality in CDH, both pre- and
post- surgical repair of the diaphragm [114],
Two infants had idiopathic, or primary, PHT. One of these infants also had trisomy
21. No other infants in the PHT group had chromosomal abnormalities. The
association between trisomy 21 and idiopathic pulmonary hypertension in the
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neonatal period has been previously described although the precise mechanism of
elevated PVR is not well understood [115]. The second infant with idiopathic PHT
had additional problems ofmacrosomia, organomegaly and structural brain
abnormalities, but no unifying diagnosis.
The primary diagnoses in the remaining infants were meconium aspiration syndrome
(MAS), alveolar capillary dysplasia (ACD), and vein of Galen malformation
(VGAM). MAS is a relatively common cause of pulmonary hypertension in which
failure of the normal fall in PVR at birth is attributed to ongoing hypoxia and
activation of the inflammatory cascade. This condition represents a major cause of
PHT in the early neonatal period, and carries a significant mortality [112, 116].
Alveolar capillary dysplasia is a rare cause of severe PHT in the newborn,
characterised by progressive and severe PHT within the first weeks of life. The
condition is characterised by developmental abnormalities and deficiency of the
pulmonary microvasculature, and is universally fatal in infancy [117]. VGAM is a
rare congenital arterio-venous fistula in the brain. In severe cases VGAM can
present with high output cardiac failure and severe pulmonary hypertension in the
newborn infant [16]. It has been proposed that PHT in VGAM is due to high blood
flows through an otherwise normal pulmonary vascular tree.
The variety of diagnoses in the PHT group reflects the many different causes of PHT
in the newborn infant [2], However, the frequency of these diagnoses in the PHT
group may not be representative of their frequency in the entire newborn population.
In a study by Walsh-Sukys et al of 385 infants with PHT, admitted to 12 neonatal
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units in North America, the commonest causes of PHT were: MAS (41%), idiopathic
PHT (17%), pneumonia and/or respiratory distress syndrome (14%), CDH (10%) and
pulmonary hypoplasia (4%) [112]. In comparison, the disproportionately high
number of infants with CDH in the PHT group reflects the unique nature of the
inpatient population at the NNU at RCH. This is the surgical referral centre for all
newborn infants with CDH within the state ofVictoria, and in the past decade has
treated up to 17 CDH infants each year. This experience in managing CDH has led
to the development of a treatment protocol (based on "gentle" ventilation, use of
inhaled nitric oxide, and prostaglandin to maintain ductal patency) which is
associated with significantly improved survival [118]. The assessment of RV
function in infants with PHT due to CDH was therefore of particular interest within
our institution.
Although the causes of PHT in the study sample, and their relative frequencies, may
differ from a wider population, the principle issue in these studies was assessment of
RV function in infants with PHT. Even if the causes and mechanisms of increased
pulmonary artery pressure may not be representative, the net result on the RV is
arguably the same - increased afterload.
None of the control infants had a diagnosis associated with pulmonary hypertension
or evidence of pulmonary hypertension on echocardiogram. Thirteen infants had
gastro-intestinal disease requiring surgery, two had genito-urinary abnormalities
requiring surgery (post-op), five were inpatients for treatment of neonatal infection,
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two had gastro-oesophageal reflux and the remaining six had other medical neonatal
problems.
3.4 Pulmonary artery pressures in PHT group
In the PHT group, thirteen infants had a tricuspid regurgitation jet from which PAP
could be measured. In the remaining three infants, PAP was assessed from ductal
shunting patterns. PAPs in each subject are listed in Table 2. One infant had PAP
greater than two-thirds peak systemic arterial pressure, but less than peak systemic
arterial pressure. Ten infants had PAP approximately equal to peak systemic arterial
pressure, and five infants had supra-systemic PAP.
Repeated echocardiograms were performed in the PHT group to investigate the
relationship between PAP and RV function. A total of 67 studies were performed
(including the 16 initial echocardiograms in each PHT subject). A minimum of two
studies and a maximum of eight studies were performed in the same infant. In these
67 studies pulmonary artery pressure could only be quantified (using an acceptable
tricuspid regurgitation jet) in 46 studies. These 46 studies were used for later
analysis of the relationship between RV function and PA pressure.
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3.5 Therapies
The current therapies of each infant were recorded at the time of the initial
echocardiogram. All of the infants in the control group were self-ventilating in air;
none received mechanical ventilation, inotropic medication, inhaled nitric oxide,
sildenafil, prostaglandin El infusion or muscle relaxant.
3.5.1 Ventilation
In the PHT group all but one infant was receiving mechanical ventilation. Of those
who were mechanically ventilated, eight (50%) received conventional ventilation,
four received high frequency oscillatory ventilation (HFOV), and three received high
frequency jet ventilation (HFJV). Three of the infants receiving HFOV, and all of
the infants receiving HFJV, had CDH. The fourth infant receiving HFOV had severe
MAS. HFOV has been found to be effective in MAS and is increasingly used in this
setting [119]. HFJV is generally reserved for infants whose lungs demonstrate
severe gas trapping or are prone to overdistension, both of which are problems
frequently encountered in the ventilation of infants with hypoplastic lungs, as in
CDH.
3.5.2 Inhaled nitric oxide (iNO)
Seventy-five percent of infants in the PHT group were receiving inhaled nitric oxide
(iNO) at the time of the initial echocardiogram. Dose varied from 7 to 30 parts per
million (ppm). iNO, a pulmonary vasodilator, is a mainstay ofmanagement of PHT
and whose efficacy has been widely demonstrated in the neonatal setting [2, 11],
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3.5.3 Sildenafil
Oral sildenafil, a phosphodiesterase type five inhibitor, was being administered to
three infants in the PHT group (dose range 1.2 to 1.5 mg/kg per dose, four times per
day). These were the oldest infants in the group. Oral sildenafil is increasingly used
in infants with severe PHT to facilitate weaning of iNO. However to date there have
been no large-scale controlled studies of this agent's efficacy, safety or longer-term
outcomes [120, 121],
3.5.4 Inotropes
Intravenous inotropes were being administered to 50% of infants in the PHT group.
Five infants received dopamine (5-15 mcg/kg/min), four infants received dobutamine
(10-20 mcg/kg/min) and three infants received milrinone, a phosphodiesterase
inhibitor (0.25-0.50 mcg/kg/min). Two infants were receiving two inotropes and one
infant was receiving all three inotropes. Indications for inotropes were hypotension
and/or ventricular dysfunction.
3.5.5 Prostaglandin Ej
Prostaglandin Ei (PGEi) infusion was being administered to eight infants (50%) in
the PHT group. This agent is employed to maintain ductal patency with the intention
of promoting right-to-left shunting through the ductus, thereby providing a "blow-
off' valve to a failing right ventricle and reducing RV afterload. PGE) may also be a
pulmonary vasodilator. Success using PGE] in severe PHT has been reported in a
number of case series [16, 38, 121], However, this therapy has not been assessed in
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a controlled study, nor have the effects of PGEi on RV function been directly
assessed.
3.5.6 Muscle relaxant
Thirty-eight percent of infants in the PHT group were receiving muscle relaxant
(either intravenous pancuronium or vecuronium). Muscle relaxation is generally
reserved for those infants in whom management of pulmonary hypertension and/or
respiratory disease is most difficult. Muscle relaxants are proposed to assist
ventilation by inhibition of spontaneous breathing and possibly by reducing
pulmonary artery pressure. Despite their routine clinical use, there is very limited
published evidence supporting the use ofmuscle relaxation in infants [122],
Is the use of these therapies in the sample group representative of the general
population of infants with PHT? In Walsh-Sukys et al's survey of neonatal PHT
management in the early 1990's ("pre-iNO" era) 39% of infants received high
frequency ventilation (HFOV or HFJV), 84% received inotropic medication, and
73% received muscle relaxant [112]. Compared to these data, the infants in the study
group received less inotrope, less muscle relaxant and, understandably, more iNO.
This may reflect a widespread change in management practice of PHT in the
subsequent decade.
These therapeutic data are also informative in demonstrating the severity of illness in
the subjects. The widespread requirement for cardio-respiratory support in the PHT
group indicates that this was a group of very sick infants. The control group, in
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contrast, required no such therapies, and was a group of stable, relatively well
infants.
The difference in therapies between the groups has implications for future
comparisons between these groups. None of the infants in the control group were
receiving any of the documented therapies whilst 94% of the infants in the PHT
group were receiving at least one therapy. Each of the therapies, has the theoretical
potential to alter RV function either directly (particularly in the case of inotropic
medications) or indirectly by altering preload or afterload. Any comparison of RV
function between PHT and control groups must take this into consideration. Any
observed difference in RV function between the PHT and control groups could in
part be influenced by these therapies, and cannot be attributed to the effects of
elevated PAP alone. An ideal control group would be one in which the subjects were
receiving the same, or similar, therapies as the PHT group. However, within the time
confines of this clinical study, it was not possible to recruit matched control and PHT
infants.
3.5.7 Ductal patency
No infant in the control group had a patent arterial duct. In the PHT group fourteen
infants had patent arterial ducts (88%), of whom eight (50%) were receiving PGEi.
Average duct diameter was 3.2 mm (range 1.7 to 4.0 mm). As discussed above, the
patent ductus may have a theoretical effect on RV function, independent of PAP, by
acting as a "blow-off valve" to reduce RV afterload. The difference in ductal
Chapter 3, 124
patency between PHT and control group therefore represents another potential reason
for differential RV function between these groups.
3.6 Limitations of the study population
The control group of infants were all inpatients in the neonatal unit. They had
medical and surgical diagnoses and were, strictly speaking, not "normal", healthy
infants. However, these control infants had no evidence of pulmonary hypertension
or other cardiovascular disease, and were not receiving any therapy known to alter
pulmonary artery pressure or myocardial function. For the purposes of assessing
myocardial function they were therefore considered to represent normal controls.
Infants in the PHT group had a variety of diagnoses. Furthermore, the presumed
mechanisms of PHT differed within these infants e.g. abnormal pulmonary
vasculature in ACD and CDH versus increased pulmonary blood flow in VGAM. It
was not possible within the confines of the study duration and setting to recruit a
PHT group of infants with a single, consistent diagnosis. However, the majority of
infants in the PHT group had CDH. The management of infants with this condition
is of particular interest within the unit therefore subgroup analysis of RV function in
the CDH subgroup was performed and is presented in the appendix.
As discussed above it was not possible to control for therapies between the PHT and
control groups. Consequently, any observed difference in RV function in infants
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with PHT, compared to controls, may not solely be due to increased PAP, but other
factors, including therapies in this group. Unravelling the individual influences of
these factors on RV function is impracticable in a clinical study and beyond the
scope of this work. Despite these limitations, it was felt that detecting changes in RV
function in infants with PHT in the clinical setting, whichever the causes of these,
was still a valid aim with clinical relevance.
3.7 Summary
These data describe the nature of the study population. The control and PHT groups
were both composed of term infants of similar gestation, corrected gestational age,
and weight. However, whilst the control infants were relatively well, stable infants,
the PHT subjects were sick infants receiving varied cardio-respiratory therapy.
Differences in age, therapy, and ductal patency between the two groups may each
potentially contribute to differences in RV function, independent of the effects of
elevated PAP. This hypothesis requires consideration in the analysis of later results.
However, it is stressed that the purpose of these experiments was assessment of RV
function in infants with PHT and not determination of the sole effects of elevated
PAP on RV function. Accordingly, these differences in baseline characteristics do
not invalidate further comparison between groups in subsequent chapters.
Chapter 4, 126
CHAPTER 4
TRICUSPID VALVE DOPPLER INFLOW VELOCITIES
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4.1 Introduction
In this chapter data relating to tricuspid valve Doppler velocities are presented. For
each group, data collection and analysis are reported together with summary statistics
of E and A wave velocities. Inter-group comparison statistics are then reported and
group data plotted to provide an impression of differences between the groups.
Finally, in the discussion section the feasibility of the technique is discussed,
together with the significance of any inter-group differences in relation to RV
function in PHT, limitations of the experiment and ofTV Doppler as a technique for
assessment ofRV function.
4.2 Control Group data
Tricuspid valve Doppler data were obtained in 28 infants in the control group
(100%). There were no clinically significant deteriorations during the collection of
this data. In two infants in the control group E and A waves appeared to be fused,
and the peak velocities of the two waves could not be distinguished. These two
infants were therefore not included in further analysis. Fusion of E and A waves is a
recognised phenomenon at higher rates [55].
Mean E wave velocity in the control group was 0.52 (0.13) cm/sec. Mean A wave
velocities in the group were 0.55 (0.10) cm/sec. Velocities passed a test of normality
(Kolmogorov-Smirnov test), indicating Gaussian distribution.
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4.3 PHT Group data
Tricuspid valve Doppler data were obtained in all 16 infants (100%) in the PHT
group. There were no clinically significant deteriorations during data collection.
In ten infants in the PHT group no E wave could be identified i.e. no tricuspid valve
flow occurred before the P wave on the ECG. In these cases there was an isolated A
wave, identified by its commencement after the P wave of the accompanying ECG.
An example of such absence of the E wave in a PHT infant is provided in Figure 4.1
below. The absence of a distinct E wave was not thought to be due to E-A fusion for
two reasons: firstly, there was no diastolic Doppler wave prior to the P wave on the
ECG (i.e. where an E wave would normally occur); secondly, the absence of an E
wave occurred in infants with heart rates as low as 130 beats per minute, and not
only at higher rates where EA fusion may be predicted.
In those ten infants in whom no E wave could be identified, no E wave velocity was
recorded. Consideration was given as to whether an E velocity of zero cm/sec should
be recorded in these infants and included in statistical analysis. However, this
probably invalidates numerical analysis, and therefore numerical group data includes
only those infants in whom an E wave could be identified and measured. In these
remaining six infants, in whom E waves were present, mean velocity was 0.39 (0.11)
cm/sec. A waves were present in all infants in the PHT group with mean velocities
of 0.70 (0.22) cm/sec.
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Figure 4.1: Tricuspid valve Doppler waveforms; normal and PHT infant
Normal tricuspid valve Doppler
waveform; E and A waves clearly
present
PHT tricuspid valve Doppler
waveform. No E wave is
present. An A wave is present
occurring after the P wave on the
ECG.
4.4 Between group comparison
The absence of E waves in ten infants in the PHT group was the most striking
difference between PHT and control groups. In those six infants in the PHT group in
whom E waves were present, E velocities were lower than in the control group,
although this did not reach statistical significance (P=0.06). Conversely A wave
velocity was significantly increased in the PHT group compared to controls.
Summary statistics for comparison between the PHT and control group are provided
in Table 4.1. These inter-group differences are represented graphically in Figure 4.2
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(E wave velocities) and Figure 4.3 (A wave velocities). It is important to note that
these summary statistics do not include the E' velocities from those ten PF1T infants
in whom no E wave was present.
Table 4.1: Peak E and A wave velocities in the control and PHT groups
Control Group PHT Group P
E wave velocity
(cm/sec)
0.52 ±0.13 0.39 ±0.20* 0.06
A wave velocity
(cm/sec)
0.55 ± 0.11 0.69 ±0.22 0.04
* data from six infants in PHT group in whom E wave identified. No E wave present in
remaining 10 PHT infants
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Line represents mean. PHT data include only those infants in whom E waves could be
identified (n=6). Data from remaining ten PHT infants, in whom no E wave identified, is not
included in this figure.


























The potential for heart rate differences or age differences between the groups to
contribute to the observed differences in Doppler velocities was considered.
Tricuspid Doppler velocities are dependent on heart rate [55] and therefore the
observed between-group differences could potentially have been due to heart rate
differences between the control and PHT group. However, in this study, mean heart
rates were not significantly different between the two groups (138 (15) vs. 150 (17),
P=0.07). Diastolic RV function is also dependent on postnatal age: in the fetus early
diastolic filling is reduced and the A wave is dominant [67], The possibility that
differences in postnatal age could contribute to the inter-group difference in E wave
velocity was investigated by plotting E wave velocity against age (in days) for each
group, as seen in Figure 4.4. For the purpose of this analysis (but not inter-group
statistical analysis) those PHT infants in whom no E wave was present were
attributed an E velocity of 0 cm/sec. The important point, shown in this figure, is that
E wave velocities were lower in the PHT group at all ages, including the youngest
infants. This does not support the hypothesis that differences in E wave velocity are
due to age differences between the groups
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E velocities tended to be lower in the PHT group than the control group, independent of
postnatal age. (NB Infants in PHT group in whom no E wave present were attributed a
velocity of zero cm/sec.)
4.5 Discussion
4.5.1 Feasibility
Tricuspid valve Doppler is an established technique in infants [55, 113], The current
data confirm the feasibility of tricuspid valve Doppler in normal and PHT infants.
This assertion is based on the findings that the technique could be performed safely
in 100% of infants in both the control and PHT groups, that meaningful quantitative
measures (of E and A wave velocity) could be made, and that intra-group velocities
demonstrated an acceptable level of variance.
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4.5.2 Reduced E wave velocity: comparison with previous reports
and significance
The most striking finding in this experiment was the reduction in, or absence of, E
wave velocities in the PHT group. Indeed, in 63% of infants in this group the E
wave was entirely absent indicating complete loss of early diastolic filling. These
findings are in agreement with previous demonstrations of reductions in E wave
velocity in adults with PEIT [66], but have not been previously reported in infants
with PHT.
A similar pattern of impaired diastolic filling is seen in the left ventricle in some
adults with ischaemic heart disease, hypertension, and cardiomyopathy [123-125], In
these patients the same pattern of reduced E wave velocity, described as "type 1
diastolic dysfunction", is attributed to an inherent impairment of myocardial
relaxation.
The absence of, or reduction in, E wave velocities in this study might also be
considered to indicate impaired myocardial function (reduced active relaxation
and/or reduced passive compliance) in the RV of infants with PHT. However, atrio¬
ventricular valve Doppler velocities are not solely dependent on myocardial function,
but are also highly load-dependent i.e. altered by preload and afterload [26]. The
trans-tricuspid velocities are determined by the instantaneous pressure gradient
across the valve. This is the difference between right atrial pressure (RAP) and RV
diastolic pressure RVEDP. RAP is both preload and afterload dependent. RVEDP is,
in turn, determined by myocardial properties (active relaxation and passive
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compliance) and by afterload (PAP) [26]. Doppler velocities are therefore highly
load-dependent [126].
The observed absence of, or reduction in, E wave velocity could therefore reflect a
reduction in RAP or an increase in RVEDP independent of, or as well as, a change in
myocardial function. It is conceivable, for example, that use of ventilation or
vasodilators in the PHT group could have contributed to a reduced preload and
therefore reduced RAP in this group. Alternatively, the increase in PAP, producing
an increased afterload in the RV, may be sufficient to produce the observed changes
in E wave velocity.
4.5.3 Increased A wave velocity: previous reports and significance
The significant increase in A wave in the PHT group has not been previously
reported in infants with PHT. It is hypothesised that this may represent increased
atrial contraction in these infants to generate increased late diastolic RAP. This
would serve as a compensatory mechanism to maintain RV diastolic filling in the
face of reduced early diastolic filling in PHT. Indeed, studies in adults have
demonstrated increased RA contractility in chronic pulmonary hypertension [127],
Stretch-induced changes in intracellular calcium may be important in mediating this
increase in atrial myocyte contractility [128], An alternative, but not mutually
exclusive explanation is that the apparent increase in A wave size in fact represents
abnormally delayed ventricular relaxation occurring late in diastole and coinciding
with atrial contraction.
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4.5.4 Limitations of this study
Failure to minimise the angle of insonation of the Doppler beam through the
transtricuspid flow may have led to under-measurement of peak velocities.
However, care was taken, even in those infants with cardiac malpositioning (e.g. in
congenital diaphragmatic hernia), to maintain an angle of insonation of less than
fifteen degrees. Sub-optimal Doppler image quality and "spectral widening" of the
Doppler waveform may have led to error in post-acquisition measurement of Doppler
velocities. Furthermore, during data analysis the researcher was not blinded to
control and PHT group data, which may have allowed introduction of bias.
4.5.5 Limitations of tricuspid valve Doppler as a measure of RV
function
As discussed above, the biggest limitation ofTV Doppler as a measure of RV
function is the load-dependence of this measure. It is unknown whether changes in
TV Doppler velocities, in particular E velocity, are the direct consequence of
changes in loading, or actual changes in myocardial function. Consequently TV
Doppler, though a rapid and practicable technique, is limited as a measure of RV
myocardial function, when used in isolation.
4.6 Conclusion
In this chapter the tricuspid valve Doppler velocities in the control and PHT groups
have been reported and compared. This data has confirmed that tricuspid valve
Doppler is a feasible technique in newborn infants. In infants with PHT early
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diastolic (E wave) velocities were reduced, or absent, although the difference
between groups did not reach statistical significance. This may be suggestive of
impaired diastolic myocardial RV function. However, different loading conditions in
the PHT group may also have contributed to the impaired early diastolic filling,
highlighting the load-dependence of tricuspid valve Doppler as a measure of
myocardial function. Increases in A wave velocity in the PHT group, meanwhile,






In this chapter the data relating to measurement of RVO are presented. The
echocardiography data acquired for RVO calculation are each reported first i.e.
pulmonary valve (PV) diameter, velocity time integer (VTI) and heart rate (HR).
RVO, calculated using these data, is then reported. Results of inter-group
comparison are provided for each of the echocardiographic measures and for RVO.
In the discussion section, the experimental data are interpreted in relation to
feasibility of the technique, agreement with previously published data, and the
significance of any differences between the PHT and control groups. Finally,
limitations of the study, and limitations of RVO as a technique are discussed.
5.2 Data collection and analysis for RVO calculation
Echocardiographic data required for calculation of RVO were successfully obtained
in all 28 infants in the control group (100%), and all 16 infants in the PHT group
(100%), without significant clinical deterioration. All data were successfully
analysed to allow measurement of PV diameter, HR, VTI, and subsequent
calculation of PV cross sectional area (CSA), stroke volume (SV) and RVO. Results
for each of these measures are reported below and summarised in Table 5.1.
5.3 Pulmonary valve diameter and cross sectional area data
PV diameters for each group are summarised in Table 5.1. Control group PV
diameter was 0.73 (0.09) cm (range 0.54-0.96cm). PHT group PV diameter was 0.91
(0.11) cm (range 0.76 to 1.12 cm), and significantly elevated compared to the control
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group (P<0.0001). Pulmonary valve cross sectional area in the control group was
9 • 9
0.43 (0.10) cm", and in the PHT group 0.60 (0.16) cm". The increased valve area in
the PHT group was statistically significant (P<0.0001).
To investigate whether the inter-group difference in valve diameter (and CSA) was
related to differences in infant weight, PV diameter was plotted against weight for
each infant in both groups (Figure 5.1). It can be seen that, for all weights, PV
diameter was lower in the control infants than the PHT infants, suggesting a genuine
increase in valve diameter in the PHT group, not related to greater infant size in this
group.











To investigate whether increased valve diameter in the PHT group was present from
birth, or developed postnatally, valve diameter and infant age were plotted for each
infant (Figure 5.2). As demonstrated in this figure PV diameter tended to be higher
in the PHT group at all postnatal ages, including the first days of life. This may
suggest that increased valve diameter in the PHT group is present from before birth.
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5.4 Velocity time integer (VTI)
Pulse wave Doppler waveforms of pulmonary valve flow were analysed offline to
obtain velocity-time integers (VTI). Control group mean VTI was 14.4 (1.6) cm.
PHT group mean VTI was 10.2 (4.1) cm. This difference was significant (P=0.004).
5.5 Heart rate
HR was obtained from the ECG accompanying pulmonary valve Doppler data.
Mean HR in the control group was 138 (18) beats per minute (bpm). In comparison,
heart rate in the PHT group was significantly elevated at 154 (19) bpm, P= 0.016.
5.6 RVO
RVO was calculated, as discussed in Chapter 2, using VTI, valve cross-sectional area
and heart rate data from each group, inserted into the equation:
VTI x heart rate x CSA
i\V() —
weight
Mean RVO in the control group was 273 ± 81 mL/kg/min (range 134 to 518
mL/kg/min), and in the PHT group was 308 ±133 mL/kg/min (range 140 - 652
mL/kg/min). This difference was not significant (P=0.60).
The product ofVTI and CSA is SV:
SV = VTI x CSA
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SV represents the volume of blood ejected across the pulmonary valve with each
heart beat, and was calculated and reported here as it gave some indication of
myocardial function, independent of heart rate. Mean SV in the control group was
6.1 (1.7) mL/kg, and in the PHT group 7.0 (4.0) mL/kg. This difference was not
statistically significant (P=0.91).








0.73 (0.09) 0.91 (0.11) <0.0001
Pulmonary valve cross-
sectional area (cm2) 0.43 (0.10) 0.60 (0.16) <0.0001
Velocity time integer (cm) 14.4 (1.6) 10.2 (4.1) 0.004
Heart rate (bpm) 138 (18) 154 (19) 0.016
Stroke volume (mLs/kg)
6.1 (1.7) 7.0 (4.0) 0.91
Right ventricular output
(mL/kg/min)
273 (81) 308 (133) 0.60
5.7 Discussion
5.7.1 Feasibility
RVO measurement in infants is a well established technique, the feasibility ofwhich
was confirmed in control and PHT infants in this study. [65],
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5.7.2 Agreement between RVO in controls and existing normative
data
Mean cardiac output in newborn infants, measured using indicator dilution
techniques and Doppler echocardiography of left ventricular output, has previously
been reported as being in the range 246 mL/kg/min and 265 mL/kg/min [129-131],
Normative RVO data, obtained using pulse wave Doppler echocardiography, has
been reported once before in a population of normal term and preterm infants, by
Tsai-Goodman et al [65], Mean RVO in that study was 255 mL/kg/min. The
slightly higher mean RVO in our control population may be due to a genuine
increase in cardiac output in this group. Five infants in the PHT group had diagnoses
which might have led to increased cardiac output, i.e. infection and metabolic
disease. Another explanation for higher RVO in our control group is measurement
error, which is a particular limitation of RVO measurement, discussed later in this
section.
5.7.3 Inter-group differences in RVO
There was no statistically significant difference between RVO in the PHT group and
control groups. There was, however, a non-significant trend toward higher RVO in
the PHT group which, if genuine, may be secondary to significant right-to-left
shunting via a PDA, which was present in 14 infants (88%). In these infants, RVO
represents a combination of pulmonary blood flow and a proportion of systemic
blood flow, and should therefore exceed the equivalent RVO in a normal infant
without shunts (e.g. the control infants in this study). Indeed, RVO up to twice
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normal values has previously been reported in infants with right-to-left ductal shunts
in PHT due to VGAM [16, 132],
Another explanation for high RVO in the PHT group is increased metabolic rate in
these sick infants. The infants in the PHT group tended to be sicker with diagnoses
associated with increased metabolic demand.
5.7.4 Inter-group differences in heart rate and stroke volume
Heart rate was significantly increased in the PHT group, whilst SV was not
significantly different. This suggests that RVO in PHT infants is maintained by
chronotropic (heart rate-dependent mechanisms) rather than by an increase in
myocardial function. It may be hypothesised that myocardial function, in the PHT
group, was depressed or could not be increased further, hence the requirement for an
increase in HR. Analysis of RVO alone, however, can give no indication of the
relative contributions of heart rate, myocardial function and loading conditions. This
highlights again, the limitation of RVO as a "global" measure ofRV function, which
cannot be used to measure myocardial function in isolation.
5.7.5 Intergroup differences in pulmonary valve diameter
It was an unexpected finding that valve diameter was significantly higher in the PHT
group compared to controls. VTI was, conversely, lower in the PHT group,
indicative of lower trans-valvar flow velocities across a wider valve. The overall
effect, as discussed above, was that RVO did not differ between the two groups. The
increased valve diameter in the PHT group was seen in infants of all weights.
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The reasons for an increase in PV diameter in infants with PHT are unclear.
Increased afterload, and increased flow (RVO), may conceivably lead to distension,
or "stretch" of the valve in PHT. However, we observed the increased valve
diameter in infants with PHT at all ages, including within the first day of life. This
suggests that increased PV diameter is a developmental phenomenon in fetal life.
Since high PAP, and high RVO, are universal findings in the normal fetus, then some
another developmental factor in the PHT infants, may be responsible for increased
PV diameter. This important, co-incidental finding represents an interesting area for
further study. Of note, Suda et al have previously observed that PV diameter tended
to be smaller, compared to normal, in infants with CDH [133]. However, their study
involved retrospective analysis of echocardiography data, which may not have
included optimal views for measuring valve diameter. Further investigation, with
larger study populations may help to identify whether PV diameter is genuinely
different in PHT.
5.7.6 Limitations of this study
The researcher was not masked to the diagnosis during data analysis, with the
potential that bias may have been introduced. The echocardiographic images were
also of variable quality. Image quality tended to be worst in those infants with lung
hyperinflation and/or significant parenchymal lung disease, in whom ultrasound
"windows" were small and image resolution poor. Error may have been introduced
in the measurement of valve diameter from poorer quality two-dimensional images,
in which identification of valvar hinge points was difficult. Repeated measurement
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of valve diameter, over five consecutive cardiac cycles in each infant, was performed
in an attempt to reduce this measurement error. Similarly, Doppler image quality
may have affected VTI measurements. In poorer quality images spectral broadening
of the Doppler waveform may have led to overestimation ofVTI.
5.7.7 Limitations of RVO as a measure of myocardial function
As discussed above, a major limitation of RVO is that it is a global measure
determined by preload, myocardial function, heart rate and afterload. The individual
contribution ofmyocardial function to RVO cannot be distinguished.
A second limitation of any Doppler measure of cardiac output, including RVO, is the
potential for high levels of variability (error) in measurement [103]. Total
variability, in RVO measurement, is a combination of physiological variability and
intra-observer variability (repeatability) or inter-observer variability
(reproducibility). Measurement variability (measurement error) may be introduced
in the collection of each of the measures required for the calculation of RVO,
particularly measurement of pulmonary valve diameter [65], Measured valve
diameter may vary depending on 1) whether the valve has been imaged across its
maximum diameter, 2) the time in the cardiac cycle at which the diameter is
measured, 3) the position within the right ventricular outflow tract at which valve
diameter was measured and 4) the quality of the echocardiographic images (as
discussed above). Any error in valve diameter is further increased by squaring this
measure to obtain CSA. It was not possible to measure repeatability of RVO
measurements in this study. Previous studies have reported co-efficients of variation,
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for both intra-observer variability and inter-observer variability, of Doppler cardiac
output as high as 22% [ 103].
The calculation of RVO is also a time consuming process. Although the time taken
to derive RVO was not formally measured in this study, it was the researcher's
experience that the entire process, including obtaining all data, performing analysis
and calculation, took at least 30 minutes per infant. This included repeating
measures over five cardiac cycles.
5.8 Conclusion
The data presented in this chapter has confirmed the feasibility of measuring RVO in
normal infants and infants with PHT. RVO was not significantly different in the
PHT group compared to the control group. However this study has also highlighted
limitations of RVO as a measure ofmyocardial function. The "global" nature of
RVO, with its load and heart-rate dependence, means that it cannot be used
specifically to assess RV myocardial function. Indeed, the observation that HR was
increased in the PHT group, whilst SV did not differ, suggested that myocardial
function was not increased (or may even have been be decreased) in the PHT group,
despite no difference in RVO. Furthermore, the presence of significant ductal shunts
in the PHT group indicates the confounding influence that shunts may have on RVO,
invalidating comparison with "normal" RVO values. The potential for error to be
introduced at various stages in the calculation of RVO brings into question the
repeatability of this technique. The time consuming nature of RVO calculation also
makes it impracticable for use in the clinical setting.
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The finding of increased PV diameter, independent of age and weight, in the PHT
group was unexpected and merits further investigation.
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6.1 Introduction
In this chapter, the data relating to measurement of the RV myocardial performance
index (RVmpi) are presented. Firstly, the experience of obtaining and analyzing
tricuspid valve and pulmonary valve Doppler data is reported. Next, the Doppler
time intervals, measured for RVmpi calculation are reported, as is heart rate for each
group. The calculated RVmpi is then reported together with inter-group comparison
statistics. The relationship between RVmpi and age is also reported for each group to
investigate whether age differences between the groups might contribute to
differences in RVmpi- In the discussion section the feasibility of RVmpi is considered.
Any differences in RVMpi between PHT and control groups are discussed in relation
to RV myocardial function. Comparison is made with prior reports of RVmpi in PHT
states. Limitations of this experiment, and of RVmpi as a technique for assessing RV
function, are then discussed.
6.2 Data collection and analysis
Tricuspid and pulmonary valve Doppler data for RVmpi calculation were obtained in
28 infants (100%) in the control group and 16 infants (100%) in the PHT group. All
echocardiograms were well tolerated without clinically significant deterioration.
Tricuspid valve Dopplers used for RVmpi calculation were the same as those
collected for measurement of diastolic trans-tricuspid velocities in Chapter 4.
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Pulmonary valve Dopplers obtained for RVmpi calculation were the same as those
obtained for RVO calculation in Chapter 5.
In five infants in the control group echocardiographic data could not be analysed to
obtain Doppler time intervals. This appeared to be a problem with the analysis
software on the Phillips IE33 which prevented measurement of time intervals from
echocardiographic data which had been stored on DVD and re-uploaded to the IE33.
This problem could not be resolved despite assistance from the manufacturer. The
same problem was not encountered in analysis of the remaining 23 control studies
directly from the inbuilt hard-drive of the IE33. All 16 studies in the PHT group
were successfully analysed.
6.3 Doppler derived time intervals for RVmpi calculation
Doppler time intervals were measured for RVmpi calculation as described in Chapter
2 and are summarised, for each group, in Table 6.1 below. The time interval from
cessation of ventricular filling in one cardiac cycle to commencement of ventricular
filling in the next cycle (a) was measured from the tricuspid valve Doppler. Mean
"a" duration was 249 (25) milliseconds in the control group and did not differ
significantly in the PHT group; 263 (33) msec, P =0.14. Right ventricular ejection
time (b) was measured from the accompanying pulmonary valve Doppler waveform
of each infant. Mean "6" duration was 201 (15) msec in the Control Group and
significantly shorter in the PHT group; 171 (21) msec, PO.OOOl.
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Table 6.1: Doppler-derived time intervals in control and PHT groups
Control PHT p




249 (25) 263 (33) 0.14
b 201 (15) 171 (21) <0.0001
(milliseconds)
а, time between cessation of and commencement of tricuspid inflow obtained from tricuspid
valve Doppler. b, right ventricular ejection time obtained from pulmonary valve Doppler.
б.4 Heart rate
Mean HR in the control group, at the time of obtaining RVMPi data, was 138.2 (16.3)
bpm. Mean HR in the PHT group was significantly elevated compared to controls:
154.3 (17.3) bpm, P=0.01. Comparison of HR between the groups was important,
since differences in HR may contribute to differences in RVmpi, independent of
changes in myocardial function.
6.5 Calculated RVmpi
RVmpi was calculated as described in Chapter 2, using the following formula:
RVKIP, =^A
b
RVmpi in the control group was 0.24 (0.09), and 0.55 (0.17) in the PHT group. The
increased RVmpi in PHT was statistically significant, P<0.0001. RVmpi in the control
and PHT groups is plotted in Figure 6.1 to demonstrate the inter-group difference.
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Control Group PHT Group
P<0.0001. Line represents mean for group.
6.6 RVmpi and age
A previous study has observed that RVmpi falls within the first days after birth [72].
The control group were significantly older than the PHT group, in terms of postnatal
age (see Chapter 3), raising the possibility that the difference in RVmpi might have
been due to age differences between the groups. The relationship between RVmpi and
age was therefore investigated for each group using linear regression analysis.
RVmpi did not correlate with age in the PHT group (r2=0.001, P=0.90; Figure 6.2) or
in the control group (r2=0.005, P=0.76; Figure 6.3). That RVmpi did not correlate
with age in either group suggests that differences in RVmpi cannot be attributed to
age differences between the two groups.
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6.7 Discussion
6.7.1 Feasibility
This study has confirmed the feasibility ofmeasuring RVmpi in infants, including, for
the first time, those with PHT. The tricuspid and pulmonary valve Dopplers required
for RVmpi calculation could be obtained rapidly and were well tolerated. The
technical issue which prevented measurement of Doppler time intervals, and hence
RVmpi calculation in five control infants, appeared to be a problem peculiar to the
Phillips IE33 machine used for these experiments.
6.7.2 RVMpi in the control group: comparison with previous reports
RVmpi in the control group was in good agreement with previous reports in
comparable normative study populations (Table 6.2). Malakan-Rad et al measured
RVmpi in a group of 51 infants in the first 48 to 72 hours of life and reported a mean
RVmpi of 0.23 (0.14). Borzoee et al, studying a population of 108 children, aged 3
days to 18 years reported an RVmpi of 0.25 (0.09) [134], Similarly, Ishii et al
reported a mean RVmpi of 0.24 (0.04) in 150 healthy children aged 30 days to 18
years [111].
Table 6.2: RVmpi in normal infants: comparison of current data with published
literature
Study n Age RVmpi
Borzoee et al [134] 108 3 days to 18 years 0.25 (0.09)
Malakan-Rad [135] 51 48 to 72 hours 0.23 (0.14)
Ishii [111] 150 30 days to 18 years 0.24 (0.04)
This study
(control group)
23 7 to 78 days 0.24 (0.09)
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6.7.3 Elevated RVmpi in PHT: significance and comparison with
previous reports
This experiment demonstrated, for the first time, elevated RVmpi in infants with
PHT. This is in good agreement with previous reports of elevated RVmpi in older
children and adults with PHT. Yeo et al demonstrated a raised RVmpi (median 0.83)
in a group of 53 adults with primary pulmonary hypertension [104], Dyer et al
subsequently reported increased RVmpi (0.64±0.30) in children with idiopathic
pulmonary hypertension [75], However, the patho-physiological processes
responsible for chronic PHT in these paediatric and adult populations may differ
from those in newborn infants. It cannot therefore be assumed that the increase in
RVmpi in our control population is produced via the same mechanisms. The only
prior report of RVmpi in a "newborn" population, was by Sugiura et al, who have
similarly demonstrated an increased RVmpi in a newborn piglet model of hypoxia-
induced pulmonary hypertension [73],
What is the mechanism and significance of a raised RVmpi in PHT and can it be
considered an indicator of RV myocardial dysfunction? RVMpi, like RVO, is a
"global" measure of circulatory function, which is dependent on myocardial function
and loading conditions. Vogel et al have demonstrated this load dependence of
RVmpi in a pig model in which RVmpi was observed to change in the face of
manipulations of preload and afterload, without changes in myocardial function [76].
The elevated RVmpi in the experiments presented here may therefore be an indication
of changing load, in particular increased afterload, and not changes in myocardial
function per se. Even if elevated RVmpi did reflect a change in RV myocardial
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function, it provides no information on the mechanism of this change i.e. the relative
contributions of systolic and diastolic function. Furthermore, because of the way the
index is calculated, a decrease in systolic function could conceivably be masked by
an increase in diastolic function and vice versa.
Examination of the individual time intervals used to calculate RVmpi, provides
further information on the possible mechanisms ofRV dysfunction in the PHT
group. RVET was shorter in the PHT group compared to controls, whilst time period
"a " was not significantly different, a is the sum of 1VRT, isovolumic contraction
time (ICT) and RV ejection time (RVET). It follows that a longer IVRT and/or
longer isovolumic contraction time (ICT) must have produced the higher RVmpi in
the PHT group. ICT may be expected to increase in the face of increased afterload,
as the contracting ventricle must generate increased pressures before the pulmonary
valve can open and ventricular ejection can occur. If IVRT were lengthened then
this would suggest that some degree of diastolic dysfunction would also be present.
However, the experimental data gave no indication of relative changes in ICT or
IVRT.
The age of the infants in the two groups required consideration when interpreting the
observed difference in RVmpi. Tsutsumi et al have previously reported that RVmpi is
age dependent, being higher in fetal life and at birth, but falling acutely within the
first 48 hours of life to approximately 0.25 to 0.3 [72], However, Borzoee found no
correlation between age and RVmpi, in infants over 48 hours old [134], Analysis of
the current experimental data also found no correlation between RVmpi and postnatal
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age. It was therefore felt that inter-group differences in RVmpi could not be attributed
to the age difference between the younger PHT group and older control group.
6.7.4 Limitations of this study
This study was not blinded in data analysis or collection, with the result that observer
bias may have been introduced. The difference in heart rates between the PHT and
control groups may have directly altered RVmpi and confounded the results. At
higher heart rates, diastole is shortened, and RVmpi might be expected to decrease.
However in this experiment, the PHT group had a higher mean HR yet RVmpi was
still significantly increased in this group. In an ideal experiment, in which HR was
the same in PHT and control groups, RVmpi might reasonably be expected to be even
higher in the PHT group than that observed in the current study.
Physiological variation in heart rate when obtaining the separate tricuspid and
pulmonary valve Doppler measurements, in each infant, may also have confounded
RVmpi calculation. Therefore care was taken to obtain these two measures
consecutively and over the shortest period of time.
6.7.5 Limitations of RVmpi
A major limitation of RVmpi, as discussed above, is that it is a "global" measure, and
gives no indication of relative systolic or diastolic function. In addition the index is
highly load-dependent, and in the setting of PHT it cannot be known whether
changes in RVmpi reflect genuine changes in myocardial function or simply changes
in afterload.
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6.8 Conclusions
RVmpi can be easily measured in infants, and is elevated in those with PHT.
Although this increase in RVmpi may represent a genuine change in myocardial
function in PHT the direct effects of preload and afterload may also have contributed
to the observed difference. Furthermore, RVmpi could not distinguish specific
changes in systolic and diastolic function. This highlights the global nature and load-
dependence of RVmpi which limit its use as a clinical measure ofRV myocardial
function.
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CHAPTER 7
PULSE WAVE TISSUE DOPPLER IMAGING
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7.1 Introduction
In this chapter the data relating to use of PWTDI assessment of RV function in
normal infants and infants with PHT are reported. The experience of PWTDI data
collection and analysis are discussed first. Next, PWTDI systolic velocities, diastolic
velocities and diastolic time intervals are presented. Summary statistics are provided
for each group together with inter-group comparison statistics. Group data is
presented graphically, when relevant, to highlight inter-group differences. The
relationship between diastolic velocities and age, and diastolic velocities and heart
rate were also considered. In the discussion section the feasibility of PWTDI in the
infant RV is considered in light of the study findings. Finally, between-group
differences in PWTDI data are discussed in relation to mechanisms of RV
dysfunction in PHT.
7.2 Data collection and analysis
PWTDI data were obtained in 25 (89%) infants in the control group and 16 infants
(100%) in the PHT group. In the three remaining infants in the control group,
PWTDI data could not be obtained because study echocardiograms were
discontinued to allow routine clinical care of the infants. All echocardiograms which
could be performed to collect PWTDI data were well tolerated without clinically
significant deterioration.
Analysis of PWTDI data was performed offline as described in Chapter 2, to obtain
systolic and diastolic time velocities and diastolic time intervals. All 25 collected
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PWTDI studies in the control group were successfully analysed. Fifteen (94%) of
the PWTDI studies in the PHT group were also analysed successfully. In the one
remaining infant in the PHT group, PWTDI data from the RV could not be analysed
due to artefact on the Doppler waveform caused by high frequency oscillatory
ventilation (HFOV). This problem was not encountered in analysis of the data from
the other three infants who were also receiving HFOV, nor in the three infants
receiving HFJV. All subsequent RV PWTDI data presented in this chapter refer to
the 15 infants in whom RV data could be analysed.
The systolic velocities IVV and S were measured in all infants. However, it was
found that IVA could not be accurately measured from PWTDI data because of
spectral broadening of the Doppler waveform. Even at the highest recording speed
(150mm/sec), and with gain settings optimised, the upslope of the isovolumic
velocity was too steep and the trace too broad to allow meaningful measurement of
the slope (IVA).
The diastolic velocities E' and A' were also measured in all infants in whom PWTDI
analysis could be performed. In eight infants in the PHT group no distinct E'
velocity could be identified, and instead only an isolated single diastolic velocity was
present (Figure 7.1). This single velocity was identified as an A' wave because of its
occurrence after the P wave of the corresponding ECG. The absence of an E' wave
in these infants was considered to be a genuine and significant finding, as is
discussed later in this chapter. However, as no E' velocity could be measured, the
data from these infants was not included in numerical statistical analysis.
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It was intended that the diastolic time period IVRT be measured in the RV and IVS
in all infants in whom PWTD1 data could be analysed. However, difficulty was
encountered when measuring IVRT in the RV in four infants in the PHT group. In
these infants the cessation of the S wave and the beginning of the E' wave (i.e. the
IVRT period) could not be accurately identified due to the presence of an unexpected
positive velocity after and continuous with the S wave (see Figure 7.1 below). This
positive velocity was designated a "post-systolic contraction" as it occurred after the
S velocity. The presence of "post-systolic contraction" in these four PHT infants
prevented IVRT measurement. Of note, a similar positive velocity, after the S wave,
was also present in a further nine infants in the PHT group and also in eleven infants
in the control group. In these cases however, the velocity was small and its
commencement was distinct from the end of the S wave, therefore IVRT could still
be measured.
Figure 7.1: PWTDI waveform from an infant with PHT
PWTDI waveform from control infant (left) and PHT infant (right). No E' velocity is present in
the PHT infant; instead only a single A' velocity occurring after the P wave of the
accompanying ECG. Also present in the PHT infant is a prominent post systolic positive
velocity (*) after the S wave in early diastole.
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RV IVRT was therefore measured in 11 infants in the PHT group, and in all 25
infants in the control group. IVRT in the IVS was measured in all infants in both
groups.
In view of these difficulties measuring IVRT in the RV in four infants in the PHT
group, it was decided to measure another diastolic time interval, which has not been
described before and which for the purposes of this study was referred to as the
diastolic myocardial displacement time (DMDT). As discussed in Chapter 2, DMDT
was defined as the period from the beginning of the E' wave to the end of the A'
wave. The sum of IVRT and DMDT represents the total duration of diastole.
Measurement of DMDT was not affected by the presence of a "post-systolic"
contraction velocity, and could be obtained in all infants in the PHT and control
groups.
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7.3 Systolic PWTDI velocity data
Systolic PWTDI velocities (IVV and S) were measured in the RV and IVS.
Velocities for each position, in each group, are reported in Table 7.1.
Table 7.1: Systolic PWTDI velocities in the RV and IVS
Control Group PHT Group P
RV
IW 6.6 (1.1) 5.3 (1.3) 0.0015
S 9.2 (1.9) 7.0 (2.0) 0.0004
IVS
IW 3.4 (0.5) 3.9 (1.1) 0.19
S 5.0 (0.7) 5.1 (1.4) 0.95
All data mean (SD)
7.3.1 Systolic PWTDI velocities in the RV:
In the RV, IVV was significantly reduced in the PHT group compared to the control
group (5.3 vs. 6.6 cm/sec, P=0.0015). S velocity was also significantly reduced in
the RV in the PHT group compared to the control group (7.0 vs. 9.2 cm/sec,
P=0.0004). These between-group differences are demonstrated graphically in Figures
7.2 and 7.3.
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7.3.2 Systolic PWTDI velocities in the IVS
In the IVS there was no significant between-group differences in IVV (3.9 [1.1] vs
3.4 [0.5] cm/sec, P=0.19) or S velocity (5.1 [1.4] vs. 5.0 [0.7] cm/sec, P=0.95). Of
note, systolic velocities were significantly lower in the IVS than in the RV, in both
the control and PHT groups.
7.4 Diastolic PWTDI velocities
Diastolic PWTDI velocities (E' and A') in the RV and IVS are summarised in Table
7.2.
Table 7.2: Diastolic velocities in the RV and IVS, in PHT and control groups
Control Group PHT Group P
RV
E'* -8.6 (2.0) -4.1 (2.2) 0.0006
A' -11.7 (4.2) -10.1 (2.5) 0.21
IVS
E'* -5.4 (1.1) -3.8 (0.5) <0.0001
A' -6.3 (1.3) -6.4 (2.9) 0.73
*E' velocity from 7 infants in PHT group in whom E' velocity was present and measurable. In
remaining 8 infants in PHT group no E' velocity was present and no velocity measured.
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7.4.1 Diastolic PWTDI velocities in the RV
E' velocities were present in the RV of all infants in the control group with a group
mean (SD) of -8.6 (2.0) cm/sec. E' velocities were present in the RV of seven
infants in the PHT group. In the remaining eight infants in the PHT group no E'
velocity could be identified. No E' velocity was recorded in these infants. This issue
is discussed in detail later in the chapter and all numerical PHT group data presented
here excludes these infants.
Mean RV E' velocity for the entire PHT group was -4.1 (2.2) cm/sec. The reduction
in E' velocity in the PHT group compared to the control group was highly significant
(P=0.0006). This inter-group difference in represented graphically in Figure 7.4.


















Lines represent means. P=0.0006
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A' velocity in the RV in the control group was -10.1 (2.5) cm/sec, and in the PHT
group was -11.7 (4.2) cm/sec. There was no significant inter-group difference,
P=0.21.
7.4.2 Diastolic PWTDI velocities in the IVS
Diastolic velocities in the IVS are provided in Table 7.2, and discussed here. E'
velocity in the IVS in the control group was -5.4 (1.1) cm/sec. In the PHT group no
IVS E' wave was present in seven infants, and in these cases no E' velocity was
recorded. These were the same infants who had no identifiable E' wave in the RV.
Mean E' velocity in IVS in the PHT group was -3.8 (0.5). The reduction in E'
velocity in IVS in the PHT group was significant (P<0.0001).
A' velocity, in the IVS, in the control group was -6.3 (1.3) and was not significantly
different from A' velocity in the PHT group; -6.4 (2.9), P=0.73.
It is notable that E' and A' velocities were of significantly lower amplitude in the
IVS than in the RV, in the control group (P<0.0001).
7.4.3 E' velocity and heart-rate
Diastole is shortened at higher heart rates. It was therefore considered that E'
velocity may also be altered by heart rate, and that heart rate differences between the
PHT and control groups might have contributed to the observed inter-group
differences in RV E' velocity. The relationship between E' velocity was therefore
Chapter 7 , 171
investigated. As shown in Figures 7.5, there was poor correlation between E'
velocity and heart rate in the control group (r2 =0.03, P=0.44).
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7.4.4 Diastolic velocities and age
RV diastolic function is known to change in the first days of postnatal life [67]. The
relationship between RV diastolic velocities and postnatal age was therefore
investigated. In the control group RV E' velocity was found to correlate negatively
with postnatal age (r =0.2, P=0.03) as shown in figure 7.6. RV A' velocity in the
control group did not show significant correlation with age (r2=0.1, P=0.1).
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Chapter 7 , 173
7.5 Diastolic time intervals
IVRT and DMDT were measured from the RV and IVS PWTDI waveforms of
infants in each group. As discussed above, IVRT could not be measured in the RV in
four infants in the PHT group due to the presence of positive "post-systolic"
velocities.
Time intervals were corrected for heart rate by dividing the time interval by the heart
rate (R-R interval) to produce a ratio i.e. IVRT:RR and DMDT: RR. This correction
was deemed valid based on the observation that, in the control group, both IVRT and
DMDT demonstrated good linear correlation with heart rate (Figure 7.7).
Figure 7.7: Relationship between diastolic time intervals and heart rate in
control group
RV IVRT (msecs) RV DMDT (msec)
1^=0.18, P=0.04 r2=0.62, P<0.0001
Corrected diastolic time intervals in the RV and IVS are listed for control and PHT
groups in Table 7.3. IVRT:RR was significantly increased in the PHT group
compared to controls in the RV (0.22 [0.04] vs. 0.11 [0.02], P<0.0001) and in the
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IVS (0.22 [0.05] vs. 013 [0.02], PO.OOOl). DMDT:RR was, accordingly,
significantly reduced in the PHT group compared to controls, both in the RV (0.30
[0.07] vs. 0.39 [0.05], P=0.0001) and in the IVS (0.31 [0.08] vs. 0.37 [0.04],
P=0.035).
Table 7.3: Diastolic time intervals in the RV and IVS in PHT and control
groups
Control Group PHT Group P
RV
IVRT:RR 0.11 (0.02) 0.22 (0.04) <0.0001
DMDT:RR 0.39 (0.05) 0.30 (0.07) 0.0001
IVS
IVRT:RR 0.13 (0.02) 0.22 (0.05) <0.0001
DMDT:RR 0.37 (0.04) 0.31 (0.08) 0.035
7.6 Discussion
7.6.1 Feasibility
These data confirmed the feasibility of performing PWTDI in the RV and IVS of
newborn infants. The technique was well tolerated and safe. Although PWTDI data
was not collected in three infants in the control group, this was not due to any
difficulty performing the technique. Instead, studies were cut short for unrelated
clinical reasons. This highlights the limitations of any study in sick newborn infants
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who require ongoing routine clinical care, which may disrupt collection of study
data.
These data also demonstrate the feasibility of post-acquisition analysis of PWTDI
data to obtain myocardial velocities and time intervals. This included analysis of
PWTDI data from three infants receiving HFOV and three receiving HFJV. In one
infant in the PHT group however, HFOV did produce artefactual disruption of the
PWTDI waveform preventing meaningful analysis. The reasons why artefact was
encountered in the PWTDI waveform in this subject, and not in the others receiving
high frequency ventilation, were unclear. However, it is hypothesised that increased
compliance of the lungs and chest wall, in combination with the ventilation settings
used, may have allowed greater transmission of oscillations from the airways to the
ultrasound transducer.
7.6.2 PWTDI velocities in the control group: comparison with
previous studies
PWTDI analysis of myocardial velocities in newborn infants has previously been
performed in two studies, Mori et al [94] and Pateman et al [105], Mori et al
measured S, E' and A' velocities, in the RV, IVS and LV, in a group of term infants
aged between one and seven days (n=135). Pateman et al, meanwhile, measured
PWTDI velocities in the IVS (S, E' and A') in 45 preterm infants, 32 of whom had
patent arterial ducts. PWTDI velocities obtained in these prior studies, together with
study group demographics, are shown for comparison with control group data from
the current study, in Table 7.4.
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Table 7.4: PWTDI velocities in control group and prior studies
Mori et al [94] Pateman et al [105] Control group
N 135 45 28
Weight 2.95 (0.3) 2.1 (1.0) 3.2 (0.7)
Gestation 39.5 (1.6) 32 (6) 37.0 (3.5)
Age 3.9 (2.0) days 16 (20) days 25 (20)days
Patent ductus Not reported 32 (71%) 0 (0%)
RV
S 6.6 (1.2) - 9.2 (1.9)
E' -7.5 (1.3) - -8.6 (2.0)
A' -9.2 (1.5) - -10.1 (2.5)
IVS
S 3.9 (0.7) 4.2 (1.2) 3.4 (0.5)
E' -5.4 (0.9) -5.9 (1.5) -5.4 (1.1)
A' -5.2 (0.9) -3.7(0.7) -2.2 (2.0)
PWTDI velocities obtained in the control group were generally in good agreement
with those reported in the work ofMori et al and Patemen et al. Of note, however,
RV S wave velocity tended to be higher in the current study control group than in the
study ofMori et al (mean velocity 9.2 vs. 6.6 cm/sec). The higher RV S velocity in
the current study may be related to age differences between the two different study
populations. In the study ofMori et al, S velocity in the RV positively correlated
with the postnatal age (in days). The control group, from which the current data
were obtained, were considerable older than the group ofMori et al (25 days vs 3.9
days), and might therefore be expected to have higher S wave velocities.
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Septal A' velocity tended to be lower in the control group compared to the data of
Mori et al (-2.2 vs -5.2 cm/sec). The lower IVS A's wave in the current control
group, compared to the data ofMori et al, cannot easily be explained by any age
differences between the study populations, as no correlation was observed between
A' velocity and age.
Gestation and ductal patency may conceivably alter PWTDI velocities and may have
contributed to any differences in PWTDI velocities between these and the current
study. The study population in the work of Pateman et al was preterm (mean
gestation 32 weeks) and also had a high frequency of PDA (71%). The frequency of
PDA in the study of Mori et al was not reported, but since these infants were between
one and seven days of age it is possible that a number may have had a patent arterial
duct.
The current study is the first to measure IVV in a newborn population, as this was
not measured in either the study of Patemen et al or Mori et al. IVV has been
previously validated as a non-invasive measure of systolic contractile function in
animal and adult studies [49, 82], The current study therefore provides the first
normative reference data (from the control group) in an infant population.
In the control group PWTDI velocities were noted to be lower in the IVS than in the
RV in all phases of the cardiac cycle. This replicates the finding ofMori et al [94],
Higher velocities in the RV have previously been attributed to lower after-load on the
RV (compared to LV and IVS after-load) [79],
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7.6.3 Correlation of E' velocity and age
E' velocity, in the control group, increased in magnitude with age, in the first three
months of life. Changes in RV diastolic function in the first weeks of life have
previously been demonstrated by tricuspid valve Doppler studies, and may reflect the
transition from a dominant fetal RV to the adult RV [55, 67], Interestingly, Mori et
al found no such relationship between RV E' velocity and postnatal age, but studied
infants in only the first week of life. This may have been too short a timescale to
observe significant change in PWTDI velocities.
Could inter-group differences in E' velocity be explained by postnatal age
differences? The control group were older than the PHT group (mean 25 vs. 17
days; P=0.05), and therefore the lower E' velocities in the control group may be, at
least in part, attributable to this age difference.
7.6.4 Reduced systolic and diastolic PWTDI velocities in PHT:
significance and comparison with previous reports
Systolic velocities
This study is the first to use PWTDI to investigate systolic function in infants with
PHT and demonstrated significantly reduced IVV and S velocities in this population.
Similar findings have been reported in an adult study by Moustapha et al which
employed PWTDI to investigate RV function in PHT [93], This group observed
reduced S wave velocity in a group of 90 adult patients with chronic pulmonary
hypertension, compared to 50 normal adult controls. IVV was not reported.
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What is the significance of reduced IVV and S velocities in RV in PHT? As
discussed in the background chapter, S wave velocity correlates well with
conductance catheter measures of systolic function [80], but also appears to
demonstrate some dependence on preload and afterload [49]. The observed
reduction in S velocity may therefore indicate impaired systolic contractile function
and/or the direct effects of increased afterload in PHT. IVV, meanwhile, appears to
be a more robust measure of contractile function [82] which is only affected directly
by extreme loading conditions [49], The finding of reduced IVV in the RV in PHT
group therefore provides stronger evidence of a genuine reduction in systolic
contractile function in the infants with PHT. This finding highlights the potential of
PWTDI as a non-invasive technique for assessing and quantifying systolic function,
independent of diastolic function, in newborn infants.
It is of note that, despite the reduction in mean systolic velocities in the PHT group,
there was overlap of the ranges of systolic velocities between the two groups, as
represented visually in Figures 7.2 and 7.3. The preservation of "normal" velocities
in some infants in the PHT group likely reflects the variability of RV function in
PHT, which is recognised clinically, but has not been formally reported in infants
before [35],
Diastolic velocities
The reduction, or loss, of distinct E' velocities in the PHT group (in both the RV and
IVS) was one of the most striking findings of this study. Indeed in eight infants in
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the PHT group E' velocities were entirely absent in the RV. Three possible
explanations for the absence of E' velocities in these infants were considered:
1. E' velocities were reduced to the extent that they were undetectable on
PWTDI analysis (i.e effectively zero).
2. E' velocities were present but were delayed and occurred later in diastole at
the same time as the A' velocity, (and were therefore "hidden" within the A'
wave).
3. E' velocities were present but were fused with A' velocities as a result of
higher heart rates in the PHT infants.
The first explanation was considered the most likely on the basis that in the
remaining eight infants E' velocities were present, preceding A' velocities, but
reduced compared to control infants. A delay in E' velocity, leading to fusion with
A' velocities, was possible but was not observed in the other infants with PHT who
did have an E' velocity present, making this a less likely explanation. Considering
the third explanation; although heart-rate in the PHT group was increased compared
to the control group E' velocity correlated poorly with heart-rate in both the PHT and
control groups suggesting that higher heart rates were not responsible for lower E'
velocities. Furthermore, even when maximal Doppler sweep speeds (150mm/sec)
were used, to separate out myocardial velocities as much as possible, no discernible
E wave could be identified in those 8 infants.
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In view of these considerations, the absence of an identifiable E' wave in eight PHT
infants was believed to represent the genuine absence of a detectable early diastolic
myocardial velocity. This was one of the most striking findings of this study.
However, as no E' velocity could be measured in these eight infants they were not
included in statistical comparison between the PHT and control groups.
Although PWTDI has not been previously employed to assess RV function in infants
with PHT, similar findings have been observed in adults with PHT. Moustapha et al
reported that E' velocities, in the lateral (RV) and medial (IVS) tricuspid valve
annulus, were significantly reduced in adults with PHT compared to healthy controls,
whilst A' velocities were unchanged [93],
What is the mechanistic significance of reduced, or absent E' waves in PHT infants?
As discussed in Chapter 2, E' velocities correlate with invasive measures of active
myocardial relaxation [27, 89]. The reduction in E' velocity in PHT may therefore
indicate impaired active myocardial relaxation in early diastole. In those cases where
no E' velocity was present it appears that early active diastolic relaxation was
entirely absent. It is hypothesised that in the dilated, pressure-loaded RV, operating
beyond the peak of the Starling curve, the contractile apparatus of the myocytes is
stretched to the point that further active relaxation is not possible and instead
ventricular filling, and myocardial displacement is dependent on atrial contraction.
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Diastolic time intervals
1VRT was lengthened in infants with PHT, and DMDT correspondingly shortened.
Lindqvist et al have similarly demonstrated prolongation of PWTD1 derived IVRT in
the RV of adults with PHT. IVRT is known to correlate with invasive measures of
myocardial relaxation [27], but also appears to be directly load-dependent [91],
Prolonged IVRT in the PHT group may therefore represent impaired relaxation
and/or the direct effects of increased afterload.
Post-systolic velocities
The finding of post-systolic positive velocities, occurring after the S wave and before
the E' or A' velocity, was of interest. These were present in 11 infants in the control
group (in whom they did not interfere with IVRT measurement). It was therefore
hypothesised that they were a normal finding and may represent re-configuration of
the ventricle, i.e. relaxation in some parts of the ventricle and contraction in other
parts, in the transition from the contracting, shrinking systolic ventricle to a relaxing,
expanding diastolic ventricle. In four infants in the PHT group, however, the post-
systolic velocities were of high velocity (approximately equal to S') and continuous
with the S' wave preventing measurement of IVRT. It was considered that in these
infants the exaggerated post-systolic positive velocities might reflect ongoing
contraction of the pressure-loaded ventricle after pulmonary valve closure, or
discoordinate, asynchronous relaxation of the failing ventricle. This unexpected
observation represents a potential area for further study. Interestingly, similar
findings have been described in the failing adult LV where it has been noted that
impaired relaxation (i.e. diastolic dysfunction) is characterised by a prolonged IVRT
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secondary to asynchronous relaxation of different parts of the diseased myocardium
[26],
7.6.5 Limitations of this study
There were limitations inherent in this study at the stages of data collection, analysis
and interpretation. Limitations relating to the study population have been dealt with
previously (Chapter 3). At the time of collection of pulse wave data there may have
been variability in the positioning of the pulse wave Doppler sample volume within
the myocardium. Care was taken to use the smallest sample volume (2mm) and
position this within the desired region of basal myocardium in the RV or IVS.
However, any movement of the heart, chest wall, or ultrasound probe may have led
to mal-placement of the sample volume and could have altered the PWTDI velocities
obtained. Care was also taken to ensure that the angle of incidence of the Doppler
beam was less than 15°. Any increase in this angle of incidence might have led to
underestimation of PWTDI velocities. This was a particular issue in infants in whom
the heart is displaced within the thorax (e.g. CDH). It must also be noted that
PWTDI velocities were only measured in the longitudinal plane (along the line of the
Doppler beam), whilst true maximal myocardial velocities may have occurred in
another direction, or combination of directions.
The observer was not blinded to PHT or control group status during data collection
or analysis, nor was intra-observer variability assessed. Furthermore, previous
studies using PWTDI in infants have reported intra-observer variability for
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measurement of S, E' an A' velocities of 5.2 (3.0)%, 5.0 (3.6)%, and 5.5 (3.6)%
respectively [94],
Finally, PWTDI velocities were measured only in the basal region of the ventricle.
Velocities may have been different in other myocardial regions, and shown different
changes in the PHT group. The timing or synchrony ofmyocardial velocities was
also not studied, but may be altered in disease states such as PHT [136, 137],
7.6.6 Limitations of PWTDI
PWTDI, though feasible in infants, has a number of limitations. Standard ultrasound
machines available in clinical neonatal practice may not have the ability to perform
this technique, although most new machines are fitted with the filters capable of
allowing PWTDI. The technique is also moderately time consuming. Although
formal timing was not performed in the current study, the separate collection of data
in each myocardial region of interest, and subsequent analysis of individual
velocities, may take too long for practical use in the clinical setting,
It was not possible to use PWTDI to measure IVA in infants due to the limitations of
spectral broadening, pulse frequency rates and sweep speeds. These are limitations
of PWTDI technology in its current form. Instead only IVV and S can be assessed in
infants as measures of systolic function. Diastolic function may be assessed using E'
velocity and IVRT, but, as discussed, these may also demonstrate varying degrees of
load-dependence and cannot be considered "pure" measures of diastolic relaxation
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[21]. No known PWTDI parameter measures the other determinant of diastolic
function - passive chamber stiffness.
7.7 Conclusions
This study has demonstrated the feasibility of PWTDI as a measure of RV function
in control and PHT infants. Importantly, PWTDI allows separate assessment of
systolic and diastolic function. This study provided normative PWTDI velocity data,
which is in good agreement with prior studies. Use of PWTDI in this study
demonstrated, for the first time, both systolic and early diastolic myocardial
dysfunction in infants with PHT compared to controls. The important incidental
finding of post-systolic positive myocardial velocities in both control and PHT
groups represents an area for further study.
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CHAPTER 8
COLOUR TISSUE DOPPLER IMAGING
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8.1 Introduction
This chapter presents and discusses the data relating to use of CTD1 to assess RV
function in control and PHT infants. CTDI was the most advanced method of
ventricular function assessment employed in this work, and has not been previously
reported in infants. This study was therefore an important feasibility assessment of
CTDI in infants, with the potential also to provide more detailed information about
ventricular function than any of the other techniques used.
CTDI data collection and analysis are discussed first, including practical difficulties
encountered. The CTDI myocardial velocities and accelerations are then presented.
Group summary statistics are provided and inter-group differences represented
graphically where relevant. The relationships between diastolic velocities and age
are described as these had the potential to contribute to any inter-group differences.
In the discussion section the study findings are considered in relation to the stated
aims and hypotheses, the feasibility of CTDI in infants is reviewed, and the
mechanistic implications of inter-group differences discussed. Limitations of this
study and ofCTDI as a measure of RV function are discussed.
8.2 Data collection and analysis
CTDI data was acquired, using the techniques described in Chapter 2, in 28 infants
(100%) in the control group and 15 infants (94%) of infants in the PHT group. CTDI
data was not collected in the one remaining infant in the PHT group because the
study was discontinued to allow ongoing clinical care of the infant. There were no
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clinically significant deteriorations during any CTDI data acquisition. Although
formal timings were not performed, it was the researcher's experience that the steps
required to collect CTDI data from a four chamber apical view, (i.e. colourising the
two-dimensional image, and recording a cine-loop of 5 cardiac cycles) could usually
be performed within twenty seconds.
CTDI analysis was a more cumbersome and time-consuming process, as has been
previously described in Chapter 2. The process is briefly described again here, to
indicate the steps involved and duration. After data acquisition, offline CTDI
analysis was performed using an additional software program (Qlab™). Within Qlab
the Doppler sample volume was positioned in the region of myocardium for analysis
(region of interest), at the beginning of each cineloop. The sample volume width and
length were then adjusted to the specifications for the study. Next, the cineloop was
played slowly and the sample region position adjusted manually, during the entire
cineloop recording, to maintain its position in the desired region of interest (i.e.
manual tracking ofmyocardial segment). A waveform of CTDI velocities in the
region of interest was produced in this way, from which systolic and diastolic
velocities could then be measured manually over five consecutive cardiac cycles.
This process was repeated to obtain myocardial velocities in both the basal RV and
interventricular septum. This multi-step process of CTDI analysis took
approximately twenty minutes per infant.
CTDI analysis was performed in all 28 infants (100%) in the control group. In two
infants in the control group distinct E' velocities could not be identified.
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CTD1 analysis was completed in all infants in the PHT group. E' waves were absent
in the RV in 10 of these infants, and in the interventricular septum in five of the
infants. In these cases no E' velocity was recorded nor included in statistical
analysis. Furthermore, in two infants in the PHT group a separate isovolumic
contraction velocity (IVV) could not be identified and therefore IVV and 1VA could
not be quantified.
A significant problem, identified in analysis of data from all infants, related to the
limited sampling frequency of the software used. The sampling frequency is the rate
at which myocardial velocities were sampled, and was determined by the frame rate
at which CTDI was acquired and the heart rate of the infant. The frame rates, heart
rates and calculated sampling frequency (frames per heart beat, i.e.samples per
cardiac cycle) are provided for each group in Table 8.1 below.






(Frames per heart beat)
Control Group
mean (range)
141 (120-186) 182 (168-213) 77.5
PHT group
mean (range)
153 (130-194) 179 (137-212) 70.2
* Sampling frequency = frame rate / (HR/60)
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There was no statistical difference between heart-rate in the control and PHT groups;
141 (19) vs. 153 (18) beats per minute, P=0.06. The average sampling frequency, in
both the control and PHT groups was only approximately 70 samples per cardiac
cycle.
This limited sampling frequency had a number of important implications for data
analysis:
• Sample points may not have corresponded to true peak velocities. Measured
myocardial velocities (corresponding to the "peak" sampled velocity) may
have been lower than the true maximum velocities. This was particularly so
for IVV which was a very brief velocity, with a short-lived peak. Any such
invalidation of IVV measurement would also invalidate IVA (the slope of
IVV).
• There was loss of the characteristic CTD1 waveform and its component
velocities (IVV, S, E' and A') in some infants. It was hypothesised that
insufficient sampling frequency had led to "fusion" of velocities in these
infants. The presence of a simultaneous ECG was therefore essential to aid
identification of velocities according to their timing in the cardiac cycle.
• Time intervals (IVRT and DMDT) could not be accurately measured in many
infants. Measurement of time intervals could only be made between sample
points in the myocardial velocity waveform. As sample points did not always
correspond to the beginning and end of the specified time intervals, these
intervals could not be accurately measured using the analysis software.
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These issues, though significant, were not considered sufficient to completely
invalidate all subsequent CTDI data analysis. However, potential inaccuracy in peak
CTDI velocities measurement was taken into account in subsequent interpretation of
the data.
8.3 Systolic CTDI velocities and accelerations
Systolic CTDI velocities obtained in the RV and septum of infants in the control and
PHT groups are summarised in Table 8.2 below.
Table 8.2: Systolic CTDI velocities and acceleration in control and PHT groups
Control PHT P
RV
IVA* 68.1 (30.2) 95.5 (31.6) 0.003
IVV* 1.3 (0.6) 1.3 (0.5) 0.641
S 2.6 (0.8) 2.1 (0.7) 0.0855
Septum
IVA 72.0 (22.4) 87.2 (33.3) 0.09
IVV 0.8 (0.4) 1.2 (0.9) 0.187
S 2.1 (0.4) 1.5 (0.4) <0.0001
All data mean (SD). Units are cm/sec (IVV and S) and cm/sec2 (IVA). *IVV and IVA not obtained in RV
of 2 infants in PHT group due to failure to identify distinct IVV.
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RV IVA was significantly increased in the PHT group compared to controls [ 95.5
(31.6) vs. 68.1 (30.2) cm/sec2, P=0.003]. However, IVV and S in the RV, were not
significantly different between the two groups.
Septal myocardial velocities tended to be lower than those in the RV. Septal IVA
and IVV were not significantly altered in the PHT group compared to controls.
However, septal S velocity, was significantly reduced in the PHT group; 1.51 (0.43)
vs. 2.13 (0.42) cm/sec, P<0.0001.
It is notable that all CTDI systolic measures demonstrated wide variation, with large
standard deviations. The systolic function data is represented graphically in Figure
8.1 and provides an appreciation of the degree of variance within each measure.
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IVV in the RV and IVS. There
were no significant differences
in IVV, in the RV or IVS,
between PHT and control
groups.
S velocity in the RV and IVS. S
velocity was significantly
reduced in the IVS in the PHT
group compared to the Control
group (t).
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8.4 Diastolic CTDI velocities
Diastolic CTDI velocities, obtained in the RV and IVS, are summarised in Table 8.3
below.
Table 8.3: Diastolic CTDI velocities in the RV and interventricular septum
Control PHT P
RV
E' *(n=5) -3.3 (1.0) -2.4 (1.6) 0.081
A' -3.4 (1.7) -4.1 (1.7) 0.170
Septal
E' * (n=10) -3.1 (0.7) -1.8 (0.5) <0.0001
A' -3.5 (0.9) -3.2 (1.0) 0.314
All data mean (SD). *E' velocity absent in RV of 10 infants in PHT group, and absent in the
interventricular septum of 5 infants in the PHT group; No E' velocity recorded in these infants
and data therefore not included in the statistical analysis presented here.
E' velocity (where present) was not significantly reduced in the RV in the PHT
group (-3.3 [l.O] vs. -02.4 [1.6] cm/sec, P<0.081). However, E' velocity was
significantly reduced in the interventricular septum in PHT infants (-3.1 [0.7] vs. -1.8
[0.5] cm/sec, P<0.0001). A' velocity was not significantly different in the PHT
compared to controls, in either position.
Sample CTDI waveforms from a control infant and a PHT infant are presented in
Figure 8.2, providing graphical demonstration of the loss of the E' wave in some ten
PHT infants.
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Figure 8.2: CTDI waveforms in control and PHT infants
CTDI waveforms from control (left) and PHT (right) infants. All systolic (IVV, S) and diastolic (E\
A') velocities identified in control infant. In PHT infant no E' velocity diastolic velocity can be
identified.
The variance in CTDI diastolic velocities, in both PHT and control groups, was
broad. This can be observed from the large standard deviations of each velocity, and
from the graphical representation of individual infant data plotted in Figure 8.3.
Figure 8.3: E' and A' velocities in the RV and interventricular septum
0.0-,
Line represents mean. Data from PHT infants in whom no E' velocity present (ten infants in RV, 5
infants in IVS) not included in this figure.
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8.5 Diastolic velocities and age
As considered in Chapters 4 and 7, diastolic function may change in the RV
following birth. The relationship between control group diastolic CTDI velocities (in
the RV) and postnatal age was therefore investigated. There was no significant
correlation between postnatal age and either RV E' velocity (r2 = 0.002, P=0.83) or
RV A' velocity (r2=0.08, P=0.14).
8.6 Discussion
8.6.1 Feasibility
This study has shown that the collection ofCTDI data could be performed rapidly
and safely in infants. However, the analysis of CTDI data was less straight-forward
and raised questions as to the feasibility of the technique.
Analysis was a time consuming process which involved multiple steps to obtain a
velocity waveform and manually measure velocities from this. Furthermore, there
were major concerns that measurement error was introduced due to the limitations of
the sampling frequencies used. Even though the frame rate was optimised to
maximise sampling frequency, it was felt the CTDI software did not sample
frequently enough to ensure that maximal myocardial velocities were accurately
detected. This was considered to have also led to distortion of the normal appearance
of the myocardial Doppler waveform (which made identification of individual
velocities difficult).
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The wide variance observed in all CTDI measures (IVV, S, E' and A'), in both
control and PHT groups, may have resulted in part from this measurement error. In
some infants the measured velocity may have been close to the true maximum (if the
sample point occurred at true peak velocity) whilst in other infants the measured
velocity may have been under-measured (if the sample point fell outwith the true
peak).
These issues highlighted limitations of the CTDI acquisition and analysis software
used and brought into question the validity of the CTDI data obtained in this study.
This was borne in mind when interpreting the study data as discussed below.
8.6.2 CTDI velocities in the control group: comparison with
previous studies
There are no prior published reports of CTDI velocities, or accelerations (IVA), in
newborn infants for comparison with the current data. In the absence of comparable
data, and in light of the concerns ofmeasurement error, the control group data cannot
be recommended to represent normative standard data.
Normative CTDI data has previously been obtained in healthy children by Pauliks et
al [138], and in healthy adults by Kjaergaard et al [74], The CTDI velocities and
accelerations obtained in the RV in these studies, and in the control group of the
Chapters, 198
current study, are listed in Table 8.4 below, together with demographic data for each
study population.
Table 8.4: CTDI velocities and accelerations in control group and previous
studies
Kjaergaard et al Pauliks et al Control Group
Demographic data
N 17 75 28
Age 31 (9) years 8.5 (5.1) years 25 (20) days
Weight (kg) - 34.4 (25.4) 3.2 (0.7)
Heart rate (beats per minute) 60 (10) 86.5(23.1) 141 (19)
Frame rate (frames/sec) 130 f/se c >100 f/sec 182
Sample frequency




IVA - 190 (60) 68.1 (30.2)
IVC - 6.4 (2.2) 1.3 (0.6)
S 10.4 (1.3) 10.0 (1.7) 2.6 (0.8)
E' -10.4 (3.8) -12.1 (3.0) -3.3 (1.0)
A' -9.5 (3.4) -7.6 (3.6) -3.4 (1.7)
Septum
IVA - 120 (40) 72.0 (22.4)
IVC - 2.9 (1.2) 0.8 (0.4)
S - 6.1 (1.1) 2.1 (0.4)
E' - -10.2 (1.8) -3.1 (0.7)
A' - -4.8 (1.6) -3.5 (0.9)
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It can be seen from Table 8.4 that the CTDI velocities obtained in infants (control
group) were much lower than those obtained in either older children (Pauliks et al) or
adults (Kjaergaard et al). This increase in myocardial velocities with age has
previously been reported by Mori et al using PWTDI, but never before using CTDI
techniques [94], In both the control group, and the older children studied by Pauliks
et al, CTDI velocities were lower in the septum than in the RV. This is again in
agreement with PWTDI data from the current study (chapter 7) and previous studies
[94].
The frame rates and heart rates in each study, together with the calculated sampling
frequency, have also been provided in Table 13. In Kjaergaard et al's study in adults
the lower heart rates allowed for a higher sampling frequency than in the control
group. However, in Pauliks et al's study the calculated sample frequency was similar
to that in the control group (based on a reported frame rate of 100 frames/sec). The
concerns that the sampling frequency may have been too low in the control group to
measure peak CTDI velocities accurately may also therefore be applicable to the data
of Pauliks et al.
No significant relationship was demonstrated between E' velocity in the RV and age.
This suggested that the observed differences between PHT and control groups could
not be attributed to age differences between the groups. Furthermore, this has
practical implications for future use ofCTDI, allowing inter-subject comparison of
CTDI velocities without age correction.
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8.6.3 CTDI velocities in PHT: significance and comparison with
previous studies
Systolic velocities
RV IVA was significantly increased in the PHT group compared to controls. IVA
has previously been demonstrated to be a relatively load-independent measure of
systolic function, and therefore the increase in IVA in the RV might be considered to
reflect increased myocardial contractility in the PHT group. However, the other
measures of systolic function, IVV and S, were not significantly different in the RV
in the PHT group.
In the inter-ventricular septum, S velocity was significantly reduced in PHT,
compared to controls, suggestive of impaired systolic function. If systolic function
were impaired one might expect IVV and IVA also to be reduced, though in the
study population they were not.
These contradictory findings were probably the result ofmeasurement error due to
the limited sampling frequency (as discussed above). This was thought to contribute
to inaccuracy in the systolic velocity measures, particularly the short-lived velocity
IVV (and hence IVA). Failure to identify an IVV in two PHT infants was probably
due to the same issue of limited sampling frequency. In view of these concerns it
was felt that no conclusions could be reached regarding systolic function differences
between the groups on the basis of the CTDI data alone.
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Diastolic velocities
No E' velocity could be clearly identified in the RV in ten infants in the PHT group,
and in the interventricular septum in five infants in the PHT group. This was
consistent with the finding of absent E' waves in the PHT group on PWTDI analysis
(Chapter 7). It was not known whether the loss of E' velocities was considered to
reflect either a genuine reduction in this velocity or a delay in E' velocity leading to
fusion with the A' wave. A genuine reduction was considered more probable based
on the observation that, in those PHT infants in whom E' velocities were present (but
reduced), the E' occurred distinct from the A' wave, before the P wave on the
corresponding ECG.
In those infants in whom an E' velocity was present and could be measured, it was
observed that E' velocity was reduced in the PHT group compared to the control
group, although this did not reach statistical significance in the RV in the PHT group.
What is the significance of a reduction in, or absence of, E' velocity in PHT? As
discussed in Chapter 7, reduction in this velocity may represent either a genuine
reduction in early active myocardial relaxation, and/or the direct effects of loading
conditions on myocardial velocities (i.e. load dependence). There are no prior
studies investigating the load-dependence of CTDI velocities in infants and it was
beyond the scope of the current study to determine this. That A' velocity was
unchanged in PHT suggesting that later diastolic myocardial displacement, due to
atrial contraction, was not altered in PHT infants.
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IVRT is another measure of diastolic myocardial function, and it had been intended
to measure this in addition to CTD1 E" and A' velocities. Unfortunately, it was
discovered in the course of data analysis that, because of the limited sampling
frequency, it was not possible accurately to measure the time points necessary to
derive IVRT from CTD1 data. This highlighted yet another limitation ofCTDI
analysis for assessment of RV function in infants.
8.6.4 Limitations of this study
Limitations related to the study population have been dealt with previously in chapter
3. The sample size was relatively small, particularly the PHT group, and this may
have contributed to the failure to demonstrate consistent, statistically significant
inter-group differences in systolic parameters.
In CTDI data analysis, error may have been introduced at a number of steps,
including mis-identification of velocities. The CTDI waveform usually has a
characteristic appearance but this was frequently distorted in the PHT group, whether
due to abnormal myocardial function or the effect of insufficient sampling frequency.
Although care was taken to identify CTDI velocities according to their timing in the
cardiac cycle (using the ECG), it is possible that velocities may have been mis-
identified and therefore the wrong velocities measured and recorded. Mal-
positioning of the Doppler sample, at any time in the duration of the cine-loop, may
have led to abnormal myocardial velocities being recorded from the pericardium,
endocardium or ventricular cavity. Furthermore, if the angle of incidence of the
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sample volume was greater than 15° this may have led to under-measurement of true
peak myocardial velocities.
No attempt was made to measure intra-observer variability of the CTDI technique in
this study. This was because CTDI analysis, using the hardware and software
employed in this study, was time consuming and there was insufficient time available
to perform the repeated analyses necessary to calculate observer variability. Pauliks
et al have assessed observer variability of CTDI in normal children and obtained co¬
efficients of variation for systolic S velocities of 6.0% for intra-observer variability
and 5.4% for inter-observer variability. For IVV the variabilities were 13.8% and
10.1% respectively, and for IVA were 10.8% and 11.5% respectively. For E'
velocity the co-efficients of variation were 5.5% and 4.6% respectively, for A'
21.5% and 15.1% respectively.
In infants, user-variability might be expected to be higher for three reasons. Firstly,
the absolute velocities are lower and therefore the percentage error is potentially
greater. Secondly, there is greater potential for malposition of the sample volume in
the smaller infant heart. Thirdly, at higher infant heart rates the limitations of sample
frequency may increase the chance ofmis-identification of velocities and under-
measurement of peak velocities.
As in PWTDI analysis (chapter 7), CTDI velocities were obtained only in the basal
RV and in the longitudinal plane. Velocities in other regions and planes of the
myocardium, and the synchrony of these, were not assessed in the current study.
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Further analysis of the CTDI cine-loops obtained in the study could potentially yield
this information, without the requirement to repeat echocardiograms on the infants
studied.
8.6.5 Limitations of CTDI
This study has highlighted major limitations of CTDI, in its current form, for
assessment ofRV function in infants.
Although collection ofCTDI data at the infant's bedside was rapid, the analysis of
the data required multiple steps which were both time-consuming and increased the
potential for measurement error.
One of the most important limitations ofCTDI, using the technology employed here,
was the insufficient sampling frequency leading to distortion of the CTDI waveform,
and inaccuracy in measurement of velocities and accelerations. Development of
echocardiographic machines with higher achievable frame rates may overcome this
issue.
At present CTDI analysis is only available on the most advanced, and most
expensive, echocardiographic machines. In practice therefore, CTDI is not available
in most neonatal intensive care units.
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8.7 Conclusion
CTDI data collection was feasible in infants. There was potential for high levels of
measurement error in data analysis, due particularly to insufficient sampling
frequency. The latter is a limitation of current echocardiographic technology. In
view of these findings, CTDI cannot be recommended for practical clinical use to
assess infant RV function.
Inter-group comparison of CTDI indices failed to demonstrate consistent differences
in systolic RV function. Nevertheless the absence, or reduction, of early diastolic
myocardial velocities was a striking observation. The latter is in agreement with
PWTDI findings in PHT.
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CHAPTER 9
RELATIONSHIP BETWEEN RIGHT VENTRICULAR
FUNCTION AND PULMONARY ARTERY PRESSURE
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9.1 Introduction
In this chapter the data relating to the investigation of the relationship between RV
function and PAP are presented and discussed. The hypothesis tested by the studies
in this chapter was that, in infants with pulmonary hypertension, RV function is not
linearly related to PAP.
Data collection and analysis are discussed first, outlining the paired collection of RV
function and PAP data. PAP data are then presented, followed by each of the
measures of RV function employed. The relationship between each measure of RV
function and PAP was investigated by performing Pearson correlation analysis.
Summary statistics (r2 and P value) are reported.
In the discussion section the presence or absence of any linear correlation between
PAP and each measure of RV function is discussed in relation to the stated
hypothesis and the limitations of the individual measures ofRV function.
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9.2 Data collection and analysis
Sixty-five echocardiograms were performed in 17 infants with PHT. A maximum of
eight and a minimum of two echocardiograms were performed in the same infant.
Echocardiograms were performed a minimum of 24 hours and a maximum of seven
days apart in the same infant.
Each echocardiographic study consisted of a paired measure of PAP and RV
function. PAP was derived from peak TR jet velocity, using a modified Bernoulli
equation. RV function was assessed using each of the following:
1. Transtricuspid Doppler E velocity
2. RVO
3. RVmpi
4. Pulse wave TDI myocardial velocities (PWTDI)
5. Colour TDI myocardial velocities (CTDI)
Each of these echocardiographic measures was performed as previously described in
Chapter 2.
9.3 Pulmonary artery pressure data
Of the 65 studies performed, a TR jet was present, from which a peak velocity could
be satisfactorily measured, in only 46 studies. In the remaining 19 studies a TR jet
was either absent, or a satisfactory TR Doppler waveform (from which peak TR
could be identified) could not be obtained.
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All further analysis and discussion of the relationship between PAP and RV function
was limited to the 46 studies in which TR velocity (and therefore PAP) could
satisfactorily be obtained. Peak TR velocity in these 46 studies was 3.65 (0.82)
m/sec. The mean calculated PAP was 60.9 (22.9) mmHg.
9.4 Tricuspid Doppler E velocity and PAP
Diastolic tricuspid valve (TV) flow Doppler measurements were performed in all 46
studies in which paired recordings of PAP were made. TV E velocities were
measured from the Doppler waveform, as a measure of early diastolic flow. The later
TV A velocity was not included in this analysis. TV A was excluded as this is
principally dependent on atrial and not ventricular myocardial function.
TV E velocity was absent in 34 studies. As discussed in Chapter 5, the absence of E
velocities in some studies was a striking finding demonstrating impaired early
diastolic filling in PHT. No numerical E velocity was recorded in those studies in
which no E wave could be identified. Accordingly, only the 12 studies in which an E
velocity was present and measurable were included in investigation of the
relationship between RV function and PAP using this data. Mean TV E velocity in
these 12 studies were 0.43 (0.13) cm/sec. There was a positive correlation between
TV E and PAP, but with poor goodness of fit: r2=0.46, P=0.02, Figure 9.1.
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TV E data from 12 studies in whom E velocity present. Data not included from 34 studies in
whom no E velocity present.
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9.5 RVO and PAP
RVO was measured in 43 of the total 46 studies in which paired PAP measurement
was made. In the remaining three studies RVO was not measured because the study
was interrupted to allow ongoing clinical care. Mean RVO was 318(114)
mL/kg/min. RVO and PAP are plotted together in Figure 9.2. RVO demonstrated a
significant positive correlation with PAP; r =0.12, P=0.03.
Figure 9.2: Right ventricular output (RVO) and PAP
r2=0.12, P=0.03
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9.6 RVmpi and PAP
RVmpi was obtained in 43 studies in which paired measures of PAP were also
obtained. RVmpi was not obtained in three studies because these were interrupted to
allow ongoing clinical care. Mean RVmpi was 0.51 (0.15). There was no significant
correlation between RVmpi and PAP; r2=0.46, P=0.17 (Figure 9.3).


















9.7 PWTDI velocities and PAP
PWTDl data was obtained in 41 of the 46 studies. In the remaining five studies
PWTDI data was not obtained. Three studies were discontinued before PWTDI data
were obtained, to allow ongoing clinical care. In two other studies PWTDI data were
obtained but velocities could not be measured due to artefact introduced by high
frequency oscillatory ventilation. All data presented relate to the 41 studies in which
paired PWTDI and PAP data were obtained and could be analysed. Systolic and
diastolic PWTDI velocities were measured in the RV as previously discussed in
Chapter 3.
9.7.1 Systolic PWTDI velocities
Mean RV IVV was 5.1(1.3) cm/sec. RV IVV did not significantly correlate with
PAP; r2=0.02, P=0.40, Figure 9.4, panel A. Mean RV S velocity was 7.0 (1.7)
cm/sec. RV S did not correlate with PAP; r2=0.07, P=0.09, Figure 9.4, panel B.
Figure 9.4: Systolic PWTDI velocities and PAP
A: PWTDI RV IVV and PAP B: PWTDI RV S and PAP
PAP (mmHg) PAP (mmHg)
r2=0.02, P=0.40 rJ=0.07, P=0.09
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9.7.2 Diastolic PWTDI velocities
E' velocities were present in 21 studies, but absent in 20 studies. It was not
considered valid to include studies in which E' velocities were absent in the
statistical analysis of the relationship between RV E' and PAP. Mean RV E' velocity
in the remaining 22 studies was -5.5 (32.8) cm/sec. There was no significant linear
correlation between RV E' velocity and PAP; r2=0.01, P=0.90. RV E' and PAP are
plotted together in Figure 9.5. The relationship between RV A' velocity and PAP
was not investigated as RV A' is more dependent on atrial function than ventricular
function and, as observed in Chapter 8, was unaffected in PHT infants compared to
control infants.
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r2=0.01, P=0.90
RV E' velocities from 21 studies in which E' velocity present. RV E' data not included from
those 20 studies in which no E velocity present.
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9.8 CTDI velocities and PAP
CTDI velocities were obtained in only 33 (71%) of the studies in which paired PAP
data were also obtained. In seven studies CTDI data were not obtained because the
studies were discontinued to allow ongoing clinical care. In the six other studies
CTDI data were not collected because the decision to include CTDI (as a means of
assessing RV function) was made after recruitment to the study had already
commenced. All data presented refer to the 23 studies in which paired CTDI and
PAP data were collected.
9.8.1 CTDI systolic velocities and accelerations
RV IVA, RV IVV and RV S were obtained as described in Chapter 2. Mean RV
IVA was 88.1 (32.6) cm/sec2, and did not significantly correlate with PAP (r =0.04,
P=0.30, Figure 9.6, panel A). Mean RV IVV was 1.2 (0.6) cm/sec and also did not
correlate with PAP (r2=0.001, P=0.9, Figure 9.6, panel B). Mean RV S was 2.2 (1.0)
cm/sec and did not correlate significantly with PAP (r2=0.01, P=0.52, Figure 9.6,
panel C).
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Figure 9.6: CTDI systolic parameters and PAP









































































9.8.2 CTDI diastolic velocities and PAP
CTDI E' velocities were absent in 18 studies and these were not included in the
investigation of the relationship between E' and PAP. Accordingly E' velocity was
only present and measured in 15 studies. Mean CTDI E' velocity was -2.8 (2.0)
cm/sec. CTDI E' velocity did not correlate with PAP; R2=0.10, P=0.25. CTDI E'
and PAP are plotted together in Figure 9.7. CTDI A' velocity was not measured as
A' velocities were deemed to reflect atrial, and not ventricular function.




This study investigated the relationship between PAP and RV function. The
hypothesis tested was that, in infants with PHT, RV function is not linearly related to
PAP. The clinical relevance of this study is in determining whether assessment of
PAP pressure alone is sufficient to predict RV dysfunction in PHT, or whether direct
assessment of RV function itself is required.
9.9.1 Measurement of PAP
For the purpose of this study PAP was quantified using the peak TR velocity and
inserting this into a modified Bernoulli equation. This provided the peak pressure
gradient between RV and RA (at end systole). The PAP was then calculated by
adding right atrial pressure to the gradient. This technique has been previously
described in infants and is widely used in clinical practice [96, 97],
In this study 65 paired measures of PAP and RV function were attempted. However,
a TR jet was present, and a satisfactory Doppler obtained of it, in only 46 of these
measures (70%). Skinner et al have previously reported the incidence of pansystolic
TR as 53% in preterm infants and 27% in term infants [97], Our findings confirm
the finding that TR is not present in all infants, even when RV pressures are
pathologically elevated. PAP may therefore not always be quantified by this method.
9.9.2 Relationship between PAP and measures of RV function
There was no linear correlation between PAP and RV function assessed using RVMpi
or tissue Doppler imaging (PWTDI or CTDI systolic and diastolic velocities).
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One interpretation of this finding is that PAP does not correlate linearly with RV
function, in support of the hypothesis being tested. It must be borne in mind,
however, that the echocardiography indices used may not be pure measures of RV
function alone. RVmpi, in particular, is load dependent and any change in this index
may be the direct effects on change in load, independent of change in ventricular
function. It is of note that the current study findings are in contrast to previous
investigations of the relationship between RVmpi and PAP in animal and paediatric
studies. Suguira et al used hypoxia to induce PHT in a newborn piglet model, and
demonstrated a significant correlation between RVmpi and PAP (r2=0.799, p<0.05)
[73], Dyer et al measured PAP in 12 children with idiopathic pulmonary
hypertension and observed a significant positive correlation between RVmpi and PAP
(r =0.94, P<0.001) [75], In light of these findings these authors had suggested that
RVMPI might be used as a proxy measure of PAP. The current study findings,
however, do not support the use of RVmpi as a proxy measure of PAP in infants with
PHT.
Tissue Doppler indices are potentially more robust, less load-dependent, measures of
RV function than RV MPI. The absence of a relationship between PAP and any TDI
measure (systolic and diastolic PWTDI and CTDI velocities) is arguably more
convincing evidence of the genuine absence of a relationship between PAP and RV
function. The absence of diastolic TDI E' velocities, in some studies, did however
raise some difficulties in analysis. As discussed in chapters 7 and 8 the absence of
early diastolic velocities in PHT was considered an important finding and indication
of early diastolic dysfunction. Use of this data in statistical analysis was nevertheless
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not straightforward. Ultimately, it was not considered valid to attribute a velocity of
zero in these cases, and instead they were excluded from statistical analysis, which
was therefore limited to those studies in which an E velocity could be identified and
measured.
The same issue applied in the interpretation of tricuspid valve Doppler data, since E
velocities were absent in the majority of these studies too. In the remaining infants
in whom E velocities were present, a positive correlation with PAP was observed.
This was interpreted cautiously, as not only was this data from only a small number
of studies, but TV Doppler is a highly load dependent measure i.e. TV Dopplers
cannot be considered to reflect RV function alone. This highlights the difficult of
interpreting TV Doppler velocities and the limitations of this technique as a measure
of RV function.
RVO was also observed to significantly correlate with PAP. Interestingly this
correlation was positive, i.e. as PAP increased RVO increased, which is consistent
with the finding in Chapter 5 that RVO tended to be higher in PHT infants than
control infants. Can this be interpreted as indicating that RV myocardial function
increases with PAP? RVO is determined by numerous factors, including preload,
afterload, RV myocardial function and intra- and extra- cardiac shunts. On the basis
of the current study, the correlation between RVO and PAP cannot therefore be
exclusively attributed to a relationship between RV function and PAP.
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One explanation for the increase in RVO with PAP, independent of any change in
RV myocardial function, is that at higher PAP there is increased right-to-left
shunting through the patent ductus arteriosus, and hence increased RVO. Supra-
normal RVO due to massive right-to-left ductal shunts in infants with severe PHT
has previously been observed in infants with Vein of Galen malformation [16].
These data illustrates the numerous factors which may affect RVO, and its
unsuitability as a measure ofmyocardial function alone.
9.9.3 Significance of the absence of a relationship between PAP and
RV function
The absence of a clear linear relationship between PAP and RV function
demonstrated by this study (with the exclusion ofTV Doppler and RVO data for the
reasons discussed above) is significant to the clinical setting. On the basis of this
conclusion RV function cannot be easily predicted from PAP. This emphasises the
importance of assessing RV function directly in infants with PHT, and not simply
PAP alone.
Why might RV function (systolic and diastolic) not closely correlate, in a linear
manner, with PAP? Two possible explanations were considered:
1. RV systolic function is not inherently related in a linear fashion to afterload
i.e. the ventricle does not have the ability to increase directly and
proportionately its systolic (contractile) and diastolic (lusitropic) function in
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response to increasing afterload. The non-linear response of the ventricle to
changes in load has previously been well described as the bell-shaped Frank-
Starling relationship between preload and contractile function.
2. As PAP increases in infants with PHT there are concomitant changes in other
factors which may independently alter RV function in a non-linear manner.
Such factors were not studied or controlled for in this study, and may have
included exogenous therapy (nitric oxide, ventilation settings, inotrope dose),
and metabolic disturbances such as hypoxia, hypercarbia or acidosis.
Future studies are necessary to investigate the relationship of RV function and PAP
to test these hypotheses.
9.9.4 Limitations of this study
Limitations of the techniques used to measure RVO have been discussed above.
Limitations related to the use of TR velocity to calculate PAP have also been
highlighted. Specifically, error may have been introduced if the continuous wave
Doppler beam was not positioned within the highest flow region of the regurgitation
jet, or if the maximum velocity was not accurately measured from the resultant
Doppler waveform. Furthermore, as with any Doppler velocity measurement, if the
angle of incidence of the Doppler beam was greater than 15° then the measured
velocities may have been lower than true velocities. For these reasons care was
taken to select only those 46 studies in which TR was present and a satisfactory
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Doppler waveform obtained, from a minimal angle of insonation, and from which
peak velocity could be clearly identified and measured.
Calculation of PAP required an estimation of right atrial pressure (RAP) of 5 mmHg
in every study. RAP could not be measured invasively as this would have created
unacceptable associated risks. It is probable that true RAP was higher than 5 mmHg,
due to the combination of tricuspid regurgitation and/or increased venous return.
Nevertheless, the relative contribution of RAP to the total calculated PAP is small,
and unlikely to have significantly altered the results.
RV function measures (transtricuspid Doppler flow, RVO measurements, RVmpi
measurements and TD1 data) were collected after collection of the TR Doppler. PAP
and RV function measures were therefore not simultaneous, but separated temporally
by up to 5-10 minutes. It is possible that either PAP and/or RV function may have
changed during this time period, and that this may in turn have affected the results of
the correlation analysis.
As PAP increases, in the clinical setting, other factors may change too which directly
alter RV function, independently of PAP. Such factors have been discussed above,
and include changes in oxygen and carbon dioxide partial pressures, acid base status,
and changes in exogenous therapy e.g. ventilation mode and settings, inspired FIO2,
and inotrope dose. No attempt was made to control for these factors and examine in
strict isolation the relationship between RV function and PAP. It is possible that in a
controlled setting, where extraneous changes are minimised, RV function may
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correlate linearly with PAP, as previously reported by Dyer et al and Suguira et al
[73, 75], The current study is more relevant to the clinical setting where these varied
factors cannot be controlled for, and PAP is therefore not seen to correlate with RV
function.
Each measure of RV function was not completed in every study. In three studies
RVO and RVmpi data was not collected, in nine studies PWTDI data was not
completed and in 23 studies CTD1 data was not completed, for the reasons discussed
earlier. This highlighted the difficulties of performing a clinical study where
collection of study data was frequently interrupted to allow ongoing clinical care.
Finally, the absence of early diastolic velocities in TV Doppler, PWTDI and CTDI
data created difficulties in data analysis. Ultimately, it was felt most valid to exclude
those studies in which no early diastolic velocity was present from statistical analysis
(as opposed to attributing a velocity of zero).
9.10 Conclusions
No significant correlation was observed between PAP and RV function, assessed
using RVMPI, PWTDI and CTDI velocities. This supports the hypothesis that RV
function does not correlate with PAP. An important clinical implication of this
finding is that RV function cannot be predicted from PAP, and that RV function
should be independently assessed.
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PAP did correlate with transtricuspid E velocities but these are a highly load
dependent measure and cannot be considered to reflect accurately myocardial
function alone. A positive correlation between PAP and RVO was also observed,
which was probably due to increased right-to-left ductal shunting in severe PHT.
These findings, rather than disproving the tested hypothesis, highlight the major







This chapter considers whether the studies have answered the research questions
posed at the beginning of this work, and what has been added to existing knowledge
and theory.
There are three principle sections, which correspond to the original research
questions;
1. Methods ofmeasuring RV function in infants,
2. Mechanisms of RV dysfunction in PHT
3. The relationship of RV function and PAP
In each section the results of the current work are used to argue for the conclusions
drawn. Limitations of the current work relating to methodology, study population
and the echocardiographic techniques, have been discussed in detail in the
preceeding results chapters. However, where relevant these are briefly discussed
again here. As a consequence of the data presented new areas for future research are
identified.
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10.2 Methods ofmeasuring RV function in infants
The first research question stated in this thesis was: Which measures can he used to
assess R Vfunction in infants with PHT?
The corresponding hypothesis was that: RV function can he quantified in the clinical
setting by non-invasive echocardiographic measures
This was considered a relevant research question because RV function is an
important consequence of pulmonary hypertension, and a determinant of disease
severity, however in current clinical practice there are no accepted conventions for
quantifying RV function in infants.
The current studies aimed to identify a feasible, quantitative technique for
assessment of RV function in infants. A number of echocardiographic measures
were investigated, chosen on their likely ability to meet the "ideal" criteria of being
rapidly obtained, accurate, load-independent and allowing quantification of both
diastolic and systolic function. These included the previously described techniques
of tricuspid valve Doppler, RVO and RVMpi, and the new technique of TD1. The
study findings in relation to each of these techniques are now discussed.
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10.2.1 Tricuspid Valve Doppler
Tricuspid valve Doppler is a proven technique for measuring diastolic ventricular
filling in newborn infants [55], but is rarely performed routinely in infants in clinical
practice. The current studies have confirmed the practicality of this technique, the
principle strength ofwhich was found to be its simplicity.
The problems of TV Doppler as a measure of RV diastolic function were evident on
attempted interpretation of the study data. Atrio-ventricular Doppler flow velocities
are highly load-dependent [26, 126], Accordingly, it could not be known whether
the observed difference in TV E velocity between control and PHT infants in the
current studies was due to differences in loading conditions alone or real differences
in RV diastolic function.
The interpretation of TV Doppler velocities in an individual infant was also
complicated by physiological variation in velocities with post-natal age [67]. A
further limitation ofTV Doppler as a means of assessing RV function is that this
technique provides no assessment of systolic function.
Taking into account the practical strengths but interpretative difficulties of TV
Doppler, does this technique have any value for use in the clinical setting?
Accepting that TV Doppler is a measure only of flow, and cannot distinguish the
varied influences of load and RV function, it is proposed to use TV Doppler as a
rapid "first-line" screening measure of RV diastolic haemodynamics in infants. The
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technique could be used to detect abnormal diastolic filling patterns and identify
those infants in whom further analysis ofRV function is warranted.
This proposed use of TV Doppler in infants to "screen" RV function, is similar to the
existing established use ofmitral valve Doppler to assess for LV diastolic
dysfunction in adults with ischaemic heart failure [27, 139],
10.2.2 Right Ventricular Output
RVO has been previously proposed as a measure of RV function, as well as
providing a measure of systemic blood flow (cardiac output) [56, 61]. The studies
conducted here however demonstrated both practical limitations of this technique
and that RVO cannot be used to assess RV myocardial function in isolation.
Measurement of RVO was found to be time consuming requiring multiple
echocardiographic measures and protracted post-acquisition analysis. Furthermore,
each measurement was prone to error and the multiplication of these to calculate
RVO had the potential to generate even greater error. Such error may have
contributed to differences in "normal" RVO observed between current and prior
studies [61, 65],
In addition to practical limitations, RVO failed to provide a measure of RV
myocardial function alone. In the PHT group, RVO was not reduced compared to the
control group even though RV dysfunction was present, as demonstrated by other
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echocardiographic measures e.g. TD1. The maintenance of RVO in PHT was
attributed to a compensatory increase in heart rate in this group. This emphasises
that RVO is a global, composite measure of cardiac performance which is dependent
not only on myocardial function but also on heart rate, preload and afterload.
In view of its global nature and practical limitations RVO is not an appropriate
technique for assessing myocardial function in the clinical setting. Furthermore, the
current studies have demonstrated that RVO is preserved even in the face of
significant RV dysfunction. Whilst this probably demonstrates the ability of the
newborn infant circulation to compensate acutely for myocardial dysfunction and
maintain cardiac output, it also highlights that RVO is a poor measure for the
clinician wishing to identify and treat RV dysfunction immediately.
The trend towards increased RVO in the PHT group, compared to controls, was
hypothesised to be due to the presence of a right-to-left shunt through the patent
ductus arteriosus in the majority of PHT infants. In these infants, RVO represents
the sum of pulmonary blood flow and a proportion of systemic blood flow. Although
this study was not specifically designed to assess the effects of the patent ductus on
RV function in PHT, this is an area of current clinical interest which has not been
previously studied and is therefore considered briefly here.
A number of authors have proposed that maintaining ductal patency in infants with
severe PHT, using prostaglandin El, may reduce afterload on the RV and provide a
"blow-off valve to prevent RV dilatation and dysfunction when pulmonary vascular
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resistance exceeds systemic vascular resistance [17, 38]. This approach has been
associated with improved outcome in the setting of PHT due to CDH [118].
However, no studies have previously examined the haemodynamic consequences for
the RV of promoting right-to-left ductal shunting in PHT. The data obtained in this
study was the first measurement of RVO in the presence of right-to-left shunting.
That RVO was increased in some infants with PHT brings into question whether the
presence of the patent ductus actually increased RV work and might worsen the
extent ofmyocardial dysfunction. This finding raises an important area for future
study; to determine whether the practice ofmaintaining ductal patency in infants
with PHT benefits RV function by reducing afterload or compounds RV dysfunction
by increasing RVO and therefore RV work.
10.2.3 RVmpi
The MPI was developed as a practical, quantitative measure of ventricular
performance which has the advantages of being independent of angle of insonation,
assessing both systolic and diastolic function and providing a means of quantifying
ventricular function [69, 70], The studies conducted here confirmed the feasibility of
performing RVmpi in normal infants, and were in good agreement with prior reports
[111, 134, 135]. The current studies also demonstrated, for the first time, the
feasibility of performing RVmpi in infants with PHT. The finding of elevated RVmpi
in infants with PHT, independent of age, was in agreement with previous studies in
adults and children with PHT, and newborn piglet models of PHT [73, 75].
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The problems of RVmpi as a measure of RV function become apparent when trying to
interpret the increase in RVmpi in the PHT group. RVMpi has been shown to be
highly load-dependent in conductance catheter studies [76] and it is therefore unclear
whether the observed increase in RVmpi was due to a change in myocardial function,
preload or afterload. Even if changes in RVmpi directly reflect change in myocardial
function (independent of changes in load), the "global" numerical index provides no
indication of whether systolic or diastolic function, or indeed both, has changed.
In view of the load dependence and global nature of RVmpi, like RVO it cannot be
recommended as a specific measure of RV myocardial function. Nevertheless, given
the practical ease of acquiring this index it may still have a role as a "screening"
measure. For example, the detection of an elevated RVmpi in an infant might be used
as an indication to perform more detailed assessment of RV function. In addition
RVmpi may have a role in the serial scoring of combined RV function and loading
conditions in infants with PHT.
10.2.4 Pulse Wave Tissue Doppler Imaging
Tissue Doppler imaging is a new echocardiographic technique which allows
measurement ofmyocardial velocities and time intervals as indicators of systolic and
diastolic myocardial function [77]. The current studies are the first reported use of
TD1 to assess RV function in infants with PHT or any other disease process. These
studies were therefore very important as investigations of the feasibility of using TDI
in this setting, and as a potential means of providing new understanding of the
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mechanisms of RV dysfunction in PHT. Two forms of TDI were employed: pulse
wave TDI (PWTDI) and colour TDI (CTDI).
The current studies confirmed the feasibility of PWTDI in normal infants and
provided normative myocardial velocity data which was in good agreement with the
two prior reports [94, 105], The feasibility of PWTDI in infants with PHT was also
confirmed for the first time. PWTDI data were obtained rapidly and without clinical
deterioration in all infants in whom clinical circumstances allowed. PWTDI data
analysis were successful in all but one infant with PHT, in whom artefact from
HFOV prevented analysis. This was not encountered in other infants receiving
HFOV and therefore this ventilation mode should not preclude use of PWTDI.
Systolic and diastolic myocardial PWTDI velocities (IVV, S, E' and A') were
successfully obtained in both control and PHT infants. However, isovolumic
acceleration (IVA) could not be accurately measured due to the combination of high
infant heart rates and spectral broadening of the PWTDI trace. PWTDI IVA cannot
therefore be recommended as a feasible measure ofmyocardial function in infants.
Interpretation of PWTDI myocardial velocities highlighted the major advantages of
these measures ofmyocardial function over TV Doppler, RVO or RVmpi- Firstly,
systolic and diastolic function may be independently measured. Secondly, the early
and late components of diastolic function can be distinguished, allowing assessment
of early diastolic relaxation (a combination of active relaxation and passive
compliance or stretch) and late diastolic function related to atrial contraction. No
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other non-invasive measure of ventricular function allows such detailed analysis of
function throughout the cardiac cycle.
The load-dependence of TDI velocities remains an area of controversy, which must
be borne in mind in data interpretation. Existing studies would suggest that, outwith
extremes of loading, systolic TDI velocities are relatively load-independent measures
ofmyocardial function [49, 82], TDI E' velocities demonstrate preload dependence
in the normal heart, but not the failing heart [85, 86], The velocities in the current
study were considered to reflect more accurately true myocardial function than TV
Doppler, RVO or RVmpi- Future studies are required to investigate the true degree of
load-dependence of TDI velocities in infants.
Unlike PWTDI velocities, the diastolic time interval IVRT (and its reciprocal
measure, DMDT) cannot be recommended as measures of RV myocardial function,
as these were difficult to measure in some PHT infants (due to post systolic positive
velocities) and are known to be highly load-dependent [27].
The demonstration of PWTDI velocities as feasible measures of both systolic and
diastolic RV function in infants may be one of the most important findings of this
thesis. Can PWTDI be recommended as a practical clinical measure ofRV function
in all infants with PHT on the basis of the current findings? This study has
confirmed that PWTDI is safe and practicable for use in infants with PHT, and has
the potential to allow detection ofmyocardial dysfunction before other measures,
such as RVO, are altered. Repeatability and reproduceability require assessment
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before PWTDI can be recommended for routine clinical use. In addition, although
there were statistically significant differences in myocardial PWTDI velocities
between PHT and control groups, it is not clear whether these changes in velocity are
of sufficient size to be clinically detectable in individual patients. Larger studies of
PWTDI velocities in normal and PHT infants may provide an indication of the
ranges of normal and abnormal velocities to aid clinical interpretation.
Another issue preventing routine use of PWTDI at present is that few neonatal
echocardiographers have experience in use of PWTDI. Training would be required if
this technique were to be put into routine practice. The availability of ultrasound
machines capable of performing PWTDI may be another barrier to widespread
introduction of this technique.
These studies have indicated the significant future potential of PWTDI as research
tool in other neonatal diseases where myocardial dysfunction is suspected, including
respiratory distress syndrome, preterm low cardiac output states, patent ductus
arteriosus, sepsis and post-operative states [61, 102, 140], Future studies could also
employ PWTDI to investigate the effects of current and future therapies on RV
function allowing future therapies to be developed which specifically target
mechanisms ofmyocardial dysfunction.
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10.2.5 Colour Tissue Doppler
Colour tissue Doppler is a more recently developed and sophisticated form of TDI,
compared to PWTDI, which theoretically allows more rapid data acquisition and
increased flexibility in the choice of size, distribution and number ofmyocardial
regions for velocity analysis [77], CTDI has never previously reported in infants. The
current studies represented an important assessment of the feasibility of CTDI in
infants.
The studies presented here demonstrated the ease with which CTDI "raw" data could
be collected in infants, from a single echocardiography window over a period of 3-5
beats. The problems of performing CTDI in infants became apparent during post-
acquisition data analysis.
The combination of high infant heart rates and limited frame rate analysis led to
insufficient sampling frequencies. The result was distorted CTDI waveforms in
which some myocardial velocities could not be accurately identified and peak
velocities were lower than "true" peaks. Subsequent inaccuracy in measuring the
velocities was thought to have led to the wide variance ofCTDI velocities. The
shorter-lived IVV was particularly affected by this issue, making measurement of
IVA inaccurate also. This was a disappointing finding, as one of the major potential
advantages of CTDI over PWTDI was the theoretical ability to measure IVA without
the problem of spectral broadening which had been encountered in PWTDI.
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The issue of insufficient sampling frequencies is entirely due to the limitations of the
current software and hardware used to acquire CTDI data. The combination of the
Philips IE33 and QLab software used in these studies was one of the most advanced
cardiac ultrasound packages currently available, yet still an optimal sampling
frequency could not be achieved.
CTDI analysis was also time-consuming and considered vulnerable to measurement
error due to potential mal-positioning of the Doppler sample outwith the
myocardium.
In view of these problems, the CTDI data obtained in the control and PHT groups
were interpreted with considerable caution. The control data, in theory, represents
the first normative CTDI data in infants, but the wide variance of the individual
velocities more likely reflects measurement error rather than true physiological
variation within the control group. Comparison of CTDI velocities between control
and PHT groups yielded inconsistent differences in systolic velocities, which were
not in agreement with PWTDI data. The CTDI data was considered too inaccurate to
provide meaningful insight into the changes in myocardial function in infants and is
not included in the discussion of the mechanisms of RV dysfunction in PHT below.
On the basis of this work CTDI, in the form employed in this work, cannot be
recommended as a measure ofmyocardial function in infants. Nevertheless,
technical advances in the future may allow higher sampling frequencies, which could
overcome the major current problems of CTDI use in infants.
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10.2.6 Conclusions
No current echocardiographic index is a perfect measure of RV function. The issues
of variable load-dependence, measurement error and limits of current technology all
prevent direct and specific measurement ofmyocardial function in systole or
diastole. All of the measures of RV function assessed in this work could be safely
and feasibly performed in normal infants and infants with PHT. PWTDI was found
to be the most useful measure of RV function in infants with PHT, providing
quantitative assessment of both systolic and diastolic function. PWTDI is proposed
as a means of assessing RV function in future research and clinical settings. TV
Doppler is limited by its load dependence but allows rapid measurement of inflow as
an assessment of function. RVMpi and RVO are limited by their global nature and
load dependence. CTDI is a promising technique but the limitations of current
technology mean that it cannot be recommended for current use in infants.
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10.3 Mechanisms ofRV dysfunction in pulmonary
hypertension
The second research question posed at the outset of this work was: What are the
mechanisms ofRVdysfunction in infants with PHT?
The related hypothesis was that "RVdysfunction in PHT is characterised by systolic
and diastolic dysfunction
This was considered an important research question as the mechanisms of RV
dysfunction in infants with PHT have not been previously studied and better
understanding of these may allow more informed therapeutic decisions.
The mechanisms of RV dysfunction in PHT were investigated by comparison of RV
function between control and PHT infant groups. For the purposes of this work
"mechanisms" of RV dysfunction refers to whether changes occurred in systolic
and/or diastolic function in the RV. It was beyond the scope of this study to
investigate changes in the RV at a morphological, cellular or molecular level.
Although a number of different echocardiographic measures were used to assess RV
function in this work, only PWTD1 and TV Doppler data were used to draw
conclusions on the mechanisms of RV dysfunction in PHT. PWTDI data was
considered the most informative as this provided assessment of both systolic and
diastolic function. TV Doppler data also provided an indication of diastolic (but not
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systolic) RV function in PHT, but was interpreted with caution in view of the direct
load dependence of this measure. RVO, RVMPI and CTDI data were not considered
useful in determining the mechanisms ofRV dysfunction in PHT: RVO and RVMpi
are global, load-dependent measures ofRV function which provided no indication of
the relative changes in systolic and diastolic function. CTDI data was considered
inaccurate due to measurement error.
10.3.1 Systolic RV function in infants with PHT
The PWTDI data demonstrated a significant reduction in systolic myocardial
velocities during both isovolumic contraction (IVV) and ejection (S). PWTDI
systolic velocities have previously been demonstrated to correlate well with gold
standard conductance catheter measures of systolic function. The reductions in IVV
and S velocities in the PHT group were therefore considered to reflect genuine
impairment of systolic function during both early isovolumic contraction and later
systolic ejection phases respectively.
This study represented the first direct demonstration of systolic dysfunction in this
setting. Assessment of systolic function in PHT has previously been limited to
animal models and adult studies. In animal models, the initial response of the RV to
acute increases in afterload was an increase in RV systolic function [100, 141, 142] -
attributed to a combination of the Frank-Starling mechanism and early compensatory
RV hypertrophy. Chronic exposure to elevated afterload, however, leads to systolic
dysfunction, as has been demonstrated in adults using TDI techniques [92, 93], The
current findings have demonstrated the same impaired systolic function in infants.
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That no increase in RV systolic function was observed in the infant PHT group
suggests that the infants studied had already undergone the "pivotal divergence"
from initial compensated RV function with increased systolic function to a chronic
failing RV with impaired systolic function [35].
10.3.2 Diastolic RV function in infants with PHT
Diastolic function has been rarely considered in infant disease states, principally due
to the absence of acceptable measures. Use of PWTDI in the current work allowed
the first direct assessment of diastolic myocardial function in infants with PHT. The
finding of reduced early diastolic myocardial velocities (E') was considered to
suggest impaired early diastolic function. This was one of the most striking findings
of the current work.
The data presented here are in agreement with prior animal and adult studies. In both
lamb and dog models of chronic PHT, RV diastolic dysfunction has been
demonstrated using "gold-standard" conductance catheter techniques [90, 100]. In
adults with primary PHT, TDI RV function has been assessed using the same TDI
techniques employed here in infants [92, 93], In these adults, just as in the PHT
infants, E' velocities were significantly reduced indicating early diastolic
dysfunction. Kjaergaard et al, also using TDI, have demonstrated the same
impairment of early diastolic function in the RV in adults with acute onset, hypoxia-
induced PHT [74].
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Why is early diastolic function impaired in infants with PHT? Early diastolic
function is a combination of active myocardial relaxation and passive chamber
stiffness (or compliance) and consists of an initial isovolumic phase (IVRT) followed
by early ventricular fdling, corresponding to the PWTDI E' wave [26], One possible
clue as to the cause of impaired active relaxation, in the infants with PHT, was the
presence of abnormal post-systolic positive myocardial velocities in the PWTDI data
from these infants. It is hypothesised that these abnormal "post-systolic
contractions'" may have represented either abnormal contraction of the failing
ventricle after pulmonary valve closure, or re-organisation of the RV morphology
between systole and diastole. Whichever the explanation, this period of post systolic
contraction may have prevented normal early active diastolic relaxation and
ventricular fdling. This represents an area for future study, both to identify the
aetiology of the post-systolic contraction and the effects on early active myocardial
relaxation.
The passive component of early diastolic function (i.e. RV compliance) might also
have been affected in infants with PHT. In support of this, Leewenburgh et al have
previously demonstrated impaired chamber stiffness (using catheter techniques) in
the hypertrophied RV of lambs following pulmonary artery banding [90], However,
the echocardiography techniques used in the current study did not allow direct
assessment of chamber compliance.
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10.3.3 Factors responsible for the observed changes in RV function
in PHT
Increased afterload on the RV is likely to have been a major contributing factor to the
development of systolic and diastolic dysfunction in the PHT group. However, other
differences between the two study groups may also have contributed to the observed
changes in RV function in the PHT group.
Infants in the PHT group were variably receiving a number of therapies which may
have altered myocardial function either directly or by modulation of afterload. These
included mechanical ventilation, inhaled nitric oxide, oral sildenafil, prostagladin El
and muscle relaxation. In addition, 50% of the infants in the PHT group were
receiving an inotrope (either dopamine, dobutamine or milrinone). The effects of
these therapies on infant RV myocardial function have not been extensively
investigated and are poorly understood despite their frequent use in the clinical
setting. Metabolic factors, genetic factors and changes in ventricular morphology
may also have contributed to altered RV function in the PHT group [143],
One major limitation of the current studies was the inability to control for, or
investigate, the individual influences of these myriad factors on RV function.
Further studies are required to determine the specific effects of these. On the basis of
the data presented here it can only be concluded that RV systolic and diastolic
function are impaired in infants with PHT, but not that PHT per se was the sole
factor responsible for this.
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10.3.4 Implications of study findings for therapies in infants with
PHT
The findings of systolic and diastolic RV dysfunction in infants with PHT have
important clinical implications for therapeutic choices in this setting.
Treatment of RV dysfunction in infants with PHT currently focuses on attempting to
reduce afterload and directly improve RV function. The cathecholamine analogues
dopamine and dobutamine are, historically, the most widely used cardiotropic agents
in newborn infants, and are chosen for their "inotropic" actions i.e. their ability to
increase systolic performance, or contractility [140], On the basis of the current
study findings, however, an ideal cardiotropic agent for use in infants with PHT
would improve both systolic and diastolic (lusitropic) function.
One promising candidate agent is the phosphodiesterase inhibitor milrinone
which has been demonstrated to improve both RV systolic and diastolic function in a
canine model of PHT [100]. Studies into the use ofmilrinone in infants with PHT
have been limited to case reports of the drug's successful use in combination with
nitric oxide, to treat preterm infants with severe persistent pulmonary hypertension
[144],
The current work provides a mechanistic rationale for the use ofmilrinone, or related
agents, in infants with PHT. Future study is necessary in the form of a randomised
controlled trial to investigate the potential benefits of milrinone in improving RV
systolic and diastolic function, and reducing afterload, in infants with PHT.
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10.3.5 Conclusions
RV dysfunction in infants with PHT is characterised by impaired systolic and early
diastolic function. Therapies aimed at directly treating RV function in PHT should
have both inotropic and lusitropic actions.
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10.4 Relationship between RV function and pulmonary
artery pressure
The third research question investigated in this thesis was: What is the relationship
between R Vfunction andpulmonary artery pressure in infants with pulmonary
hypertension?
The corresponding testable hypothesis was: that RVfunction does not correlate
linearly with PAP.
10.4.1 RV function measures and pulmonary artery pressure
This is an important question to address. If RV function is variable in PHT then
measurement of PAP alone does not allow prediction of RV function, or
measurement of illness severity. Conversely, if the RV function and PAP are linearly
related then measures of RV function might be used as proxy measures of PAP, for
example in those circumstances when a TR jet is absent and PAP cannot be directly
measured.
The relationship between RV function and PAP was investigated, by repeated paired
measurement of PAP and each of the measures of RV function (TV Doppler, RVO,
R-Vmpi, PWTDI and CTDI). There was poor linear correlation between measures of
RV function and PAP. This was true even for those measures of RV function which
are relatively load-independent (i.e. PWTDI and CTDI).
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The absence of a linear relationship between RV function and PAP may indicate that
RV myocardial function is not inherently linearly related to afterload, and cannot
proportionately increase as PAP increases. Indeed, the non-linear response of the
ventricle to changes in load is recognised in the bell-shaped Frank-Starling
relationship.
Additionally, failure to demonstrate a linear relationship may have been due to the
presence of other variable factors in the PHT group which modulated RV function. It
is hypothesised that alterations in therapies (ventilation, inhaled NO, inotropes) and
in metabolic condition, accompanying changes in PAP, altered the relationship
between RV function and PAP. It is of note that, in studies in piglets and children
where such variations in therapy were minimised, or absent, linear relationships
between RV function and PAP were observed [73, 75, 101].
RV morphology and gene expression may also change in response to chronic
pressure overload [143]. This in turn would conceivably lead to variable RV
function at any given PAP, and the absence of a linear relationship between the two.
Future studies investigating gene expression in the RV in PHT represent an
interesting avenue of further research, and a potential area for development of new
therapies.
The current work was not designed to determine the individual influences of these
varied factors on RV function. Instead, in demonstrating the absence of a linear
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relationship between RV function and PAP in the clinical setting, it has indicated the
importance of directly assessing RV function in infants with PHT to determine the
severity ofRV dysfunction.
Finally, the failure to establish a linear relationship between RV function and PAP
may have been due to experimental error. As discussed in Chapter 2, the use of
tricuspid valve Doppler to measure PAP is dependent on an assumption of right atrial
pressure, and on accurate measurement of peak tricuspid regurgitation jet velocity.
Error in either of these variables may have affected PAP calculation.
10.4.2 Conclusions
This study has demonstrated that in infants with PHT RV function is not linearly
related to PAP. This new finding has significant implications for the clinical
assessment of infants with PHT. PAP cannot be used as a proxy measure of RV
function and illness severity. Instead, RV function should be directly assessed in
infants with PHT.
10.5 Overall Conclusions
The studies presented in this thesis have important implications for the assessment
and management of infants with PHT. The demonstration that RV function is not
linearly related to PAP emphasised the importance of measuring RV function
directly. Such measures of RV function were investigated. TV Doppler and RVMPI
allow rapid assessment of diastolic and global RV function respectively. This work
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also included the first investigation of PWTD1 in a newborn disease state and
demonstrated the powerful potential of this technique to quantify both systolic and
diastolic function. The subsequent demonstration of both systolic and diastolic RV
dysfunction suggests a potential future role for new agents with both inotropic and
lusitropic actions, and a possibility of improved outcome in this group of infants.
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APPENDICES
Appendix 1 : RV function data in congenital diaphragmatic
hernia subgroup




E (cm/sec) 0.52 (0.13) 0.35 (0.13)* 0.04
A (cm/sec) 0.55 (0.10) 0.63 (0.18) 0.34
RVO (mLs/kg/min) 273 (81) 258 (96) 0.44
RVmpi 0.24 (0.09) 0.58 (0.18) <0.0001
PWTDI
IVV 6.6 (1.1) 5.2 (1.5) 0.007
S 9.2 (1.9) 6.3 (1.3) 0.0001
E' -8.6 (2.0) -3.6 (1.8)* 0.0006
A' -10.1 (2.5) -10.8 (4.3) 0.68
CTDI
IVA 68 (30) 95 (39) 0.04
IVV 1.3(0.6) 1.4 (0.6) 0.54
S 2.6 (0.8) 1.9 (0.6) 0.03
E' -3.3 (1.0) -1.42 (0.4)* 0.007
A' -3.4 (1.7) -3.8 (1.9) 0.6
All data mean (SD).
* TV E, PWTDI E' and CTDI E' velocities were present in only four infants in PHT group.
These velocities were absent in the remaining seven infants in PHT group, and were not
included in statistical analysis.
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Appendix 2: Published papers
Appendix 2.1:
Patel, N., Mills, J. F. and Cheung, M. M. H. 'Use of the
myocardialperformance index to assess right ventricular
function in infants with pulmonary hypertensionPediatric
Cardiology 2009; vol.30(2), pp.133-137
Summary
Objective
To measure and compare right ventricular (RV) function in normal infants and
infants with pulmonary hypertension (PHT) using the myocardial performance index
(RVmpi) and to investigate the relationship between RV function and pulmonary
artery pressure.
Design
A case control study in which RVmpi was measured in 16 infants with PHT (of whom
nine had congenital diaphragmatic hernia) and 28 normal control infants. Forty-three
paired measures of RVmpi and pulmonary artery pressure (estimated from tricuspid
regurgitation jet velocity) were made in the PHT infants to allow investigation of the
relationship between RVmpi and pulmonary artery pressure.
Results
RVmpi in control infants was 0.24 ± 0.09 (mean ± SD). RVmpi was significantly
elevated in the PHT group (0.55 ±0.17, P<0.0001) including a subgroup of infants
with PHT secondary to congenital diaphragmatic hernia (0.58 ±0.18, P<0.0001).
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There was poor correlation between RVmpi and pulmonary artery pressure in the
infants with PHT (R2 = 0.05, P=0.17).
Conclusions
RVmpi allows quantification of right ventricular function in infants and detection of
RV dysfunction in PHT. RVmpi was not linearly related to pulmonary artery
pressure. Use of RVmpi in the clinical setting must take into account the global and
load-dependent nature of this measure.
Article proper:
Introduction
Pulmonary hypertension (PHT) is a cause of significant morbidity and mortality in
the newborn infant (7). Pulmonary hypertension may be idiopathic or secondary to
conditions such as congenital diaphragmatic hernia (CDH), meconium aspiration,
pulmonary hypoplasia and sepsis (14).
In infants with PHT the ability of the right ventricle (RV) to function under increased
afterload is an important determinant of illness severity. RV dilatation and
dysfunction may in turn lead to impaired LV function due to ventricular
independence, leading to poor cardiac output and worsening cardio-respiratory
failure (4). Assessment of RV function is therefore central to management of infants
with PHT, but has been complicated by the absence of a suitable clinical technique.
Qualitative assessment of function by 2-dimensional echocardiography is the most
widely used technique in current practice, but is subjective and has high inter-
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observer variability (1). Furthermore, the complex geometry of the RV makes it
unsuited to geometric measures of ventricular function such as ejection fraction and
fractional shortening (2).
A reliable, quantitative measure ofRV function would be useful in clinical practice
to accurately assess function in PHT, monitor response to therapies, and predict
outcome. The myocardial performance index (MPI), or Tei index, is a quantitative
echocardiographic-derived measure of global (diastolic and systolic) ventricular
function, which is non-invasive, simple to calculate and reproducible (17, 19). Right
ventricular MPI (RVMPi) has previously been used to quantify RV function in adults
and children with PHT, where a linear relationship between RVmpi and pulmonary
artery pressure was reported (5, 23). RVMpi has previously been measured in normal
newborn infants and fetuses (3, 10, 12, 13), but not in infants with PHT and potential
RV dysfunction.
The aims of this study were firstly to measure RVmpi in a group of normal newborn
infants and in a group of infants with PHT, including a subgroup of infants with
congenital diaphragmatic hernia, and secondly to investigate the relationship
between RVmpi and pulmonary artery pressure.
Methods
This study was conducted in the Neonatal Unit of the Royal Children's Hospital,
Melbourne, Australia between May 2006 and February 2007. Approval was granted
by the local Ethics Committee.
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Control Group
Control infants were recruited from the inpatient population. They had normal
cardiovascular structure and function, were being treated for unrelated illness, were
self-ventilating in air and were not receiving any cardiac medication. There was no
clinical or echocardiographic evidence of pulmonary hypertension in this group.
Single echocardiograms were performed in each subject to measure RVmpi for
comparison with the PHT group.
PHTgroup
Infants with PHT were identified on admission on the basis of clinical suspicion or
previous echocardiographic findings. Infants were eligible for inclusion if they had
pulmonary pressures equal to or greater than half systemic pressure, when estimated
from tricuspid regurgitation jet velocity (see below) or if they had significant right to
left shunting through a patent ductus. Infants were excluded if they had structural
heart disease, other than a patent ductus. Infants received routine clinical
management, including respiratory and cardiovascular support as deemed necessary
by the attending medical team.
Initial echocardiograms were performed on PHT infants at the time of admission.
RVmpi was calculated from these studies to allow comparison with RVmpi in controls.
In order to investigate the relationship between RVmpi and pulmonary artery
pressure, repeated echocardiograms were performed in the PHT infants, during their
admission, from which paired RVmpi and peak TR velocity could be obtained.
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Studies repeated in the same infant were performed between one and four weeks
apart.
Echocardiographic measurements
Measurements were made using a Philips™ IE 33 (Philips Medical, Andover, MA,
USA) using a 12 MHz or 8 MHz probe. Tricuspid valve Doppler flow was recorded
from an apical four chamber view using pulse wave Doppler, with the sample
volume positioned at the valve tips. Pulmonary valve Doppler flow was recorded
from a left parasternal view with the sample volume placed at the level of the
pulmonary valve tips.
Pulmonary artery pressure was calculated using a modified Bernoulli equation from
the tricuspid regurgitation (TR) jet velocity obtained from the apical 4 chamber view
using continuous wave Doppler (24). The pressure gradient calculated in this way
represents the pressure difference between right atrial and right ventricular pressures.
Pulmonary artery pressure was estimated by adding 5 mmHg (an estimation of right
atrial pressure) to this gradient. In the absence of an adequate TR jet, pulmonary
pressures were estimated by assessment of the pattern of shunting through the patent
ductus arteriosus, using pulse-wave Doppler from a high left parasternal view (11).
MPI calculation
RVmpi is the sum of RV isovolumic contraction time (ICT) and isovolumic relaxation
time (IRT) divided by the RV ejection time. RVmpi was calculated in practice from
tricuspid valve inflow and pulmonary valve outflow Dopplers, as shown in Figure 1.
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The time period from cessation to beginning of tricuspid inflow (a) and the right
ventricular ejection time (b) were measured. RVmpi is equal to (a-b)/b. Doppler-
derived time intervals were measured offline from stored data and averaged over five
consecutive cardiac cycles. Care was taken to select paired pulmonary and tricuspid
Doppler flows between which R-R intervals varied by less than five beats per
minute.
Statistical analysis
Demographic data (weight, gestation and age) were compared between control and
PHT groups using unpaired t-tests. All RVmpi data are expressed as mean and SD.
RVmpi for the PHT group, and CDH subgroup, were compared with control RVmpi
using Mann-Whitney tests. The relationship between RVmpi and pulmonary artery
pressure was investigated by linear regression analysis. Subgroup analysis of infants
with PHT and CDH was performed. This data was of particular interest within our
institution which has a specialist interest in the management of infants with CDH.
Results
Twenty-eight infants were recruited to the control group and 16 to the PHT group.
Causes of PHT were CDH (eleven infants), PPHN (two infants), meconium
aspiration (one infant), vein of Galen malformation (one infant) and congenital cystic
adenomatoid malformation (one infant)._Demographic details are provided in Table
1. There were no significant differences between the groups based on weight,
gestation or age.
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RVmpi was significantly elevated in the PHT group compared to the control group
(0.55±0.17 vs. 0.24±0.09 [P<0.0001] respectively; Table 2 and Figure 2). Sub-group
analysis of the eleven infants with CDH demonstrated a significant elevation in
RVmpi this group alone (0.58±0.18), compared with the control infants (P<0.0001).
The relationship between RVmpi and pulmonary artery pressure was also
investigated. Paired measures of RVmpi and were obtained on 43 separate occasions
in the fourteen infants in the PHT group. There was poor correlation between these
variables (R2 = 0.05; P=0.17; Figure 3).
Discussion
This study has demonstrated a significant elevation in RVmpi in infants with PHT
compared to normal controls. There was, however, no correlation between RVmpi
and pulmonary artery pressure.
The MP1 is an echocardiographic measure of ventricular function which is derived
from Doppler flows across the ventricular inflow and outflow valves (17). MPI has
been validated against invasive measures of cardiac function; it shows good
reproducibility, heart rate independence and because it is not dependent on angle of
insonation it can be measured rapidly from limited echocardiographic views (6, 20).
RVmpi has previously been used to assess RV function in adults, children and normal
newborn infants (12, 18,21). Our finding of an RVmpi of 0.24 ± 0.09 in normal
control infants is in good agreement with previous reports in normal newborn infants
(3, 13).
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RVmpi has previously been measured in adults and children with primary PHT and
by Sugiura et al in a newborn piglet model of hypoxia-induced PHT (5, 16, 23).
These studies demonstrated a significant elevation in RVmpi in PHT and suggested
that RVmpi may be used clinically to quantify RV dysfunction. Our study has
demonstrated elevated RVmpi in newborn infants with PHT of varied cause,
including congenital diaphragmatic hernia.
RVmpi has been proposed as a prognostic marker of outcome in adult disease states
including PHT, acute myocardial infarction and cardiac failure (7, 8, 23). Tei et al
demonstrated that in adults RVmpi independently predicted cardiac death or need for
transplantation in PHT (23). RVmpi has also been employed as a means of assessing
RV function in response to pulmonary vasodilator therapies in adult PHT (15).
Further studies are now required to investigate the role of RVmpi in predicting
outcome and assessing therapeutic response in infants with PHT.
Previous studies have shown good correlation between RVmpi and pulmonary artery
pressure and have suggested that RVmpi may be used as a proxy measure of the latter
(5, 16). Our study did not support this finding. RVmpi correlated poorly with
pulmonary artery pressure calculated from tricuspid regurgitation jet velocity. One
interpretation of this finding is that RV function is itself not linearly correlated with
pulmonary artery pressure, a finding that is well recognised clinically (4).
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Another possible explanation of the poor correlation between RVmpi and pulmonary
artery pressure is that RVmpi was being altered by other factors. The PHT infants in
this study were receiving standard clinical management as deemed necessary
including cardio-respiratory support. It is possible that these therapies may have
influenced RVmpi, either by directly altering myocardial function or loading
conditions. We have previously demonstrated that MPI is significantly directly
affected by changes in afterload or preload without alteration ofmyocardial function
(22). This load-dependence means that RVmpi cannot be considered a pure measure
ofmyocardial function.
Another limitation of RVmpi is that it is a global measure of ventricular function
which cannot be used to distinguish between systolic and diastolic dysfunction and
therefore cannot inform the clinician's choice of inotropic or lusitropic therapy.
Furthermore, because of the way the index is calculated a decrease in systolic
function may be masked by an increase in diastolic function and vice versa.
Limitations of this study
We calculated MPI from tricuspid valve and pulmonary valve Doppler flows which
were obtained consecutively over a number ofminutes. However, physiological
changes in heart-rate between these two recordings can introduce inaccuracy (10).
We studied only a small group of infants, with heterogeneous diagnoses. Age at
inclusion in the study also varied widely which may impact on our results since
RVmpi appears to fall within the first days of life in normal infant (1). Any
inaccuracy in the estimate of pulmonary artery pressure from tricuspid regurgitation
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jets will invalidate the analysis of the relationship of pulmonary pressure and RVmpi-
Care was taken to include only optimal TR Doppler flows, from which peak velocity
could be clearly measured, but this led to exclusion of some data which may have
biased the results. We assumed a right atrial pressure of 5 mmHg in all calculations
of pulmonary artery pressure, but true atrial pressures may have been significantly
higher. However, even if true atrial pressures were higher the relative contribution to
the calculated pulmonary artery pressures would have been small and unlikely to
significantly alter the results obtained.
Conclusion
RVmpi can be easily measured in newborn infants and is elevated in those with
pulmonary hypertension. However, use of RVmpi in this clinical setting should take
into account the global nature and load dependency of this measure.
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Table 1: Demographic details of control and pulmonary hypertensive groups
(Mean (range))
Controls PHT P
(n = 28) (n=16) (Controls vs. PHT
group)
Male Sex 17 8
Weight (kg) 3.31(2.1-4.9) 3.40(2.7-4.7) 0.34
Gestation (weeks) 38 (28-42) 39 (36-41) 0.08
Corrected gestational 40 (36-48) 41 (36-44) 0.51
age (weeks)
Table 2: RVmpi in control group, pulmonary hypertension (PHT) group and
congenital diaphragmatic hernia subgroup (CDH)
Group RVMPI
Control infants 0.24 (0.09)
All PHT infants 0.55(0.17)*
CDH subgroup 0.58 (0.18)*
*P<0.0001 compared to control group
Figures










































*P<0.000l compared to Control Group
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Patel, N., Mills, J. F. and Cheung, M. M. H. Assessment of
right ventricularfunction using tissue Doppler imaging in




In infants with pulmonary hypertension, right ventricular (RV) function may be
altered and contribute to disease severity. Tissue Doppler imaging (TDI) is a new
echocardiography modality which directly measures myocardial velocities and may
allow quantative assessment of systolic and diastolic ventricular function in infants.
Objective
To measure and compare RV myocardial velocities in infants with pulmonary
hypertension and in normal control infants, using TDI.
Methods
This was a prospective, case control study. Twenty-eight control infants and 15
infants with pulmonary hypertension (PHT), of whom 11 had congenital
diaphragmatic hernia (CDH) were recruited. Tissue Doppler imaging (TDI) was used
to obtain systolic and diastolic myocardial velocities in the RV and interventricular
septum in all infants.
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Results
There were significant reductions in systolic isovolumic contraction velocity (IVV;
5.3 vs. 6.6 cm/sec) and systolic ejection velocity (S; 6.6 vs. 9.2 cm/sec) in the PHT
group compared to the control group. Early diastolic myocardial velocity, E', was
also significantly reduced in the RV in the PHT infants compared to controls (-4.3
vs. 8.6 cm/sec). The same significant reductions in systolic and early diastolic TD1
velocities were observed in the sub-group ofCDH infants alone.
Conclusions
TDI permits non-invasive assessment of RV myocardial velocities in infants.
Reduced systolic and diastolic velocities in PHT may represent impaired systolic
contraction and early diastolic relaxation. Therapies which target inotropic and
lusitropic function may be appropriate in infants with PHT and RV dysfunction. The
load-dependency of TDI measures in infants, and the effects of specific therapies on




Pulmonary hypertension (PHT) is a cause of significant morbidity and mortality in
the neonatal population, including in infants with congenital diaphragmatic hernia,
meconium aspiration, sepsis and pulmonary hypoplasia [2], Irrespective of the
underlying cause of PHT, a principal consequence and a major determinant of
disease severity is right ventricular (RV) dysfunction due to increased afterload [35],
RV function, or dysfunction, in infants with PHT may be highly variable and may
not be predicted by measurement of pulmonary artery pressure alone [ 145], A
missing element in the clinical management of infants with PHT has been the
absence of objective, quantitative measures of RV function and an understanding of
the mechanisms of RV dysfunction on which to base therapeutic decisions.
Tissue Doppler Imaging (TDI) is a new echocardiographic technique which directly
measures the velocities ofmyocardial motion during systole and diastole. TDI
myocardial velocities have been validated as measures of myocardial function
against gold-standard conductance catheter measures [77], TDI has been employed
to assess RV function in animal and adult studies [91-93, 146] but its application in
newborn infants has been limited, thus far, to normal infants [94], TDI may be a
useful non-invasive means of assessing RV function in infants with PHT, to elucidate
mechanisms of RV dysfunction and guide therapy.
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AIMS
The aim of this study was to measure RV myocardial velocities in infants with
pulmonary hypertension and in normal control infants, using TDI. The hypotheses
tested were, that in newborn infants:
• RV myocardial systolic and diastolic velocities can be measured using tissue
Doppler imaging




This prospective case-control study was conducted in the Neonatal Unit (NNU) of
the Royal Children's Hospital, Melbourne. Approval for the study was granted by
the local institutional Ethics Committee. A Pulmonary Hypertension (PHT) group
was prospectively recruited consisting of consecutive admissions with
echocardiographic evidence of pulmonary artery pressures equal to, or greater than,
two-thirds peak systemic pressure. Infants were excluded if they had structural heart
disease evident on echocardiogram.
A control group was also recruited prospectively who had no echocardiographic
evidence of pulmonary hypertension, and no structural or functional cardiac disease.
Control infants were a convenience sample, inpatient in the NNU with unrelated non-
cardiac diagnoses during the same period the PHT group.
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Clinical data
The gestation, age, corrected age, sex, weight and diagnoses of the subjects were
recorded. Systemic blood pressure, for estimation of pulmonary artery pressure in
the PITT group, was recorded from the bedside monitor (Philips Intellivue Patient
Monitor MP 80/90, Philips Medical Systems, Bothwell, WA) obtained via an intra¬
arterial catheter or cuff sphygmomanometer. Heart rate was recorded from a three-
lead ECG recorded simultaneously with all echocardiographic data. Current
therapies were recorded, including; invasive ventilation, inhaled nitric oxide, and use
of inotropes.
Echocardiographic data
In each subject, an echocardiogram was performed to assess RV function using TDI
and conventional tricuspid valve Doppler inflows. All echocardiograms were
performed using a Philips IE33 (Philips Medical Systems Bothwell, WA) with an 8
Mhz probe, by a single operator (NP), and digitally recorded to DVD for offline
analysis. Doppler data was obtained from a minimal angle of insonation (<15°).
Each echocardiographic parameter was measured over five consecutive cardiac
cycles and the mean was calculated. All echocardiographic data was collected and
analysed by a single observer (NP). Control group data was anonymised. PHT
group data was archived for ongoing clinical purposes and was therefore not




Pulse wave Tissue Doppler Imaging (PWTD1) was used to measure RV myocardial
velocities. PWTDI data were obtained using an apical four chamber view from the
lateral tricuspid annulus (RV) and basal interventricular septum, as previously
described [94], A Doppler sample volume of two millimetres was used. Figure 1 is
a representative trace of PWTDI velocities during one cardiac cycle. Systolic
velocities measured were peak isovolumic systolic velocity (IVV) and peak ejection
systolic velocity (S), corresponding to early systolic isovolumic contraction and later
systolic ejection phases [82]. Diastolic velocities measured were the early diastolic
E' velocity corresponding to early diastolic relaxation and later diastolic A' velocity,
corresponding to atrial contraction [84],
Tricuspid Valve Doppler
Tricuspid valve Doppler, an established clinical method of assessing diastolic fdling,
was included in the study as an adjunct to TDI. A tricuspid valve inflow pulse wave
Doppler recording was obtained at the tip of the valve leaflets from an apical four-
chamber view. Peak E and A wave velocities were then measured.
Echocardiographic determination of pulmonary artery pressure
Pulmonary artery pressure was estimated using two techniques; velocity of tricuspid
regurgitation (TR) and pattern of ductal shunting. TR velocity was measured using
continuous wave Doppler from an apical four chamber view. A modified Bernoulli
equation was used to calculate the pressure gradient between the right atrium and
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right ventricle [97], Pulmonary artery pressure was quantified by adding 5 mmHg
(an estimation of right atrial pressure) to this gradient. Pulmonary pressures were
also qualitatively estimated from the pattern of shunting through the patent ductus
arteriosus using pulse wave Doppler from a high left parasternal view [98], Low
velocity bi-directional shunting was considered to reflect systemic pulmonary artery
pressures, whilst exclusive right-to-left shunting was considered to reflect
suprasystemic pulmonary artery pressure.
Statistical analysis
Within each group myocardial velocities were summarised as mean and standard
deviation (SD). Demographic data were compared between control and PHT groups
using an unpaired t-test. RV function data was compared between control and PHT
groups using Mann-Whitney tests.
RESULTS
Twenty-eight infants were recruited to the control group and 15 to the PHT group.
There were no significant differences in gestation, corrected age in weeks, or weight
between the two groups (Table 1).
Infants in the control group were older than the PHT group; this difference just
reached statistical significance (P=0.05). There was a preponderance of female
infants in the control group. Heart rate was not significantly different between
control and PHT groups. Importantly, infants in the PHT group were more likely to
be mechanically ventilated (93%), receiving inotropes (47%), and/or inhaled nitric
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oxide (73%), than infants in the control group. Inotropes being administered were
dopamine alone (four infants), dobutamine alone (one infant), milrinone alone (one
infant) and combined dopamine and dobutamine (one infant).
In 11 infants PHT was secondary to congenital diaphragmatic hernia (CDH), and in
the remaining infants secondary to meconium aspiration (one infant), alveolar
capillary dysplasia (one infant) and idiopathic (two infants). All infants had PHT
secondary to increased pulmonary vascular resistance. The predominance of infants
with CDH in our study reflects the high numbers of infants with this diagnosis
treated by our institution. The mechanisms, chronicity and severity of PHT in CDH
may differ from other causes of PHT in infants [11], CDH infants were included in
analysis of the entire PHT group, but were also considered separately in a subgroup
analysis.
Echocardiograms were well tolerated. One infant in the PHT group had a pulmonary
artery pressure greater than two-thirds systemic arterial pressure, but less than
systemic arterial pressure. The remaining 14 infants (94%) had a pulmonary arterial
pressure equal to or greater than systemic arterial pressure.
PWTDI and tricuspid valve Doppler data were obtained in all infants. However, in
one infant in the PHT group, artifact from high frequency oscillatory ventilation




Systolic PWTDI velocities in the RV and septum are summarized for the PHT and
control groups in Table 2. IVV was significantly reduced in the RV in infants in the
PHT group compared to controls. S wave velocity in the RV was also significantly
reduced in the PHT group. No significant difference was observed in systolic
PWTDI velocities in the interventricular septum. Subgroup analysis of the CDH
infants alone, also demonstrated significant reduction in IVV and S velocities in the
RV, compared to the control group.
Diastolic tricuspid valve flow and myocardial velocities
Tricuspid valve Doppler analysis in the PHT group demonstrated significant
reduction in E wave velocity compared to controls, whilst A wave velocity was
unchanged (Table 2). These findings indicate reduced early RV diastolic filling in
the PHT group.
Analysis of diastolic TDI velocities revealed a reduction, or complete absence, of the
E' velocity in the PHT group. In seven infants in the PHT group an E' wave was
identifiable, and of significantly reduced velocity compared to the control group, in
both the RV and interventricular septum. In the remaining eight PHT infants, E'
waves were entirely absent (Figure 2). Absence of the E' wave was observed even in
infants with lower heart rates, and therefore was considered to represent genuine
absence of an early diastolic E'velocity, rather than E-A wave fusion. A' wave
velocities were unchanged in TDI analysis. Subgroup analysis of CDH infants alone
also demonstrated significant reductions in E' velocity compared to controls (Table
2).
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In five infants in the PHT group prominent "post-systolic" positive velocities were
present. These were positive myocardial velocities occurring after the systolic S
wave, but before the E' or A7 wave (Figure 2).
DISCUSSION
This is the first study to use TDI to assess RV function in sick newborn infants and
has demonstrated significant reductions in systolic and early diastolic myocardial
velocities in infants with pulmonary hypertension.
RV function, or dysfunction, is a principle determinant of illness severity in infants
with PHT [34], However, RV function assessment is rarely performed in infants
with PHT, or is limited to qualitative assessment using 2-dimensional
echocardiography. Alternative attempts to quantify RV function using ejection
fraction and fractional shortening are time consuming and of questionable accuracy
due to the RV's complex geometry [57],
TDI is a relatively new technique allowing direct measurement of myocardial
velocities as measures ofmyocardial function [77], TDI velocities correlate well
with gold standard conductance catheter measures of ventricular function and are
non-invasive and practical for use in the clinical setting [80, 81, 84]. Importantly,
unlike other global measures of ventricular function, TDI measures allow separate
analysis of systolic and diastolic function.
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We have confirmed the feasibility of PWTDI in the RV in normal and PHT infants.
Our measurements of systolic S velocity and diastolic E' and A' velocities in normal
infants are in good agreement with previous normative infant data reported by Mori
et al [94], We were additionally able to measure IVV, as another measure of systolic
function.
In the PHT group we observed reduced systolic myocardial velocities (IVV and S)
and a significant reduction, or absence, of early diastolic (E') velocities. These
changes may be considered to indicate inherent impairment of systolic and early
diastolic function in the PHT group. However, the observed changes in myocardial
TDI velocities might also be due to the direct effects of altered load, independent of
changes in myocardial function. The degree of load-dependence ofTDI velocities
remains unclear - some animal studies have demonstrated relative load-
independence, whilst others have demonstrated load-dependency at extremes of
loading conditions [49, 82], In infants, validation of TDI velocities against load-
independent conductance catheter measures of RV function has not been performed,
in this or prior studies, due to the unacceptably invasive nature of catheter
techniques.
If the observed changes in TDI myocardial velocities genuinely reflect impaired
systolic and diastolic function (independent of changes in loading) then this is
consistent with prior demonstrations of systolic and diastolic RV dysfunction in
animal models of PHT and adults with PHT [91-93]. One explanation for impaired
early diastolic relaxation in the current study may be abnormally prolonged
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contraction of the RV after pulmonary valve closure, producing the "post-systolic"
positive myocardial velocities, which were observed in five infants in the PHT
group.
It is of note that there was overlap of the ranges ofmyocardial velocities between
PHT and control groups. This overlap between groups likely reflects the
preservation of normal myocardial velocities in some PHT infants, demonstrating the
variable nature of RV function in PHT [35, 145], This finding emphasises the
importance of directly assessing RV function, and not measuring pulmonary artery
pressure alone, in infants with PHT.
It is important to note that the changes in myocardial velocities in the PHT group
may not solely be due to increased afterload i.e. pulmonary artery pressure. The
PHT infants were variably receiving a number of therapies (inotropes, pulmonary
vasodilators and mechanical ventilation), which may have altered myocardial
velocities either by directly altering myocardial function, or indirectly by modulating
afterload. Specifically, dopamine, dobutamine and milrinone may, theoretically,
affect systolic and diastolic myocardial function, whilst inhaled nitric oxide may
have reduced afterload. It was beyond the scope of the current work to investigate
the individual effects of these therapies on myocardial function though this remains
an important area for future study, and potential use of TDI. Of note, the same
findings of impaired RV systolic and diastolic myocardial velocities were present in
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one infant in the PHT group who was not mechanically ventilated and was receiving
no cardiac medications.
The findings of this study are relevant to the clinical management of infants with
PHT, including those with CDH. Specifically, pulse wave TDI may have a practical
role in the initial identification ofRV dysfunction in infants with PHT, and in the
assessment of response to therapies both in the clinical and research setting. For
example, the use of pulmonary vasodilators and PGE1 (to maintain ductal patency)
to reduce RV afterload [16, 114] has been proposed in infants with PHT and CDH.
However, there have been no objective assessments of the direct effects of these
therapies on RV function. TDI may represent a useful tool for measuring RV
function in response to such new therapies.
The finding of diastolic and systolic abnormalities in PHT also has potential
implications for the choice of drugs to directly improve RV function in PHT.
Theoretically, agents which improve both inotropic and lusitropic (diastolic) function
may be most effective. The phosphodiesterase inhibitor milrinone and calcium
sensitizing agent levosimendan, are two such drugs [100, 147, 148]. Further studies
are required to investigate the effects of these agents on RV function in infants with
PHT.
Limitations of this study
Firstly, considering inter-group differences; the control group was older in postnatal
age (but not gestational age or corrected gestational age) than the PHT group. This
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age difference may have contributed to observed differences in RV velocities, as RV
function is known to change in the first weeks of life [67], It is also unclear what
contribution, if any, the female preponderance in the control group may have made to
the observed results. Additionally, the PHT group was a heterogenous group of
infants with a variety of diagnoses. Only CDH infants were present in large enough
numbers to allow sub-group analysis ofmyocardial velocities, and it is not known
whether the same findings would be replicated in all other causes of PHT.
Secondly, the absence of long term outcome data, due to the limitations of study size
and duration, means that no investigation of the utility ofTDI velocities for outcome
prediction or risk stratification could be made. The investigation of links between
changes in TDI indices and outcome in infants with PHT is an important are for
future study.
Thirdly, no assessment of observer variability was made. Specifically, since all data
collection and analysis was performed by a single observer no assessment of inter-
observer variability could be made. Future investigation of both intra- and inter-
observer variability ofTDI techniques is important before these can be recommended
for clinical use in infants.
CONCLUSION
We have confirmed the feasibility of PWTDI in newborn infants and demonstrated
reduced systolic and diastolic RV myocardial velocities in pulmonary hypertension,
including in CDH. RV myocardial velocities were variable in PHT, likely indicating
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variable RV function. The load-dependency and observer variability of TDI
measures in infants requires further investigation, as do the utility of therapies which
target both inotropic and lusitropic function in infants with PHT and RV dysfunction.
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FIGURES




1VV, isovolumic contraction velocity; S, systolic ejection velocity; E'.early diastolic velocity; A', late
diastolic velocity
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Right image from normal infant; with E' and A' velocities clearly present.




Table 1: Demographic and therapeutic data
Control Group PHT Group p
n=28 n=15
Gestation (weeks) 37.0 (3.5) 38.4 (2.0) 0.24
Postnatal age (days) 25 (20) 18 (28) 0.01
Corrected age (weeks) 40.5 (2.3) 40.9 (3.6) 0.80
Weight (kg) 3.22 (0.67) 3.34 (0.70) 0.70
Male/female 20/8 8/8 -
Heart rate (bpm) 140 (14) 148 (15) 0.16
Ventilated 0 (0%) 14 (93%) -
Inotrope* 0 (0%) 7 (47%) -
Inhaled nitric oxide 0 (0%) 11 (73%) -
All demographic data mean (SD).
* Of those infants receiving inotropes: four infants on dopamine alone, one infant on dobutamine alone, one infant
on milrinone alone, and one infant on dopamine and dobutamine.












E wave velocity 0.52 (0.13) 0.14 (0.20) <0.0001 0.13 (0.19) <0.0001
A wave velocity 0.55 (0.11) 0.69 (0.22) 0.21 0.63 (0.18) 0.34
Systolic PWTDI data
RV IVV 6.6 (1.1) 5.2 (1.3) 0.001 5.2 (1.5) 0.007
RV S 9.2 (1.9) 6.6 (1.3) <0.0001 6.3 (1.3) 0.0001
Septal IVV 3.4 (0.5) 4.0 (1.1) 0.16 3.5(0.7) 0.94
Septal S 5.0 (0.7) 5.1 (1.4) 0.82 5.0 (1.5) 0.46
Diastolic PWTDI data
RV E" * -8.5 (2.0) -4.3 (2.3) 0.0001 -3.6 (1.8)) 0.0006
RV A' -10.1 (2.5) -11.4 (4.2) 0.34 -10.8 (4.3) 0.68
Septal E' wave* -5.4 (1.14) -3.7 (0.5) <0.0001 -3.6 (0.5) 0.0004
Septal A' wave -6.3 (1.3) -6.6 (2.9) 0.94 -6.4 (3.2) 0.561
All data mean (SD). All velocities are expressed as cm/sec.
* Data from those PHT infants in whom E' velocity could be identified. In remaining eight PHT infants
no identifiable E' velocity present.
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Appendix 3: Presentations of data at scientific meetings
• Relationship between right ventricular function and pulmonary artery pressure
in infants with pulmonary hypertension
Patel N, Mills J
Perinatal Medicine (British Association of Perinatal Medicine / Neonatal Society),
Harrogate, June 2008
• Tissue Doppler imaging demonstrates systolic and diastolic dysfunction in
infants with pulmonary hypertension
Patel N, Mills J, Cheung M
Presented to the World Congress of Perinatal Medicine, Florence, September 2007
• Assessment of right ventricular function in infants with pulmonary
hypertension
Patel N, Mills J, Cheung M
Presented to the Perinatal Society of Australia and New Zealand, April 2007
Winner ofYoung Investigator Award
